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Abstract 
In 2012, the first pharmacological HIV preventative agent, pre-exposure prophylaxis (PrEP) was 
approved in the U.S. for individuals at high-risk of contracting HIV.  Men who have sex with 
men (MSM) are at increased HIV risk, due to their engagement in anal intercourse (AI), which is 
the most common mode of HIV transmission and the riskiest type of sex.  Although evidence 
indicates that most PrEP paients are MSM, a paucity of evidence exists on MSM’s PrEP initation 
decision-making process.  The purpose of this study was to explore how HIV-negative MSM 
engaging in protected or unprotected AI decide to initiate PrEP based on the evaluation and 
perceptions pertaining to their:  (a) PrEP knowledge and HIV risk(s)/concern(s); (b) personal and 
social motivations to initiate PrEP; and (c) behavioral skills and abilities to adhere to PrEP.  
Guided by the Information-Motivation Behavioral (IMB) skills model, a six-item questionnaire 
was constructed and used to conduct one-on-one semi-structured interviews.  Fourteen MSM 
(71% African-American) living in the Southern U.S. consented to an interview between March 
and August of 2018.  Several themes emerged from the inductive content analysis, and these 
themes were categorized into five broader concepts:  (1) acknowledged HIV-risks, (2) HIV 
concerns, (3) PrEP understanding, (4) PrEP accessibility, and (5) PrEP consideration.  On further 
analysis, the data revealed the PrEP Initiation Decision-making (PID) model, a conceptualization 
of this sample’s non-linear thoughtful process of weighing and evaluating their perceptions and 
attitudes surrounding these five factors in deriving at their decision to initiate PrEP.  The findings 
give insight into the PrEP initiation decision-making process of an HIV-vulnerable population.  
Knowledge of patients’ rationale and decision-making process for initiating PrEP allows nursing 
professionals to provide in-depth PrEP patient education, ensuring that patients receive accurate 
and complete PrEP information including the (1) relationship between adherence and efficacy; 
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(2) utilization of traditional risk-reduction behaviors in conjunction with PrEP; and (3) the 
availability of financial assistance programs.  This study’s evidence is foundational, establishing 
a knowledge base for PrEP initiation inquiries in the MSM and other PrEP patient populations in 
the U.S.       
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Exploring Men who have sex with men’s HIV Pre-exposure Prophylaxis 
Initiation Decision-making Processes in the Southern United States 
Chapter 1:  Introduction 
The incidence of human immunodeficiency virus (HIV) in the United States (U.S.) 
disproportionately affects men who have sex with men (MSM).  MSM make up less than 3% of 
the U.S. population (Ward, Dahlhamer, Galinsky, & Joestl, 2014), but represent 56% of people 
living with HIV (PLWH) (Centers for Disease Control & Prevention [CDC], 2018a).  Despite a 
national HIV incidence decline of 19% between 2005 and 2014, MSM’s incidence rose by 6% 
during that same nine-year period (CDC, 2016c).  Additionally, fifty thousand new cases of HIV 
are reported annually in the U.S., and MSM continually account for majority of these cases.  In 
2016, MSM accounted for 82% and 67% of new HIV infections among men and nationally, 
respectively (CDC, 2018a).  MSM’s HIV incidence rate is 44 times higher than in men engaging 
in heterosexual intercourse or injection drug use (IDU) and 40 times higher than in women 
(CDC, 2016d).  If the incidence continues at the current rate, the CDC (2016c) estimates that 1 in 
6 MSM will contract the virus in their lifetime.   
HIV is the virus that causes acquired immune deficiency syndrome (AIDS), an incurable 
and potentially fatal disease.  AIDS' morbidity and mortality occurs when the virus proliferates 
in the body, attacking CD4 cells (Fan, Conner, & Villarreal, 2014).  CD4 cells are important 
white blood cells that fight infections; a depleted or low CD4 count damages the body's immune 
system, increasing one's risk of acquiring and dying from an AIDS induced opportunistic 
infection or complication (Fan et al., 2014).  Advances in HIV treatment through antiretroviral 
therapy (ART) reduces HIV/AIDS related morbidity and mortality, as it works to decrease the 
viral load, the amount of virus circulating in the body to a low or undetectable level (AIDS Info, 
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2017b).   A low or undetectable viral load is imperative for PLWH to live a long and optimal 
life.  ART increases life expectancy, as data show that between 2000 and 2007 the number of 
years lived post-ART for PLWH increased from 36.1 to 51.4 years (Samji et al., 2013).  Barring 
additional co-morbidities, PLWH diagnosed and treated early and consistently with ART have a 
life expectancy equivalent to those of the general population (Nakagawa, May, & Phillips, 2013; 
Romley et al., 2014; Samji et al., 2013).   
Unfortunately, not all PLWH achieve this optimal outcome, as in the absence of ART, 
HIV progresses to AIDS.  Data show that only 30% of PLWH have a low or undetectable viral 
load count (Center for AIDS Information and Advocacy [CFA], 2015; CDC, 2016b, 2016f), and 
this statistic contributes to the HIV/AIDS related mortality apparent in the U.S.  AIDS still 
claims the lives of 13,000 people each year in the U.S. (CDC, 2016c; Fan et al., 2014).  Similar 
to the HIV incidence, no other group is affected more by AIDS than MSM.  MSM accounted for 
54% of AIDS diagnoses in 2014 (CDC, 2016c), and since the start of the epidemic, MSM have 
accounted for more than 360,000 (CDC, 2017b) of the 675,000 AIDS deaths (CDC, 2016f).  HIV 
prevention is the key to decreasing AIDS deaths, and the current and predicted HIV incidence in 
the MSM population (CDC, 2016c; Fan et al., 2014). 
The MSM population experiences significant HIV burden and vulnerability.  MSM’s 
sexual behaviors are the primary catalyst driving their HIV incidence disparity.  MSM are men 
who engage in anal intercourse (AI), protected or not, with other men, and most MSM report 
engaging in protected and unprotected AI (UAI) (Meng et al., 2015).  Although MSM are also at 
HIV risk when engaging in oral sex with men and women, vaginal/AI with women, and IDU, AI 
is the greatest risk factor for contracting and transmitting the disease.  Overall, AI in MSM is the 
most common mode of HIV transmission, as IDU accounts for the smallest percentage of new 
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and existing HIV cases (CDC, 2016d).  Additionally, AI is the riskiest type of sex, as HIV risk 
with AI is 18 times higher than vaginal intercourse (CFA, 2014; Pebody, 2010).  HIV risk is 
significantly higher because rectal tissue is fragile and thin that easily tears during AI, which 
allows viral transmission through rectal tissue and penile openings, scratches, or sores (CDC, 
2016a).  Although both partners are at high HIV risk, the receptive partner has an HIV risk 6.2 
times higher than the insertive partner (Meng et al., 2015).  Therefore, accurate and consistent 
condom use is the best defense to prevent new HIV infections (CDC, 2015c, 2016c).  During AI, 
male condom use significantly decreases HIV risk by 63% for the insertive partner, and 72% for 
the receptive partner (CDC, 2015c).  Unfortunately, MSM's condom use adherence is an ongoing 
challenge; a secondary analysis utilizing data from two previously conducted prospective studies 
sampling HIV-negative MSM concluded that only 16% of MSM report consistent condom use 
with each sexual encounter (Smith, Herbst, Zhang, & Rose, 2015).   
MSM HIV prevention efforts have focused on interventions promoting individual 
behavioral changes in both HIV positive and negative persons (CDC, 2015a).  Using peers or 
health professionals in virtual or in-person settings, individual interventions provide counseling 
and information about utilization of HIV risk-reduction behaviors through problem solving and 
skill building (CDC, 2015a, 2017a).  In addition to consistent condom-use, other risk-reduction 
behaviors include decreasing sexual partners, serosorting (having unprotected sex only with 
persons with the same HIV status), avoiding sex cognitively impaired, substance abuse 
treatment, and abstinence (Caceres et al., 2015; CFA, 2014; CDC, 2016c).  For the purposes of 
this paper, the investigator will refer to the aforementioned behaviors collectively as traditional 
HIV prevention behaviors.  A combination of traditional behaviors is recommended for optimal 
HIV protection (Caceres et al., 2015; CFA, 2014; CDC, 2016c).  Interventions targeting 
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individual behavior changes are best practices to increasing MSM’s and other individuals’ risk-
reduction behaviors (CDC, 2014a).  Despite these best practices, the MSM HIV incidence rate 
and epidemic are a public health concern.  As a result, HIV scientists and researchers developed 
a new preventative modality (CDC, 2014b). 
HIV Pre-exposure Prophylaxis (PrEP) 
 In July 2012, the U.S. Food and Drug Administration (FDA) approved the first 
pharmacological HIV preventative regimen.  Pre-exposure prophylaxis (PrEP) is the fixed daily 
dose of Truvada (emtricitabine and tenofovir disoproxil fumarate) in HIV-negative persons 18 
years of age and older (CDC, 2014b), and in May 2018, the FDA approved PrEP for adolescents 
and persons under 18 years of age weighing at least 35kg or 77lbs (CDC, 2018b).  Truvada is a 
nucleoside reverse transcriptase inhibitor (NRTI), initially approved in 2004 for HIV ART; 
however, Truvada as PrEP is used for HIV prevention to reduce transmission risk (CDC, 2014b).  
Clinical trial data showed that in the event of an exposure, PrEP is efficacious, reducing the risk 
of HIV seroconversion by as much as 92% (CDC, 2014b), but it has limitations.  Adherence to 
the daily regimen is necessary to achieve optimal efficacy (CDC, 2014b; Koenig, Lyles, & 
Smith, 2013).  Additionally, Truvada does not provide invincibility to HIV transmission; 
therefore, PrEP is a complementary regimen, recommended to be used in conjunction with other 
traditional HIV risk-reduction behaviors, especially consistent condom use (CDC, 2014b).   
PrEP is clinically indicated for HIV-negative persons with reported and documented high 
HIV-acquisition risks (CDC, 2014b).  Due to MSM’s HIV incidence and vulnerabilities, MSM is 
a population with PrEP clinical indications.  Specifically, PrEP is appropriate for MSM when 
their sexual history confirms:  (a) one or more bacterial sexually-transmitted infections (STIs) in 
the past six months, (b) multiple sex partners, (c) inconsistent or no condom use with vaginal or 
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anal sex, (d) work as a commercial sex worker, (e) involved in a serodiscordant relationship, or 
(f) frequent non-occupational post-exposure prophylaxis (nPEP) treatment (receiving ART after 
a suspected or known sexually related exposure to HIV) (CDC, 2014b).   
PrEP initiation has remained slow nationally (Mayer et al., 2015; Siemieniuk et al., 
2015).  Utilizing a representative U.S. sample, the CDC (2015d) determined that 25% of MSM 
have PrEP indications.  Gilead®, the pharmaceutical maker of PrEP, surveyed U.S. retail 
pharmacies about the number of patients that filled a PrEP prescription for the first time during 
2012 to 2015 and found that most patients initiating PrEP to be male (76%) and White (74%) 
(National AIDS Manual [NAM], 2018).  Additional data indicate that most current and former 
PrEP patients are MSM (Krakower et al., 2015; Rooney, 2013; Tellalian, Maznavi, Bredeek, & 
Hardy, 2013), but that only accounts for a small percentage of this HIV-vulnerable population.  
Data show that approximately 3% of the MSM population are, or have initiated PrEP (Krakower 
et al., 2015; Krakower & Mayer, 2015; Tellalian et al., 2013).  These descriptive statistics 
regarding PrEP patients confirm that despite PrEP’s indications and efficaciousness, initiating 
the complementary regimen is an individual choice and decision. 
Problem and Purpose Statement  
PrEP initiation decision-making processes are unknown in MSM or any population.  
Decision-making details what and how individuals consider and evaluate the different factors 
surrounding a choice or option (Poortaghi et al., 2015; Popejoy, 2005).  The purpose of the study 
is to apply qualitative methods to explore PrEP initiation decision-making processes of HIV-
negative MSM engaging in protected or unprotected AI.  Qualitative research is necessary when 
the study’s purpose is to understand the meaning of a human experience in the terms and 
perspectives from the people experiencing the phenomenon (Creswell, 2013; Lo-Biondo & 
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Haber, 2014).  Congruent with qualitative research, this study explores the factors and process 
that influence this population’s decision to initiate PrEP based on what they know and perceive 
about PrEP and their HIV risk(s)/concern(s). 
Background 
Despite FDA approval of Truvada as PrEP in 2012, a paucity of literature exists about 
MSM's PrEP initiation decision-making process.  Most research on MSM and PrEP pertain to 
gauging their interest in initiating this complementary regimen.  The literature documents 
MSM’s interest in initiating PrEP to arise for different reasons.  MSM perceive PrEP to be a 
form of proactive prevention (Oldenburg et al., 2016), which is more effective than reactive 
prevention (i.e., nPEP treatment) (CDC, 2014b; Siemieniuk et al., 2015).  Research show that 
MSM believe PrEP is empowering, as it provides added HIV protection (Brooks et al., 2012; 
Collins McMahan, & Stekler, 2016; Taylor et al., 2014).  Pertaining to MSM's PrEP initiation 
decision-making, limited data exist.  Inquiries about MSM’s PrEP initiation either are few in 
numbers or conducted in the hypothetical context of PrEP (Hoff et al., 2015; Koblin et al., 2011).  
Currently in the literature, two publications explore some aspect of MSM's PrEP initiation from 
actual patients; however, these studies only confirm that MSM initiate PrEP to prevent 
contracting HIV (Garcia & Harris, 2017; Parker et al., 2015), as the processes determining how 
MSM came to the decision is not known.  Given MSM’s HIV prevention challenges and PrEP's 
efficacy, knowledge of MSM's PrEP initiation decision-making processes is necessary to 
understand this population’s most important and valued factors motivating and determining their 
initiation of this new and effective HIV preventative regimen.   
Decision-making to initiate other HIV preventative regimens have been studied in the 
MSM population, especially condom use.  Consistent condom-use is the best defense to HIV 
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prevention regarding AI (CDC, 2015c, 2016c), and MSM’s decision-making processes to utilize 
condoms has been extensively researched and discovered to be a complex entity.  HIV concern, 
psychosocial issues, and relationship dynamics all are factors in their decisional process to use or 
not use condoms (Balan et al., 2013; Bauermeister, Carballo-Dieguez, Ventuneac, & Dolezal, 
2009; Calabrese, Reisen, Zea, Poppen, & Bianchi, 2012; Campbell et al., 2014; Eaton, 
Kalichman, O’Connell, & Karchner, 2009; Goldenberg, Finneran, Andes, & Stephenson, 2015; 
Greene, Andrews, Kuper, & Mustanski, 2014; Herrmann, Johnson, & Johnson, 2015; Neville & 
Adams, 2009; Neville, Adams, Moorley, & Jackson, 2016).  Like condom use, PrEP initiation is 
a preventative behavior, but findings regarding MSM's condom-use decision-making cannot be 
automatically generalized to PrEP initiation decision-making.   
PrEP shares similarities with condom use.  Both PrEP and condom-use significantly 
reduce HIV risk, up to 92% and 72%, respectively, and are personal choices.  Additionally, for 
optimal risk-reduction, both are recommended to be used together and in combination with other 
traditional HIV prevention practices (Caceres et al., 2015; CFA, 2014; CDC, 2016c, 2014b).  
Despite these similarities, several variances exist, as accessibility, pharmacotherapeutic risks, 
drug-resistance, and clinical indications make PrEP significantly different from condom use.   
PrEP is not readily accessible in comparison to condoms.  Truvada’s monthly cost ranges 
from $1300 to $1425 U.S. dollars (USDs), with an estimated annual cost of at least $10,000 to 
$17,000 USDs (Hellinger, 2013; Horberg & Raymond, 2013; Krakower & Mayer, 2015; 
McMahon et al., 2014; Petroll, Staden, & Westergaard, 2016).  Given FDA approval, most third 
party payers should cover PrEP, and many state Medicaid formularies declare that it will be 
covered (Krakower & Mayer, 2015).  Data also show that private insurances are covering some 
portion of the cost, but actual insurance coverage percentages and out-of-pocket patient expenses 
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are presently unknown (McMahon et al., 2014; Rooney, 2013).  Due to PrEP’s exorbitant cost, 
patients may receive assistance from Gilead®.  Gilead® provides a medication assistance 
program for qualifying persons with a low socioeconomic status (SES) and inadequate insurance 
coverage (Horberg & Raymond, 2013; McMahon et al., 2014; Rooney, 2013).  Condoms, 
however, are cheap (Terris-Prestholt & Windmeijer, 2016), costing $6 to $12 USDs for a box of 
three to twelve condoms, respectively (Planned Parenthood, 2017).  Due to low cost, condom 
distribution programs (CDPs) in the U.S. are able to provide condoms free of charge to the 
public (CDC, 2015b), which is not an option for PrEP.   
Compounding PrEP access is the fact that the approved drug, Truvada, is a prescription 
medication.  Consequently, initiating PrEP requires one to access a prescribing provider and to 
submit to follow-up care at least quarterly (CDC, 2014b); however, there are a limited number of 
PrEP providers.  Studies report that less than 20% of sampled providers in the U.S. have ever 
prescribed PrEP (Krakower et al., 2015; Tellalian et al., 2013), and 30% of providers who have 
never prescribed PrEP believe they are unlikely do so in the future (Krakower et al., 2015).  
Access to a prescribing provider is not apparent with condoms, as they are conveniently 
available in stores throughout the U.S., detached from any required follow-up care.   
Like many medications, Truvada poses pharmacotherapeutic risks.  Although typically 
resolved within the first two weeks of initiation, nausea, headache, and abdominal pain are 
common side effects of Truvada (CDC, 2014b); however, long-term risks are associated with 
PrEP.  Over a period of taking Truvada, patients can develop nephrotoxicity and bone mineral 
density loss (CDC, 2014b).  These pharmacotherapeutic risks have been reported as reasons that 
providers are resistant to prescribing PrEP (Blackstock et al., 2016; Hakre et al., 2014; Krakower 
et al., 2015; Krakower, Ware, Mitty, Maloney, & Mayer, 2014; Tellalian et al., 2013).  
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Additionally, there is a chance Truvada can cause other unknown side effects, adverse effects, or 
decrease in efficacy.  Another pharmacological aspect to Truvada is the onset of effectiveness.  
For optimal efficacy, Truvada must be taken daily, but its effectiveness is not immediate (CDC, 
2014b).  At present, no data exists regarding when HIV protection is achieved in penile tissues, 
but evidence shows Truvada reaches an optimal HIV prevention level in blood and rectal tissue 
approximately after seven days of consistent use (CDC, 2014b).  Adherence remains the caveat, 
as continued adherence to the daily regimen is necessary to maintain effectiveness (CDC, 
2014b).  Condoms do not present patients with pharmacotherapeutic risks, and with proper use, 
condoms are instantly effective, and only need to be used during sexual encounters.  
For PrEP patients who seroconvert, development of Truvada-associated drug resistance is 
also a possibility (CDC, 2014b; Grant & Liegler, 2015; McCormack et al., 2016).  Truvada-
associated drug resistance develops because an individual continues to use the drug after 
becoming infected (acquired drug resistance, ADR) (Dimitrov et al., 2016).  Although Truvada is 
approved for treating HIV, Truvada, an NRTI alone is not an appropriate HIV treatment regimen 
(AIDS Info, 2017b).  Generally, treatment naive PLWH’s first regimen includes two NRTIs in 
conjunction with an integrase strand transfer inhibitor (INSTI), an non-nucleoside reverse 
transcriptase inhibitor (NNRTI), or a protease inhibitor (PI) with Tybost or Norvir to increase the 
PI's effectiveness (AIDS Info, 2017b).  After contracting HIV, the virus replicates rapidly; viral 
replications that develop while taking an inadequate HIV regimen cause the virus to mutate into 
a resistant strain resulting in therapy ineffectiveness and treatment failure (AIDS Info, 2017a).  
Although PrEP clinical trial data show the development of overall ADR to be low (37 out of 117 
seroconverters in the investigational groups developed resistance in six different clinical trials) 
(CDC, 2014c; Gupta et al., 2013), more research is necessary to assess the relationship between 
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PrEP seroconversion and ADR (Dimitrov et al., 2016; Grant & Liegler, 2015; Gupta et al., 
2013).  The implications of PrEP-ADR is another barrier and reason preventing providers from 
implementing and offering PrEP in their practices (Blackstock et al., 2016; Hakre et al., 2014; 
Krakower et al., 2015; Krakower et al., 2014; Tellalian et al., 2013), and condoms do not present 
ADR concerns or threats. 
Lastly, depending on one’s HIV risk factors, PrEP may not always be clinically indicated.  
PrEP is recommended for those at increased risk for contracting HIV (CDC, 2014b).  An 
individual’s personal behaviors and circumstances can change, making PrEP not always 
necessary, whereas, condoms and other traditional behaviors are always appropriate for reducing 
HIV transmissions.  Given the differences between PrEP and condom use, an inquiry regarding 
MSM’s decision-making to initiate this new and unique HIV preventative regimen is appropriate 
and necessary.   
Research Question 
Based on the knowledge gap and study purpose, the investigator proposes the following 
research question:  How do HIV-negative MSM, engaging in protected or unprotected AI, decide 
to initiate PrEP?  The study objective is to explore how HIV-negative MSM decide to initiate 
PrEP based on the evaluation and perceptions pertaining to their:  (a) PrEP knowledge and HIV 
risk(s)/concern(s); (b) personal and social motivations to initiate PrEP; and (c) behavioral skills 
and abilities to adhere to PrEP.      
Theoretical Framework  
A theory is a set of empirically defined assumptions, concepts, perceptions, and 
predictions that explain phenomena logically in a particular context or setting (McEwen, 2014).  
This study explores the PrEP initiation decision-making processes in HIV-negative MSM, and an 
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appropriate theoretical framework captures decision-making’s dynamic process in the context of 
HIV prevention.   
The investigator reviewed HIV/AIDS prevention behavioral literature, and found the 
Health Belief Model (HBM) and Theory of Planned Behavior (TPB) to be commonly used.  
These theories have historically guided inquiries including partner condom-use discussions, HIV 
testing, pregnancy prevention (Li, Lei, Weng, He, & Williams, 2016; Montanaro & Byran, 2014; 
Schnall, Rojas, & Travers, 2015); PLWH’s medication adherence (Jones, Smith, & Llewellyn, 
2014); STI testing and treatment adherence; receipt of HIV results; and condom and drug use 
(Gredig, Nideroest, & Parpan-Blaser, 2006; Mausbach, Semple, Strathdee, & Patterson, 2009; 
Montanaro & Byran, 2014; Prabawanti, Dijkstra, Riono, & Hartana, 2015; Prati, Mazzoni, & 
Zani, 2014; Thomas, Shiels, & Gabbay, 2014; Thompson-Leduc, Clayman, Turcotte, & Legare, 
2014; Tyson, Covey, & Rosenthal, 2014). 
The HBM and TPB both explain and represent some aspect regarding health behavioral 
decision-making; however, these models do not fit this inquiry’s clinical context.  Developed in 
the 1950s and 1960s by social psychologists Hochbaum, Rosenstock, and Kegels, the HBM is a 
cognitive model to explain and predict the likelihood or intention of performing health behaviors 
(Jones et al., 2014; Li et al., 2016; Montanaro & Byran, 2014; Schnall et al., 2015).  In this study, 
intention to initiate PrEP is not the investigated phenomenon, as participants have already 
initiated PrEP, therefore, deeming the HBM’s to be inappropriate to guide this study.  The TPB 
originated from the psychology discipline by Ajzen to predict heath behaviors based upon one’s 
personal perceptions (Ajzen, 2002, 2011; Madden, Ellen, & Ajzen, 1992).  The TPB is not a 
befitting theory for this investigation, because it conceptualizes decision-making to be based on 
the personal perceptions about the behavior alone, but this inquiry’s context includes PrEP 
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initiation based upon multiple factors:  (a) PrEP knowledge and HIV concern(s)/risk(s); (b) 
personal and social motivations to initiate PrEP; and (c) behavioral skills and abilities to adhere 
to PrEP.  Since neither model represents the clinical context of the proposed study, the 
investigator chose a different framework that better attests to this study’s context.   
The Information-Motivation-Behavioral (IMB) skills model is the theoretical framework 
guiding this exploration into MSM’s PrEP initiation decision-making processes.  The IMB skills 
model is rooted in and specific to AIDS preventative and treatment behaviors (Aliabadi et al., 
2015; Chang, Choi, Kim, & Song, 2014; Fisher & Fisher 1992; L. Smith, Fisher, Cunningham, & 
Amico, 2012).  Originating from the psychology discipline, Fisher and Fisher (1992) conducted a 
comprehensive review of AIDS-related risk-reduction literature.  From their empirical synthesis 
and analysis, they constructed the IMB skills model (see Figure 1) to explain one’s process for 
initiating AIDS risk-reduction behaviors (Aliabadi et al., 2015; Chang et al., 2014; Fisher & 
Fisher 1992; L. Smith et al., 2012; Traube, Holloway, & Smith, 2011).  For clarity, the 
investigator refers to the model’s purpose to explain the phenomenon of an individual initiating 
HIV risk-reduction behaviors, as HIV is the virus that causes AIDS, and HIV prevention is 
necessary to reduce HIV/AIDS incidence (CDC, 2016c; Fan et al., 2014). 
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The IMB skills model conceptualizes the decision to initiate HIV risk-reduction 
behaviors as involving one’s information, motivation, and skills (Aliabadi et al., 2015; Amico, 
Toro-Alfonso, & Fisher, 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; 
Macapagal, Greene, Andrews, & Mustanski, 2016; L. Smith et al., 2012).  Information is the 
initial prerequisite to health behavior, as it is the knowledge, myths, and means known to reduce 
the risk of contracting HIV (Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang 
et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016).  Motivation encompasses two types, 
personal and social.  Personal motivations are one’s attitudes, beliefs, and perceptions regarding 
the outcomes from performing or not performing HIV prevention behaviors (Aliabadi et al., 
2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; 
Macapagal et al., 2016).  Social motivations are the perceived social support and acceptance 
from peers and significant others in performing the specific behavior (Aliabadi et al., 2015; 
Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et 
al., 2016).  Behavioral skills are the abilities needed to perform that behavior, and are a reflection 
of one’s knowledge and motivation (Chang et al., 2014; Traube et al., 2011).  Engagement in a 
behavior requires one to possess and utilize certain skills to achieve and perform the behavior 
(Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & 
Fisher, 1992; Macapagal et al., 2016).  In regards to MSM HIV prevention, those skills include 
having condoms readily available and accessible, using condoms accurately and consistently, 
reducing sexual partners, and avoiding sex while cognitively impaired (Herbst et al., 2007; 
Motley, Hammond, & Mustanski, 2017; Sullivan et al., 2012).  While the model’s three concepts 
individually influence HIV prevention behaviors, the combination of all three concepts shows 
the decision-making process for initiating HIV preventative behaviors (Aliabadi et al., 2015; L. 
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Smith et al., 2012).  The information and motivation one has regarding HIV risk-reduction 
behaviors directly influence their skills and abilities to perform and adhere to the behavior 
(Fisher & Fisher, 1992).  In this model, however, information and motivation are unique 
constructs, meaning that these concepts do not directly influence the other (Chang et al., 2014; 
Fisher & Fisher, 1992).  A highly motivated person can lack adequate knowledge, while a well-
informed person can have little to no motivation (Traube et al., 2011).   
As a whole, the three concepts influence initiation of HIV prevention behaviors, but the 
concepts are context and value-dependent (Aliabadi et al., 2015; Chang et al., 2014; Fisher & 
Fisher, 1992; L. Smith et al., 2012).  Under this framework, an individual’s culture, values and 
beliefs, social standing, SES, environment, and life circumstances determines their 
understanding, motivation, and abilities regarding their decision-making to utilize HIV 
preventative behaviors (Aliabadi et al., 2015; L. Smith et al., 2012; Traube et al., 2011). 
Therefore, Fisher and Fisher (1992) recommend conducting HIV prevention research among a 
subsample of a population in order to prevent making overzealous generalizations (Aliabadi et 
al., 2015).  Additionally, Aliabadi et al. (2015) stated that a qualitative approach is appropriate 
with the IMB skills model so information can be elicited using dialogue and open-ended 
questions. 
Although not as commonly used in HIV research as the HBM and TPB, investigators 
have applied the IMB skills model to investigate different behaviors related to HIV prevention.  
These investigated HIV behaviors include risky sexual behaviors in HIV positive and negative 
persons (Chang et al., 2014; Macapagal et al., 2016), PLWH medication adherence (Aliabadi et 
al., 2015; Chang et al., 2014; Horvath, Smolenski, & Amico, 2014; Rongkavilit et al., 2010), and 
intervention development and testing (Chang et al., 2014).  The IMB skills model has also been 
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applied in exploring health-related behavioral initiation in other diseases and diagnoses:  
coronary artery disease (Zarnai, Besharat, Sarami, & Sadeghian, 2012), Type 2 diabetes mellitus 
(Gavgani, Poursharifi, & Aliasgarzadeh, 2010; Meunier et al., 2016; Osborn et al. 2010), and 
cervical or endometrial cancers (Jefferies, Robinson, Craighead, & Keats, 2006).  As the newest 
and first pharmacological HIV prevention intervention, PrEP, inquiries into initiating this 
regimen can be conducted utilizing this framework.   
The proposed study explores MSM's decision-making processes to initiate PrEP based on 
their (a) PrEP knowledge and HIV concern(s)/risk(s); (b) personal and social motivations to 
initiate PrEP; and (c) behavioral skills and abilities to PrEP adherence.  This investigator 
believes the IMB skills model provides the most congruent context given the complexity 
surrounding HIV behavioral prevention initiation.  Figure 2 displays the theoretical construct 
specific to this study.   
 
Assumptions 
 Assumptions for this inquiry are based on the presumption that individuals institute 
prevention behaviors due to a health concern or scare (Poortaghi et al., 2015), and that qualitative 
research seeks to understand human experiences from participants’ personal experiences 
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(Creswell, 2013; Lo-Biondo & Haber, 2014).  Therefore, specific to this inquiry, the investigator 
assumes MSM PrEP patients:  (a) acknowledge they are at risk for HIV; (b) are concerned about 
contracting HIV; (c) do not want to contract HIV; (d) believe PrEP initiation decreases their HIV 
risk(s); (e) are the experts of this phenomenon; and (f) tell the truth as they see it.  The 
investigator also assumes health decision-making to be a personal and individualistic process of 
considering, weighing, and rationalizing the benefits and consequences perceived by initiating or 
not initiating health related behavior(s).       
Definition of Terms 
 Defining key terms is imperative to provide phenomenal clarity throughout the 
investigation. 
Health professionals are licensed nurses, physicians, and mid-level practitioners providing 
medical services and care to patients. 
HIV is the virus that causes AIDS, which is transmitted through blood, breast milk, semen, and 
vaginal fluids.  
MSM are men who engage in sex with other men.   
PrEP or Truvada as PrEP is the fixed daily oral-dose of Truvada in HIV-negative persons.  
PrEP initiation is the act of a person beginning to take PrEP.   
Decision-making process is the individual process of weighing different factors, as understood 
by the individual, surrounding that behavior or choice’s requirements, benefits, and outcomes, 
prior to one taking action or inaction regarding that particular behavior or choice (Poortaghi et 
al., 2015; Popejoy, 2005).  
Limitations 
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Limitations are weaknesses in a study, restricting the application and relevance of its 
findings in clinical practice (Colorafi & Evans, 2016; LoBiondo-Wood, 2014b; Neergaard, 
Olsesen, Andersen, & Sondergaard, 2009).  In this study, limitations relate to the proposed 
study’s research question, methodology, and implications.   
Inquiring about MSM's PrEP initiation decision-making process makes this investigation 
privy to respondent bias.  Respondent bias occurs when participants are less than honest, 
answering research questions according to social norms and acceptance; relevant research data 
depend on participants’ responses being authentic and truthful (Friis & Sellers, 2013).  Although 
PrEP is initiated in HIV-negative persons, HIV and PrEP are sensitive topics, as fears and 
concerns of stigmatization remain among patients seeking HIV care and prevention services 
(CDC, 2016b).  Given that PrEP is clinically indicated for those at high HIV risk, PrEP users 
have been labeled “Truvada whores”, and the negative stigma prevents patients from seeking and 
initiating PrEP (Auerbach, Kinsky, Brown, & Charles, 2015; Calabrese & Underhill, 2015; 
Collins et al., 2016; Dolezal et al., 2015; Haire, 2015).  Likewise, the negative stigma might 
deter participants from being honest about their PrEP initiation decision-making process.  
Patients are shown to have reservations when discussing sexual health matters with health 
professionals.  Suspicions and experiences of medical judgment and mistrust prevent patients 
from discussing their sexual behaviors (Auerbach et al., 2015; Collins et al., 2016; Eaton et al., 
2014; Garcia & Harris, 2017; Perez-Figueroa, Kapadia, Barton, Eddy, & Halkitis, 2015; Taylor 
et al., 2014).  These reservations can extend into this study, as participants may not be as open 
and honest with discussing their HIV risks and concerns, or motivations for initiating PrEP.  
Gender differences can also influence respondent bias, as participants may not be as forthcoming 
and honest in their responses with a female interviewer. 
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Utilizing a qualitative methodology causes this study to be limited by interviewer bias 
(Sullivan-Bolyai & Bova, 2014).  Interviewer bias, implicit or explicit, occurs when the 
interviewer leads the participant to answer in a certain manner (Sullivan-Bolyai & Bova, 2014), 
distorting the emic view.  The emic view is the actual view and perspective of the person 
experiencing the phenomenon (Streubert, 2014).  The researcher’s professional experience with 
HIV and PrEP patients can cause the investigator, intentionally or not, to lead participants’ 
responses during interviews.  While the investigator is experienced in clinical research, she is a 
novice investigator, inexperience in conducting and analyzing qualitative research.  During data 
collection and analysis, inexperience and interviewer bias makes this process at risk to 
misinterpretations, threatening the authenticity of study findings.   
Study implications are also limited in this study, as these findings are not transferable to 
the larger MSM PrEP population.  Usually, a rigorous study is transferable to the larger 
population of the study sample (Colorafi & Evans, 2016; Creswell, 2013; LoBiondo-Wood, 
2014b; Neergaard et al., 2009); however, those studies are generally replications of previous or 
similar studies (Houghton, Casey, Shaw, & Murphy, 2013).  Prior to this investigation, there are 
no publications exploring MSM’s PrEP initiation decision-making processes.  Given the lack of 
knowledge on MSM’s PrEP initiation decision-making processes, it is premature to assert that 
these initial findings are applicable to other MSM PrEP patients.  Additionally, qualitative 
research is based on a philosophical foundation that “reality is socially constructed and context 
dependent” (Toles & Barroso, 2014b, p. 96).  Therefore, these findings are transferable to this 
sample, and possibly to MSM of similar social demographics who are accessing PrEP.  Future 
replicated studies are needed before making generalizations regarding MSM’s PrEP initiation 
decision-making in the U.S. 
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Significance to Healthcare & Nursing  
Health behavior decision-making has been studied in numerous specialties and areas:  
exercise (Lee, Chiang, Hwang, Chi, & Lin, 2016), hormone replacement therapy (Carpenter, 
Studts, & Bryne, 2011), medication adherence (McGrady, Brown, & Pai, 2016), healthy eating 
(Haws, Reczek, & Sample, 2017), smoking cessation (Hoie, Moan, Rise, & Larsen, 2012), self-
care (Karimi & Clark, 2016), and sexual behaviors (Scott-Sheldon et al., 2016).  The consensus 
is that decision-making is an individualistic process where the decision-maker weighs different 
factors, as they understand them, surrounding that choice’s requirements, benefits, and outcomes 
(Poortaghi et al., 2015; Popejoy, 2005).  Exploring MSM's PrEP initiation decision-making 
processes informs health professionals of MSM’s (a) knowledge and values about PrEP, (b) HIV 
risks and concerns; and (c) perceptions and abilities surrounding PrEP initiation and adherence.   
Knowledge from this study has cost saving implications for the U.S. health-care system.  
HIV care and treatment costs the health-care system an estimated $12.3 billion annually (CDC, 
2015a).  Each prevented HIV infection saves an estimated $355,000 in lifetime HIV treatment 
costs (CDC, 2015a).  Experts estimate that PrEP initiation in at-risk groups can reduce HIV 
incidence by 70%, preventing 185,000 U.S. infections by 2020 (CDC, 2016e), but the capacity to 
achieve the projected decline depends on PrEP indicated persons deciding to initiate the 
complementary regimen.  Although this study will not lead to an increase in PrEP initiation, the 
findings are informative, providing context and information surrounding MSM's PrEP initiation 
in the U.S.  MSM is the population most affected and vulnerable to HIV, and given the poor 
PrEP initiation in this population (Krakower et al., 2015; Krakower & Mayer, 2015; Tellalian et 
al., 2013), knowledge of HIV-negative MSM’s PrEP initiation decision-making processes is a 
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step to gauge if the complementary regimen can have the estimated impact to change the 
narrative surrounding the current U.S. HIV epidemic and MSM disparity. 
Knowledge of MSM’s PrEP initiation decision-making processes implicates the nursing 
profession.  Nurses advocate, support, and educate patients on health-promoting options to help 
patients achieve the best outcomes they perceive for themselves (Kemppainen, Tossavainen, & 
Turunen, 2012; Kim, 2015).  The findings inform nurses of how MSM process and rationalize 
these factors when deciding to initiate PrEP.  With greater understanding of the knowledge and 
factors influencing and determining PrEP initiation decision-making, nurses are able to identify 
opportunities to assist patients in resolving occurrences of internal and external conflict, 
misunderstanding, or other concerns regarding HIV and PrEP. 
Empirical evidence of MSM’s PrEP decision-making processes informs nurses of 
possible content to include when providing PrEP patient education to MSM.  This study’s 
findings educate nurses on ways to counsel and support MSM considering PrEP.  A greater 
feeling of support and advocacy increases health behavioral adherence (Popejoy, 2005; Thom et 
al., 2016), and optimal and accurate PrEP initiation among willing and HIV at-risk persons is the 
most effective way for PrEP initiation to have the projected impact on the HIV epidemic (CDC, 
2016e).   
Findings from this study are foundational, extending the current knowledge base 
encompassing MSM's PrEP initiation decision-making.  Additionally, findings from this study 
build on previous evidence pertaining to health behavioral decision-making, HIV prevention, and 
PrEP and MSM decision-making.  PrEP initiation is a new phenomenon, and this study’s 
findings establish a knowledge base for conducting future inquiries into PrEP initiation.  
Qualitative explorations such as this inquiry are indicated and useful in contributing to the 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 33 
 
development of evidenced-based instruments and tools (Toles & Barroso, 2014b).  Evidenced-
based practice is applying and instituting clinical standards and interventions based on empirical 
evidence (Lo-Biondo & Haber, 2014).  Specific to MSM's PrEP initiation decision-making, 
decision aids and decisional coaching are possible interventions, which can be developed from 
inquiries such as this.  Decision aids assist nurses to counsel and coach patients when debating 
between different options (Stacey et al., 2008), as it is a complementary, pamphlet, form, web 
page, or video “that helps patients make decisions by (a) providing information about the 
available options and outcomes and (b) clarifying their personal values” (Eggertson, 2010, p. 
39).  Decision coaching is another avenue in which nurses educate and support patients in 
choosing the best health-care plan and intervention (Stacey et al., 2008; Thom et al., 2016).  For 
accuracy and relevancy, best practices recommend the targeted population to be involved in the 
development of population-specific interventions (Dugas et al., 2017).  Therefore, this study 
contributes to future development and testing of MSM PrEP initiation decision tools and 
interventions, which can lead to devising and implementing evidenced based resources and 
strategies for achieving PrEP initiation success. 
Summary 
The MSM HIV epidemic continues to thrive in the U.S., as MSM account for majority of 
current and past HIV/AIDS diagnoses.  MSM’s HIV incidence rate is 44 times higher than in 
other men and 40 times higher than in women (CDC, 2016d).  At this rate, the CDC (2016c) 
estimates that 1 in 6 MSM will contract the virus in their lifetime.  AI is MSM’s greatest risk 
factor for contracting and transmitting HIV, as it is the overall most common mode of HIV 
transmission (CDC, 2016d), and the riskiest type of sex (CFA, 2014; Pebody, 2010).  HIV 
prevention is the key to decreasing MSM’s current and predicted HIV incidence in the U.S. 
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(CDC, 2016c; Fan et al., 2014).  Although HIV prevention behavioral interventions provide best 
practices to increasing MSM’s implementation of HIV risk-reduction behaviors (CDC, 2015a, 
2017a), the HIV incidence shows that prevention challenges persist.  Therefore, a new HIV 
prevention modality, PrEP, was introduced as the first pharmacological agent.   
PrEP is the fixed daily dose of Truvada in HIV-negative persons with reported and 
documented high HIV-acquisition risk (CDC, 2014b).  Clinical trial data showed that in the 
event of an exposure, PrEP reduces HIV seroconversion by as much as 92%; however, adherence 
to the daily regimen is necessary to achieve optimal efficacy (CDC, 2014b; Koenig et al., 2013).  
Although efficacious, PrEP does not provide 100% HIV protection and is complementary, 
recommended to be used in conjunction with other traditional HIV risk-reduction behaviors, 
especially consistent condom usage (CDC, 2014b).  Despite PrEP’s indications and 
efficaciousness, initiating PrEP is an individual choice and decision.  Most current and former 
PrEP patients are MSM (Krakower et al., 2015; Krakower & Mayer, 2015; Tellalian et al., 
2013), but currently there is no research exploring PrEP initiation decision-making processes in 
MSM or any population. 
This study's purpose is to explore PrEP initiation decision-making processes of HIV-
negative MSM engaging in protected or unprotected AI.  Decision-making details what and how 
individuals consider and evaluate the different factors surrounding a choice or option (Poortaghi 
et al., 2015; Popejoy, 2005).  The study objective is to explore how HIV-negative MSM decide 
to initiate PrEP based on the evaluation and perceptions pertaining to their:  (a) PrEP knowledge 
and HIV concern(s)/risk(s); (b) personal and social motivations to initiate PrEP; and (c) 
behavioral skills and abilities to adhere to PrEP.  The IMB skills model guides this inquiry, as it 
is consistent with this study’s objective and the conceptualization of health-behavioral and HIV 
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decision-making.  Under this framework, the decision to initiate HIV risk-reduction behaviors 
includes one’s knowledge, motivation, and skills regarding the preventative behavior (Aliabadi 
et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; 
Macapagal et al., 2016; L. Smith et al., 2012).        
Knowledge from this study implicates the health-care system and nursing profession.   
Although this study will not lead to increasing PrEP initiation in the U.S., the findings are 
informative.  Experts estimate that PrEP initiation in at-risk groups can reduce HIV incidence by 
70%, and prevent 185,000 U.S. infections by 2020 (CDC, 2016e).  Each prevented HIV infection 
saves an estimated $355,000 in lifetime HIV treatment (CDC, 2015a).  Knowledge from this 
study is a step to gauge if this complementary regimen can have the estimated impact on the HIV 
epidemic, and change the current MSM HIV disparity.  MSM's PrEP initiation decision-making 
process informs nursing practice of factors that influence PrEP decision-making and how MSM 
rationalize initiating PrEP based on their HIV and PrEP perceptions and understanding.  With 
this knowledge, nurses are able to identify opportunities to assist patients during the decision-
making process, clarifying HIV and PrEP misunderstandings and misconceptions.  Therefore, 
this study’s findings educate nurses on ways to counsel and support MSM considering PrEP.  
Additionally, this study contributes to the future development and testing of MSM PrEP 
initiation decision tools and interventions, which can lead to devising and implementing 
evidenced based strategies for achieving PrEP initiation success. 
 Despite the study’s implications, this study is still privy to limitations.  Inquiring about 
MSM's PrEP initiation decision-making process requires the investigator to ask about behaviors 
and perceptions related to HIV, sex, and PrEP.  PrEP users are negatively stigmatized as 
“Truvada whores” (Calabrese & Underhill, 2015; Haire, 2015), and some patients fear discussing 
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their sexual behaviors with health professionals (Auerbach et al., 2015; Collins et al., 2016; 
Eaton et al., 2014; Garcia & Harris, 2017; Perez-Figueroa et al., 2015; Taylor et al., 2014).  
These fears and concerns make this study at risk for respondent bias, as participants may be less 
than truthful with their responses (Friis & Sellers, 2013).  A qualitative methodology and the 
investigator’s professional background also make this study limited by interviewer bias, which 
can distort the emic view due to data collection errors or misinterpretation.  Lastly, as the first 
known investigation into MSM’s PrEP initiation decision-making processes, transferability is 
limited.  Rigorous studies are usually transferable to the study sample’s larger population 
(Colorafi & Evans, 2016; Creswell, 2013; LoBiondo-Wood, 2014b; Neergaard et al., 2009); 
however, these findings are only transferable to this sample, and possibly to MSM of similar 
social demographics and accessibility means to PrEP.  
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Chapter 2:  Literature Review 
In July 2012, pre-exposure prophylaxis (PrEP) was introduced as HIV prevention’s 
inaugural pharmacological agent for individuals at increased HIV risk.  As PrEP, HIV-negative 
patients take Truvada, an antiretroviral therapy (ART) drug, once a day to decrease HIV risk by 
as much as 92% (CDC, 2014b).  PrEP is complementary, as it is to be used in conjunction with 
other traditional HIV risk-reduction behaviors, and strict adherence is required to achieve 
optimal efficacy (CDC, 2014b).  Despite these limitations, the introduction of Truvada as PrEP 
has the potential to end the HIV epidemic in the U.S., as PrEP initiation in HIV at-risk 
populations is predicted to result in a 70% reduction in HIV incidence in the U.S. by 2020 (CDC, 
2016e).  Although HIV risk is significant in other populations, men who have sex with men 
(MSM) are most vulnerable, experiencing the highest HIV incidence and prevalence annually 
and historically.  MSM represent 56% of people living with HIV (PLWH), and account for more 
than half of the new cases each year in the U.S. (CDC, 2018a).  The MSM HIV epidemic is so 
alarming that CDC (2016c) estimates that 1 in 6 MSM will contract the virus in their lifetime if 
this rate continues, making PrEP initiation HIV-negative MSM significant to the U.S. MSM HIV 
epidemic.   
Research shows that MSM are interested in initiating PrEP (Brooks et al., 2012; Collins 
et al., 2016; Taylor et al., 2014), because they perceive it to be an empowering form of HIV 
proactive prevention (Oldenburg et al., 2016).  Although most current and former PrEP patients 
identify as MSM (Krakower et al., 2015; Rooney, 2013; Tellalian et al., 2013), approximately 
3% of the MSM population have ever initiated the complementary regimen (Krakower et al., 
2015; Krakower & Mayer, 2015; Tellalian et al., 2013).  At present, the literature lacks evidence 
of PrEP initiation decision-making processes in any population and this study attempts to address 
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this knowledge gap by exploring PrEP initiation decision-making processes in the most HIV-
vulnerable population, HIV-negative MSM.   
In order to understand this study’s implications, a literature review was conducted to 
establish the foundation for the proposed study.  A literature review functions as the knowledge 
base on a phenomenon by gathering and appraising current and relevant evidence (Fulton & 
Krainovich-Miller, 2014).  PrEP is an HIV preventative regimen, and this chapter provides the 
literary foundation for an inquiry into this exploration into MSM’s decision-making to initiate 
this regimen.  First, the investigator discusses recommendations and best practices for MSM 
behavioral HIV prevention.  Second, the significance health-behavioral decision-making 
research has in clinical practice are revealed.  Thirdly, the synthesis details the factors and 
processes involved in HIV-negative MSM’s condom-use decision-making.  Finally, the results of 
this literature review determines the current knowledge base on MSM and PrEP.  The chapter 
concludes with a summary validating the need for the proposed study based on the literature's 
current knowledge gap.  
HIV Prevention  
Since the beginning of the epidemic, HIV incidence shows that “HIV prevention is 
neither simple nor simplistic” (Coates, Richter, & Caceres, 2008, p. 669).  In the initial onset, 
HIV prevention was a challenge due to the lack of knowledge and understanding about HIV’s 
etiology and disease progression.  Over the past three decades, HIV science and research have 
discovered the virus’ transmission modes, therefore, allowing successful development of best 
practice prevention strategies.  Although the national HIV incidence has declined by 19% 
between 2005 and 2014, prevention challenges remain, as approximately fifty thousand new HIV 
cases are reported annually in the U.S. (CDC, 2016c).  Due to these continued challenges, HIV 
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prevention has expanded into a three-tiered approach:  behavioral interventions, routine testing, 
and treatment as prevention (TasP) (CDC, 2015a; Yagoda & Moore, 2016).   
Undiagnosed infections fuel the HIV epidemic, as these cases allow the virus to spread 
unknowingly (CDC, 2016b).  To eliminate missed opportunities for early diagnosis, the CDC 
(2006, 2012) currently recommends routine testing, which advises health professionals to 
conduct HIV testing on all patients 13-65 years of age during all health care encounters 
regardless of clinical indications or reported risks.  Patients meeting the age criteria with an HIV-
negative or unknown status should be offered an HIV test each and every time they present for 
any medical services, but patients maintain the right to decline, or “opt-out” of the service (CDC, 
2006, 2012).  Routine testing’s goal is to identify new and unknown cases sooner and more 
frequently by making it an aspect of routine care (CDC, 2012).  Once diagnosed, treatment naïve 
PLWH can be connected to care to begin ART.   
Connection to care or, TasP, involves PLWH receiving consistent and adequate ART.  
ART decreases the viral load in the body to a low or undetectable level, which decreases HIV 
transmission risk by at least 90% (CDC, 2016f; CFA, 2015; O’Byrne & MacPherson, 2016; 
Young & McDaid, 2014).  PLWH not on ART strains prevention, as the virus remains unstable 
in their body and readily transmissible.  Both routine testing and TasP play a significant role in 
HIV prevention; however, this study pertains to PrEP initiation, which is the newest option in 
HIV prevention behavioral interventions.   
MSM’s HIV Prevention Behavioral Best Practices 
Behavioral interventions encourage individuals to utilize risk-reduction behaviors by 
“ensuring people have the information, motivation, and skills necessary to reduce their risk” 
(CDC, 2015a, p. 1).  Although behavioral interventions are specifically devised for several at-
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risk populations, only those interventions targeting HIV-negative MSM are relevant to this 
literature review.  Anal intercourse (AI) is the most common mode of HIV transmission (CDC, 
2016d), the riskiest type of sex (CFA, 2014; Pebody, 2010), and the most common sexual 
behavior practiced by MSM (Meng et al., 2015).  Therefore, most MSM HIV prevention 
behavioral interventions target reducing HIV risk during AI.  Specific to AI for MSM, traditional 
risk-reduction behavioral interventions include abstaining, using condoms consistently, 
decreasing sexual partners, serosorting, avoiding sex cognitively impaired, and submitting to 
substance abuse treatment (CDC, 2017a).  A combination of these traditional behaviors is 
recommended for optimal HIV protection (Caceres et al., 2015; CFA, 2014), but the CDC 
(2016a) affirms that correct and consistent condom use is the best defense to prevent the spread 
of HIV during sexual encounters.  Protected AI reduces HIV risk by 63% for the insertive 
partner and 72% for the receptive partner (CDC, 2015c), and serosorting provides an estimated 
54% in risk reduction (CDC, 2015c).  Although no statistics are available, the logic behind 
decreasing sexual partners is that this action lessens one’s exposure to an individual with a 
known or unknown HIV positive status (CDC, 2017d).  Additionally, engaging in sexual acts 
while under the influence of drugs or alcohol decreases one’s inhibitions and cognitive ability to 
avoid risky sexual encounters and behaviors (CDC, 2017d).  Therefore, avoidance of sex while 
cognitively impaired and substance abuse treatment reduces opportunities for HIV risky 
encounters (CDC, 2017d).  Behavioral interventions’ provide HIV prevention education and 
support at individual, group, and community levels with the shared goal of increasing at-risk 
individual’s utilization of HIV preventative behaviors (CDC, 2014a, 2017a, 2017c); however, 
each level's intervention is distinct and implemented differently.   
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Specific to HIV prevention, individual interventions are strategies provided in an intimate 
setting on a one-on-one basis (CDC, 2014a, 2017a, 2017c), while group interventions are 
rendered amongst a group of homogenous persons (Herbst et al., 2007).  Both individual and 
group interventions' effectiveness are determined by individual participants’ responses to 
treatment (CDC, 2014a, 2017a, 2017c).  Although either of these intervention types can be 
provided in health care facilities/specialties or other group organizations, they are often 
conducted and administered at an HIV clinic or health care entity/institution (CDC, 2014a, 
2017a, 2017c).   
Unlike HIV prevention’s individual and group interventions, community interventions 
bring the intervention directly to the population (CDC, 2014a, 2017a, 2017c).  In this type of 
research, community is defined as a group of individuals sharing common traits and 
characteristics in a relative close geographic region prior to initiating the intervention (CDC, 
2017c).  MSM community interventions take place in settings frequented by MSM:  gay bars, 
community based organizations (CBOs), and other social and public areas (i.e., outpatient or 
community clinics, community colleges, and gay pride events) (CDC, 2017a).  The effectiveness 
of community interventions is measured according to the response from the entire studied 
community, and not on an individual basis (CDC, 2014a, 2017a, 2017c).   
To identify HIV prevention behavioral interventional best practices, the investigator 
reviewed the CDC’s HIV Evidenced Based Interventions (EBIs).  Determining evidenced-based 
interventions is a systematic process of analyzing and evaluating relevant and related research 
based on data and outcomes (Lo-Biondo & Haber, 2014).  The result of the literature analysis 
and synthesis assists in defining best practice recommendations, protocols, or standards based on 
objective and sound evidence (Lo-Biondo & Haber, 2014).  The CDC’s EBIs is a compendium 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 42 
 
from their analysis of published HIV behavioral interventional evidence shown to increase 
initiation of HIV traditional risk-reduction behaviors at the individual, group, and community 
levels (CDC, 2014a, 2017c).  For MSM, the following were considered traditional prevention 
behaviors:  abstinence, decreasing the number of sexual partners, and decreasing the occurrence 
of unprotected sex (CDC, 2014a, 2017c).  Appendix A provides a list of the eleven identified 
EBIs for MSM at the individual, group, and community levels. 
Evidenced Based Interventions (EBIs) 
Relative to individual and group interventions, counseling strategies utilizing technology, 
peers, and health professionals are shown to be most effective (CDC, 2017a).  Although these 
approaches are facilitated differently, the commonalities remain the same and are imperative to 
their successes.  Regardless of whether information is delivered by a video or virtual component, 
an MSM peer, or a health professional, information is culturally adapted to provide behavioral 
risk-reduction education, recommendations, and support specific to MSM of different races and 
ethnicities (CDC, 2017a).  After receiving HIV counseling, participants engage in discussions 
within their group or individual sessions to clarify and expound upon the presented information 
(CDC, 2017a).  Counseling strategies utilizing MSM peer counselors provide opportunities to 
discuss social barriers, hardships, decision-making, and problem solving (CDC, 2017a).    
Trained counselors and health professionals are not MSM’s peers, but they are equipped and 
capable to have candid conversations in a safe, non-judgmental environment, as they support and 
assist clients to devise risk-reduction goals and strategies (CDC, 2017a).   
Although not considered best practices, community interventions are shown to be 
effective and good strategies in improving MSM’s HIV risk-reduction behaviors.  Community 
interventions utilize peers and community leaders respected and trusted by MSM to render risk-
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reduction counseling (CDC, 2017a).  Similar to individual interventions, community 
interventions empower MSM to develop risk-reduction goals, plans, and skills (CDC, 2017a).  
At the community level, HIV prevention is an ongoing collaborative effort, as these interventions 
are provided within the community as an attempt to provide preventative services to those who 
may not be able to access individual and group level interventions due to personal and 
disadvantaged circumstances:  limited finances, unreliable transportation, and/or inadequate 
health care access, to name a few.  
The CDC conducted a comprehensive and exhaustive review of several literature 
databases to identify and evaluate applicable studies meeting defined research criteria (CDC, 
2014a, 2017c).  Although complete details of this evaluation process were not available, the 
CDC (2014a, 2017c) analyzed each study rigorously according to specific criteria to determine 
which interventions demonstrated optimal evidence to increase the studied sample’s HIV risk-
reduction behaviors (CDC, 2017c).  Reviewed interventional studies had to meet and 
demonstrate certain risk-reduction efficacy standards set by the CDC’s Prevention Research 
Synthesis (PRS) Project (CDC, 2017c).  The pre-defined evaluation criterion for reviewing the 
interventional studies strengthens the EBIs’ evidence, as setting the required criteria first 
standardizes and reduces bias in the evaluation process (LoBiondo-Wood, 2014a).   
The criteria measuring the interventions' efficacy was determined by evaluating a 
combination of the intervention’s study design and reported outcomes (CDC, 2017c).  PRS 
Project’s standards placed more value on a study being a randomized clinical trial (RCT), having 
a large sample size, maintaining a high retention rate, and utilizing multiple comparison groups 
(CDC, 2017c).  Additionally, included studies reported a statistically significant (p< .05) increase 
in one or more of the HIV traditional prevention behaviors in comparison to the control group 
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(CDC, 2017c).  These characteristics are indicators of a robust study, increasing the findings' 
reliability and trustworthiness (LoBiondo-Wood, 2014a).  From the analysis, the interventions 
were classified as either best or good practice (CDC, 2014a, 2017c).   
The distinction between good and best practice was based upon the overall quality of the 
study's design and methodology (CDC, 2017c).  Individual and group interventions were 
evaluated utilizing the same criteria (CDC, 2017c); this investigator assumes that was done 
because both interventions evaluate behavioral change in the individual.  For individual and 
group level interventions, best practices were derived from RCTs utilizing a sample greater than 
50 participants per study arm, with a 70% retention rate, and a follow-up period of at least three 
months post intervention completion (CDC, 2017c).  On the other hand, good evidence for 
individual and group interventional studies utilized random assignment of 40 participants per 
study arm, with a 60% retention rate, and a follow-up period of at least thirty days post 
intervention completion (CDC, 2017c).  A similar pattern was apparent in the distinction 
between best and good practices for community interventional research.  Best practice 
community interventional studies utilized four or more communities per study arm, maintained a 
70% retention rate, and had a follow-up period of at least three months post intervention 
completion (CDC, 2017c).  Good practice community interventional studies had at least one or 
more communities per arm, a 60% retention rate, and a follow-up period of thirty days post 
intervention completion (CDC, 2017c).   
 Although not an aspect of the PRS Project’s evaluation criteria, each reviewed study 
utilized a theoretical framework to guide the investigation.  Appendix B provides a list of the 
applied theories.  Applied theory strengthens the EBIs' conclusions, as developing effective and 
efficient knowledge for clinical practice depends “on marshaling the most appropriate theory to 
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guide inquiries that contextually represent the investigated phenomenon” (Glanz et al., 2008b, p. 
35).  Systematic reviews show interventions constructed from a theoretical framework are more 
effective compared to interventions not founded on theory (Glanz, Rimer, & Viswanath, 2008a).  
One benefit of theory application in research is that it allows researchers and health professionals 
to understand the context and practice settings in which the study findings are most applicable 
(McEwen, 2014).  All interventions are not universally feasible, and should be selected 
strategically and systematically based upon characteristics and resources of the population and 
community being served (Collins & Sapiano, 2016).  Therefore, theory allows health 
professionals to better identify the best strategies to implement given their clinical practice 
settings and populations.   
Evidenced Based Interventions (EBIs) Synthesis 
Synthesis of the CDC’s compendium implicates the proposed study’s significance to the 
nursing profession.  The applied theoretical frameworks assume that health behavior 
interventions at different levels are necessary to support individuals and populations being able 
to initiate and sustain effective behavioral change (Glanz et al., 2008a).  Therefore, the 
compendium demonstrates that health professionals are integral to increasing MSM’s use of risk-
reduction behaviors, as MSM need support and guidance from a professional, trusted resource, or 
program knowledgeable in HIV prevention in order to increase utilization of HIV risk-reduction 
behaviors (CDC, 2017a, 2017c).  Additionally, this evidence shows that MSM are receptive to 
counseling and education from health professionals in an environment and manner that 
acknowledges their specific needs and perspectives respectfully and without judgment.  
Therefore, findings from an exploration of MSM's PrEP initiation decision-making processes 
inform and educate nurses on the ways and content necessary to counsel and support this 
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population during this decision-making process.  This study is foundational to devising best 
practices for MSM’s PrEP initiation successes, and contributes to the development of future 
evidenced-based PrEP initiation interventions. 
The EBIs' evidence is still privy to weaknesses.  Most of the synthesized studies utilized 
participant self-reporting (i.e., condom use percentage and number of sex partners) to measure 
effectiveness.  The effect of social desirability may have caused research participants to answer 
questions according to socially expected or accepted norms (Friis & Sellers, 2013), making 
participant bias a limitation of the evidence.  Although nearly impossible to gather, more 
objective data would have strengthened this evidence, but there was no way to know the true 
extent of participants' behaviors before study enrollment, and if a participant actually increased 
their risk-reduction behaviors.  Therefore, the evaluation of the treatment's effectiveness may not 
have been indicative of reality.  Additionally, the follow-up period to evaluate the interventions’ 
effectiveness ranged from three to twenty-four months, a period that this investigator believes to 
be rather short.  While the EBIs offer sufficient evidence on the strategies that improve MSM's 
usage of HIV preventative and risk-reduction behaviors, this evidence does not attest to these 
interventions’ long-term effect.  Additionally, none of the referenced studies investigated 
decision-making, therefore weakening this evidence, as it does not explain MSM's decision-
making to implement those behaviors.  HIV prevention is an on-going and long-term endeavor of 
deciding to perform behaviors that reduce one’s HIV risks (Caceres et al., 2015; CFA, 2014).  
Decision-making is the process of weighing different factors surrounding a behavior or choice 
determining if one will implement the respective behavior (Poortaghi et al., 2015; Popejoy, 
2005).  The effectiveness of the referenced EBIs’ strategies to influence long-term and 
permanent behavior change is unknown.   
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 47 
 
Health Behavior 
Health behavior is the action patients take to attain information and tools regarding health 
promotion, risks, and illness (Poortaghi et al., 2015).  These actions are ongoing, and may occur 
purposefully or inadvertently, as individuals perform health behaviors with or without potential 
or actual health concerns (Poortaghi et al., 2015).  A preponderance of evidence exist regarding 
health behavioral decision-making and is relevant to this study and clinical practice. 
Health-behavioral Decision-making Research 
Investigators have inquired about health-behavioral decision-making regarding 
engagement in primary, secondary, and tertiary care.  Specifically, studies have been conducted 
to explore and understand individuals’ choices and decisions to initiate or not initiate behaviors 
related to health promotion (Brown-Kramer & Kiviniemi, 2015; Rao, Lozano, & Taani, 2014; 
Thom et al., 2016; Wang, Clymer, Davis-Hayes, & Buttenheim, 2015), immunizations (Allan & 
Harden, 2014; Perez et al., 2015; Wang et al., 2015; Wheldon et al., 2016), screenings and 
treatment (Bayliss, Duff, Stricker, & Walker, 2017; Brown-Kramer & Kiviniemi, 2015; Mac 
Bride et al., 2013; Schmidt, Damm, Prenzler, Golpon, & Welte, 2016; Tranberg et al., 2016; 
Wheldon et al., 2016), and diet and exercise regimens (Bui, Droms, & Craciun, 2014; Kaur, 
Scarborough, & Rayner, 2017; Kosma, Buchanan, & Hondzinski, 2017), to name a few.  There 
was some variance seen in how investigators conducted decision-making research.  The literature 
showed decision-making research to use sample sizes ranging from five (Schmidt et al., 2016) to 
87 (Allan & Harden, 2014).  While some studies utilized quantitative methods (Schmidt et al., 
2016), most research designs implemented a qualitative methodology, interviewing participants 
using focus groups or semi-structured interviews (Allan & Harden, 2014; Hussain, Flemming, 
Murtagh, & Johnson, 2015; Rose, Rosewilliam, & Soundy, 2017).   
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Decision-making research has been conducted within a variety of contexts.  The process 
of making health choices has been studied from the experiences and perspectives of the patient/ 
patient's legal authority (Allan & Harden, 2014; Coombs, Parker, & de Vries, 2016; Grant, 
Rodger, & Hoffmann, 2015; Hamilton, Soinks, White, Kavanagh, & Walsh, 2016; Ling, Payne, 
Connaire, & McCarron, 2015; Lucas, Cabral, Hay, & Horwood, 2015; Perez et al., 2015), the 
family (Allan & Harden, 2014; Coombs et al., 2016; Grant et al., 2015; Hamilton et al., 2016; 
Ling et al., 2015; Newson, Povey, Casson, & Grogan, 2013; Nichol, Thompson, & Shaw, 2011; 
Perez et al., 2015; Siouta et al., 2015), and health professionals (Chong, Aslani, Chen, 2013; 
Coombs et al., 2016; Rose et al., 2017; Siouta et al., 2015; Thom et al., 2016).  Explorations of 
decision-making did not necessarily compare one group to another; however, the investigators 
narrowed their inquiry to a specific population.  Decision-making has been investigated among 
different social statuses:  low socioeconomic status (SES) (Vesely, 2013), racial/ethnic 
minorities (Carvajal, Gioia, Mudafort, Brown, & Barnet, 2017; Kosma et al., 2017; Lu, 2017; 
Mead et al., 2013; Tung, Cook, & Lu, 2012; Vesely, 2013), indigenous persons (Dugas et al., 
2017; Gainer et al., 2017; Mitchell, 2011; Tranberg et al., 2016), sexual minorities (i.e., lesbian, 
gay, bisexual, and transgender persons) (Wheldon et al., 2016), men and women (Kosma et al., 
2017; Mead et al., 2013; Tranberg et al., 2016; Wheldon et al., 2016), different age groups 
(Kosma et al., 2017; Mitchell, 2011; Rao et al., 2014; Wheldon et al., 2016), and specific 
diagnoses and conditions (Coombs et al., 2016; Gainer et al., 2017; Ling et al., 2015; Mitchell, 
2011; Rose et al., 2017; Siouta et al., 2015).  Geographically, these studies have been conducted 
throughout the U.S. (Bui et al., 2014; Thom et al., 2016; Wheldon et al., 2016) and abroad (Grant 
et al., 2015; Mitchell, 2011; Perez et al., 2015; Siouta et al., 2015).  The numerous inquiries in 
combination with the various contexts health behavioral decision-making research has occurred 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 49 
 
provides this investigation the necessary foundation to understand this phenomenon, and reveals 
the importance and impact health behavioral decision-making research evidence has on clinical 
practice.   
Even in the different contexts that health behavioral decision-making research has 
occurred, systematic reviews and meta-analyses consistently reveal that decision-making is an 
individualistic process of weighing and considering various factors (Allan & Harden, 2014; 
Poortaghi et al., 2015; Schmidt et al., 2016; Tranberg et al., 2016).  Factors most commonly 
involved in health-related decision-making include one’s personal and social circumstances like 
SES and employment, gender, race/ethnicity, culture, religion/spirituality, neighborhood and 
environment, relationship status, and previous experiences (Poortaghi et al., 2015; Popejoy, 
2005).  Additionally, knowledge and perspectives (i.e., attitudes, beliefs, myths, and motives) 
about health, the health behavior, and the disease or condition itself are also weighed in this 
process (Bui et al., 2014; Clifford, Ryan, Walsh, & McCurtin, 2017; Dugas et al., 2017; 
Hamilton et al., 2016; Keatley, Clarke, & Hagger, 2013; Newson et al., 2013; Nichol et al., 
2011).  Replicated studies reporting the same factors in this phenomenon strengthens this 
evidence’s reliability to generalize what is typically involved in health behavioral decision-
making. 
Although the literature shows the factors of knowledge, personal and social 
circumstances, and perceptions about health, the health behavior, and the health condition to be 
involved in health-related decision-making, it is still difficult to generalize and ascertain how 
each individual values, weighs, views, and processes those factors.  The literature inquiries about 
decision-making occur in homogenous populations, as commonly those with similar 
backgrounds are more likely to experience and perceive phenomenon in the same way (Popejoy, 
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2005); however, researchers are cautioned against generalizing.  Decision-making is 
individualistic and value dependent, determined by one’s previous and current personal 
experiences and circumstances (Allan & Harden, 2014; Bui et al., 2014; Clifford et al., 2017; 
Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al., 
2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016).  Even within narrowed and 
uniquely defined samples, each person is an outlier, as no one’s existence is exactly like another.  
Therefore, disseminating and applying study implications to the sample’s larger population is 
challenging and limited (Allan & Harden, 2014; Bui et al., 2014; Clifford et al., 2017; Dugas et 
al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al., 2011; 
Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016).  Despite these limitations, decision-
making research provides health professionals with knowledge that allows them to assist patients 
deciphering between health options (Chong et al., 2013; Coombs et al., 2016; Popejoy, 2005; 
Rose et al., 2017; Siouta et al., 2015; Thom et al., 2016).   
Health Professionals’ Roles 
Health professionals play an important role in patients’ health-related decision-making 
processes (Chong et al., 2013; Coombs et al., 2016; Popejoy, 2005; Rose et al., 2017; Siouta et 
al., 2015; Thom et al., 2016), and knowledge gained from health-behavioral decision-making 
research is used to educate and prepare health professionals to function in that role.  Health-
related decision-making evidence informs health professionals about what patients know, 
understand, and perceive about the health behavior and condition (Clifford et al., 2017; Thom et 
al., 2016).  With this knowledge, health professionals are able to clarify patients’ 
misunderstandings, uncertainties, and concerns regarding the particular health option and 
condition.  For example, health professionals can offer coaching and support, assisting patients in 
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identifying their self-defined goals, applicable choices, and avenues for implementing change 
(Popejoy, 2005; Thom et al., 2016).  Decisional coaching “provide[s] support to patients to 
achieve quality decisions by . . . assessing patient’s level of decisional conflict, knowledge 
deficits, [and] their values and [needed] support” (Stacey et al., 2008, p. 25).  Similar to the 
investigator’s conclusion from the EBIs’ evidence, when engaged and engrossed in health related 
decision-making, patients value open communication and the transparent, non-judgmental 
exchange of information (Carvajal et al., 2017; Chong et al., 2013; Siouta et al., 2015; Thom et 
al., 2016).  An increased sense of support and advocacy increases behavioral adherence, which 
improves patient outcomes and successes with health choices (Popejoy, 2005; Thom et al., 
2016).   
Decision-making research has led to the development and testing of interventions and 
tools devised to render support and assistance to patients deciding between available health 
options and treatment (Clifford et al., 2017; Dugas et al., 2017; Llic et al., 2015; Mead et al., 
2013).  For example, decision aids are complementary tools used to explain and help patients 
make decisions by providing information about the available options and possible outcomes 
(Clifford et al., 2017; Dugas et al., 2017; Eggertson, 2010; Stacey et al., 2008).  A systematic 
review of decision aids literature reveals that these tools are treatment-specific and targeted to a 
specific population affected by a particular disease (Clifford et al., 2017).   
Health-behavioral Decision-making Literature Synthesis 
Regardless of the context or situation, synthesis of health-related decision-making 
research defines health decision-making as an individual process of weighing different factors 
surrounding that behavior or choice that determine one’s implementation or not of that particular 
behavior or choice (Poortaghi et al., 2015; Popejoy, 2005).  The literature shows the common 
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factors involved in this process to include an individual’s social and personal factors, as well as 
knowledge and perspectives about health, the health behavior, and the disease (Allan & Harden, 
2014; Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et 
al., 2013; Newson et al., 2013; Nichol et al., 2011; Schmidt et al., 2016; Tranberg et al., 2016).  
These repetitive factors to be a part of health-related decision-making process demonstrate 
consistency, strengthening this evidence.  Additionally, this evidence is congruent with this 
study’s context, as this study explores how HIV-negative MSM make the decision to initiate 
PrEP based on their PrEP and HIV knowledge/concerns, social and personal motivations to 
initiate PrEP, and abilities to adhere to PrEP.  Additionally, these concepts are consistent with 
the conceptualization of decision-making in the Information-Motivation-Behavioral (IMB) skills 
model.  The IMB skills model conceptualizes one’s decision to initiate HIV prevention behaviors 
to be based on their knowledge, motivation, and skills surrounding HIV and HIV risk-reduction 
behavior (Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher 
& Fisher, 1992; Macapagal et al., 2016; L. Smith et al., 2012).  From this synthesis, it was 
discovered that the proposed study’s conceptualization of decision-making is consistent with the 
literature, demonstrating the significance and contribution this study’s findings have on 
extending the existing decision-making knowledge base. 
Decision-making being individualistic and value dependent (Allan & Harden, 2014; Bui 
et al., 2014; Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; 
Newson et al., 2013; Nichol et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 
2016), determines this study’s methodology and implications.  This review found that most 
decision-making research is conducted using qualitative methods (Allan & Harden, 2014; 
Hussain et al., 2015; Rose et al., 2017), and this investigator believes this approach is used to 
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account for the variances and differences among individuals’ experiences and circumstances 
influencing their decisions.  This investigator agrees that factors involved in decision-making are 
unique and are constructed based on the person’s reality and experiences, justifying this 
qualitative exploration into HIV-negative MSM’s PrEP initiation decision-making processes.  
The uniqueness and individualism of decision-making restricts generalizability, as findings from 
this inquiry into MSM’s PrEP initiation decision-making are reflective of the sampled 
participants and possibly MSM with similar experiences and circumstances.  Therefore, the 
initial implications this study has in the MSM population and PrEP initiation will not be 
immediate.   
Synthesis of health-related decision-making research implicates the proposed study’s 
impact on clinical practice.  As seen with the EBIs, health professionals have a pivotal role in 
patients’ health-behavioral decision-making processes.  The literature demonstrates that 
decision-making research allows health professionals to clarify patients’ knowledge and 
understanding, and can lead to the development and testing of decision tools and interventions 
(Clifford et al., 2017; Dugas et al., 2017; Llic et al., 2015; Mead et al., 2013).  Despite the 
limitations in transferability, this study’s findings educate nurses on ways and topics for 
counseling and supporting MSM considering PrEP, which can increase HIV prevention through 
PrEP initiation success.  Optimal and accurate PrEP initiation among willing and HIV at-risk 
persons is the most effective way for PrEP to have the projected impact on the HIV epidemic 
(CDC, 2016e).  This study contributes to establishing a foundation regarding MSM’s PrEP 
initiation decision-making that can be integral in developing more evidence on this phenomenon 
and evidenced-based and best practice interventions for this population. 
HIV-negative MSM’s Condom-use Decision-making 
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 As the first pharmacological HIV preventative regimen, PrEP, finding evidence 
comparable to PrEP initiation decision-making in the context of MSM HIV prevention is 
difficult.  PrEP is indicated in HIV-negative MSM practicing other at-risk behaviors (i.e., 
intravenous drug use (IDU), unprotected anal/vaginal sex with women, serodiscordant 
relationship, etc.), but this study investigates PrEP initiation decision-making among MSM who 
engage in AI with other men.  AI is the primary catalyst driving the HIV incidence disparity in 
MSM, as most MSM report engaging in AI (Meng et al., 2015).  Additionally, AI is the riskiest 
type of sex (CFA, 2014; Pebody, 2010), and the overall most common mode of HIV 
transmission (CDC, 2016d).   While there are other recommendations in reducing MSM’s HIV 
risk during AI, accurate and consistent condom use is the best defense to prevent new HIV 
infections (CDC, 2015c, 2016c).  Not only is condom-use the best behavior to reduce HIV risk, 
but condom use decision-making is frequently investigated in this population regarding HIV 
prevention.  Therefore, reviewing the literature specific to HIV-negative MSM’s condom-use 
decision-making provides a foundation into MSM's HIV-prevention decision-making processes.    
Researchers report that MSM understand that condom use is necessary for HIV 
prevention (Neville & Adams, 2009; Neville et al., 2016), but MSM recognize that their 
community’s commitment to condom-use consistency is an ongoing challenge.  A secondary 
analysis utilizing data from two previously conducted prospective studies sampling HIV-
negative MSM revealed that 84% of MSM do not use condoms consistently (Smith et al., 2015).  
This outcome demonstrates that MSM’s decision-making to use condoms is not due to a 
knowledge deficit, but to other factors.  There is also a consensus that certain situations increase 
the chances of engaging in unprotected AI (UAI):  internet-hook-ups, dating internet sites and 
applications, and substance abuse (Neville & Adams, 2009; Neville et al., 2016).  Researchers 
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agree that pleasure is another factor in condom-use decision-making, as data showed MSM to 
deliberately serosort to avoid condoms, as condoms diminish sexual sensations and penile 
erections (Calabrese et al., 2012; Eaton et al., 2009; Neville & Adams, 2009; Neville et al., 
2016).  This review was not merely identifying factors influencing MSM’s condom-use decision 
making, but understanding how those factors are processed and rationalized in their decision-
making.  Therefore, this section of the literature review is organized thematically according to 
the common concepts apparent in HIV-negative MSM’s condom-use decision-making process:  
HIV concern, psychosocial issues, and relationship dynamics.   
HIV Concern 
Researchers found that HIV-negative MSM are concerned about contracting HIV (Balan 
et al., 2013; Neville & Adams, 2009; Neville et al., 2016); however, there is no consensus 
showing HIV concern to result consistently in MSM deciding to use condoms.  Evidence 
demonstrates that HIV concern is rationalized in the process, but MSM are shown to decrease 
and increase condom use despite or because of the concern, and various phenomenon:  ART 
success, delayed discounting, barebacking, sexual positions, and “bug-chasers” address the 
conflicting findings.   
Like many Americans, MSM no longer view HIV as a serious problem or public health 
issue (CDC, 2016b).  Data analysis from qualitative studies of 960 participants, mixed-methods 
studies of 89 participants, and literature reviews of 250 articles have documented the advances in 
HIV care have diminished HIV concern (Balan et al., 2013; Neville et al., 2016; Neville & 
Adams, 2009).  ART has changed HIV from being a fatal disease, to a chronic disease, which 
rationalizes some MSM to have UAI, as becoming infected is no longer feared (Balan et al., 
2013; Neville& Adams, 2009; Neville et al., 2016).   
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 56 
 
One example showing a decreased fear and concern in contracting HIV, which influences 
condom-use decisions, is the concept of delay discounting.  As defined by Herrmann et al. 
(2015), "delay discounting is how sometimes individuals choose less valuable, immediate 
rewards (e.g., UAI with a risky partner) over more valuable, delayed options (e.g., greater odds 
of a remaining HIV negative)" (p. 1656).  Questionnaires from Herrmann et al.'s (2015) study of 
108 MSM practicing UAI revealed that delay discounting is an important factor in condom-use 
decision-making, as that sample of MSM discounted the value of protected AI, more so than 
increased HIV protection and concern (Herrmann et al., 2015).  In most instances, delayed 
discounting occurred in the context when a condom was not readily accessible, and immediate 
gratification had more value than waiting to use a condom (Herrmann et al., 2015).  Results 
showed delay discounting to occur most often in MSM who are younger in age, of a lower SES, 
abuse substances, routinely engage in sex cognitively impaired, or suffer psychological issues 
such as depression; however, the investigators reiterated that delayed discounting to be 
individualistic and value-dependent (Herrmann et al., 2015), which is consistent with decision-
making.  Delayed discounting is a relatively new concept in the realm of MSM HIV prevention 
and condom use decision-making, making future research necessary for phenomenal 
understanding before any conclusions can be determined (Herrmann et al., 2015); however, this 
evidence indicates that MSM’s apparent HIV concern does not always result in consistent 
condom use.   
Barebacking, or the intentional act of engaging in UAI, demonstrates HIV concern exists.  
Evidence shows that barebacking has been explored as a factor surrounding HIV concern and 
engaging in unprotected sex (Balan et al., 2013; Bauermeister et al., 2009).  Balan et al.’s (2013) 
investigation of 89 barebacking MSM showed this sample to have HIV concern, however, 
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instead of using condoms, the concern led to the substitution of condoms with other prevention 
behaviors:  serosorting, occasional condom-use, reducing sexual partners, proof of partner’s HIV 
and STI status, avoiding persons with STIs, touching and masturbation, and cleansing rituals 
(i.e., washing, enemas, gargling, and urination).  Upon reviewing the literature, there is not 
sufficient evidence to explain the rationale and process behind MSM’s decisions to substitute 
these behaviors for consistent condom use.  This lack of knowledge makes it difficult to 
understand MSM’s thought processes, but confirms MSM’s concerns for contracting HIV cause 
them to implement other preventative measures, in addition to occasional condom use.   
HIV concern in relation to sexual positioning is also a factor influencing MSM’s condom 
use decision-making.  Receptive partners have a significantly higher HIV risk than insertive 
partners (CDC, 2015c, 2016c; Meng et al., 2015).  Neville et al.’s (2016) findings demonstrated 
that HIV concern associated with sexual positioning is a part of the condom use decision-making 
process.  Concern due to positioning determines a need to use condoms, as explained by one 
MSM study participant: “we are unwilling to [be on the] bottom without a condom, but we are 
willing to [be on] top without using one ourselves” (Neville et al., 2016, p. 3594).   
Although not as commonly documented, researchers have reported that some MSM have 
a desire to become infected with HIV (Neville & Adams, 2009).  “Bug chasers” is the term for 
individuals who purposefully engage in UAI with the goal of contracting HIV (Neville & 
Adams, 2009, p. 133).  Due to the higher risk of HIV transmission as the bottom partner, “bug 
chasers” are primarily the receptive partner and refuse to use condoms (Neville & Adams, 2009).  
“Bug chasers” are not devoid of HIV concern, as they seek to seroconvert; however, evidence of 
their rationale for desiring to become positive is unknown.  More data are necessary to 
understand this thought process (Neville & Adams, 2009).     
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Psychosocial Issues  
Social and personal motivations like, psychosocial issues are also involved in MSM’s 
condom use decision-making process.  Neville and Adams (2009) identified AIDS fatigue or 
burnout as a reason justifying UAI.  AIDS burnout is “a direct consequence of constant exposure 
to prevention messages” (Neville & Adams, 2009, p. 133).  HIV is a significant national public 
health issue, as HIV prevention campaigns and messages are scattered abound.  Qualitative 
interviews revealed MSM’s decision to engage in UAI is a form of social resistance to public 
standards (Neville & Adams, 2009; Neville et al., 2016).  Ironically, decisions to have UAI are 
supported with the common notion and cliché that it is a man’s nature to take risks (Neville et al., 
2016).  AIDS burnout and social resistance are not common factors a part of decision-making 
(Neville & Adams, 2009).  At present, further research is needed to understand the impact AIDS 
burnout and social resistance have on MSM’s condom use decision-making.  Researchers have 
more commonly reported intrapersonal influences upon condom use decision-making 
(Bauermeister et al., 2009; Neville & Adams, 2009).  Depression, low self-esteem, loneliness, 
homophobia, and sexual identity conflict are issues and reasons deterring condom use 
(Bauermeister et al., 2009; Neville & Adams, 2009).  This evidence demonstrates that condom-
less or UAI is an avenue and mechanism to escape these personal hardships (Neville & Adams, 
2009), but it is difficult to understand whether MSM with significant intrapersonal prioritize 
escaping personal-psychosocial hardships over a concern of contracting HIV, which warrants the 
need for more additional research. 
Relationship Dynamics 
Relationship dynamics are a factor in HIV-negative MSM’s condom use decision-making 
process (Campbell et al. 2014; Neville & Adams, 2009; Neville et al., 2016).  MSM’s habit to 
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use, or not use, condoms depending on the relationship status being open or closed is well 
documented (Neville & Adams, 2009; Neville et al., 2016).  MSM routinely report having 
protected sex with a casual partner, and having unprotected sex with their main or monogamous 
partner (Neville et al., 2016).  This literature search, however, sought to understand the influence 
relationship dynamics have on condom use decision-making.  Partner conversations and 
emotions are relationship aspects that MSM commonly state decide condom use.  
Partner conversations are a decision-making process of its own, as they involve 
discussing each persons’ sexual risks, preferences, and concerns (Campbell et al., 2014).  
Campbell et al. (2014) conducted 48 interviews of MSM couples regarding their practice and 
outcomes from implicit and explicit sexual decision-making discussions.  The findings confirm 
stark differences in the rationales and results from each type of discussion.  Explicit discussions 
among HIV concordant couples involve discussing each partners’ HIV and condom-use 
“concern, boundaries, and level of comfort” (Campbell et al., 2014, p. 704).  The discussions 
allow an open dialogue to express each person’s perspective regarding the risks and benefits of 
UAI given their relationship status (Campbell et al., 2014).  Campbell et al. (2014) found that a 
similar process occurs between HIV discordant couples, but the discussions pertain to each 
partner’s comfort level with the HIV risk for the uninfected partner given the positive person’s 
HIV treatment, viral load, and CD4 count.  With viral suppression, TasP rationalize their 
decision to have UAI, as HIV transmission risk is significantly decreased (Campbell et al., 
2014).  On the other hand, implicit conversations do not allow partners to acknowledge each 
other’s risks and concerns (Campbell et al., 2014).  The decision to not use condoms is “just 
understood”, as the absence of the “full picture of their partner’s testing and sexual history” 
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rationalizes UAI (Campbell et al., 2014, p. 704).  Despite MSM’s knowledge of AI being an HIV 
risk factor, without a definitive cause of concern, condom-less sex is acceptable. 
Other researchers have investigated and found that emotions to rationalize decisions 
about condom use (Bauermeister et al., 2009; Goldenberg et al., 2015; Green et al., 2014).  
Studies by Goldenberg et al. (2015) and Greene et al. (2014) found that love, intimacy, and trust 
between partners decrease condom use.  Green et al. (2014) had 23 MSM couples complete 
questionnaires and interviews while Goldenberg et al. (2015) conducted interviews and analyzed 
diary entries from 25 MSM about the influences of relationship characteristics on condom use 
decision making.  The presence of love, intimacy, and trust lower the perception of their 
partner’s HIV risk and concern, justifying UAI (Bauermeister et al., 2009; Goldenberg et al., 
2015; Green et al., 2014).  Lust is another emotion integral to condom use decision-making.  
Although lust does not alter risk perception (Goldenberg et al., 2015), lust rationalizes UAI, as 
the desire and immediate gratification from UAI is worth the risk (Herrmann et al., 2015).   
HIV-negative MSM’s Condom-use Decision-making Literature Synthesis  
Synthesis of this literature is consistent with previous explorations of health-related 
decision-making research.  From this evaluation of MSM's condom-use decision-making 
research, health-related decision-making is revealed to be a process of evaluating and assessing 
the different personal, social, and knowledge factors surrounding that choice (Poortaghi et al., 
2015; Popejoy, 2005).  This evidence confirms that even in a homogenous group, decision-
making is unique, individualistic, and value dependent (Allan & Harden, 2014; Bui et al., 2014; 
Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et 
al., 2013; Nichol et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016).  This 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 61 
 
conclusion provides further validation of this study’s conceptualization of decision-making, but 
also has significant implications for the proposed study’s findings.   
Research showed MSM know that condom use is necessary for HIV prevention (Neville 
& Adams, 2009; Neville et al., 2016), but MSM still have inaccuracies and misconceptions about 
HIV prevention strategies.  Balan et al. (2013) reported MSM still believe cleansing rituals like 
washing, enemas, gargling, and urination are appropriate substitutes to condom use.  Cleansing 
rituals have never been an approved HIV prevention behavior since the first HIV incidence in the 
1980s.  In addition, MSM still errantly rely on perceptions and emotions to determine a current 
or potential partner’s HIV risk/status and their decision to use condoms (Bauermeister et al., 
2009; Campbell et al., 2014; Goldenberg et al., 2015; Green et al., 2014).  Therefore, this 
evidence indicates to the investigator that misconceptions and elements of trust are aspects of 
MSM's condom-use decision-making process, warranting the need for decision-making research, 
especially with PrEP, a new and unique prevention modality.  
As the newest and first pharmacological HIV preventative agent, this investigator 
concludes that there may be some possible inaccurate information regarding HIV prevention 
through PrEP initiation.  Exploring HIV-negative MSM’s decision-making processes to initiate 
PrEP may uncover such misconceptions regarding HIV or PrEP.  Due to PrEP’s distinct 
differences from condoms (i.e., ADR, nephrotoxicity, bone density loss, and unknown adverse 
events) (CDC, 2014b), knowledge of the decision-making process is imperative to ensure MSM 
accurately understand PrEP’s clinical indications, instructions, and consequences.  From these 
findings, nurses can devise education and counseling tools that target HIV and PrEP knowledge 
inaccuracies and deficits.  
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Health behaviors can occur with or without an actual concern (Poortaghi et al., 2015); 
however, this literature evidence on HIV-negative MSM’s condom-use decision-making 
consistently documented HIV concern as a factor in this process.  Despite MSM having any HIV 
concern, there is no consensus on how that concern determines MSM’s decision to use or not use 
condoms.  Despite the lack of consensus regarding how HIV concern influences condom use, the 
consistency of HIV concern to appear in condom-use HIV prevention decision-making is the 
strength of this evidence, and leads to the conclusion that HIV prevention decision-making is 
best understood in the context of HIV concern.  For that reason, exploring MSM’s PrEP 
initiation decision-making based on HIV concern is a part of this study’s objective.  However, 
this concept is inconsistently defined, as none of the articles explicitly defined concern.  
Participants, investigators, and readers can have their own conceptualization of concern.  In 
Neville and Adams’ (2009) and Neville’s et al. (2016) studies, concern is assumed to pertain to 
susceptibility to contracting the virus.  While Balan et al.’s (2013) qualitative analysis perceive 
concern to be the difficulties and challenges associated with being HIV positive.  The 
investigator believes that having both definitions represented in the literature to have equal merit 
and relevance to condom-use decision-making, therefore, both types of concern are incorporated 
into the proposed study’s investigation into MSM’s PrEP initiation decision-making processes.  
The ambiguity associated with how each study defines concern is related to the inconsistency of 
researchers to identify or utilize theoretical frameworks that define the conceptualization of HIV 
concern.  Therefore, another significant finding from this review is the importance of applying an 
appropriate theoretical framework.   
IMB Skills Model in MSM's HIV Prevention Research 
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The IMB skills model guides this study, as it conceptualizes the decision to initiate HIV 
risk-reduction behaviors as involving one’s information, motivation, and skills (Aliabadi et al., 
2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; 
Macapagal et al., 2016; L. Smith et al., 2012).  Fisher and Fisher (1992) developed this 
conceptualization of HIV-related behavior change by conducting an extensive review of AIDS 
risk-reduction literature.  Information is the knowledge, myths, and means known to reduce HIV 
risk; motivation is the attitudes, beliefs, and perceived social support regarding the preventative 
behavior; and behavioral skills are the abilities to perform that behavior (Aliabadi et al., 2015; 
Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et 
al., 2016).  This model assumes an individual’s culture, values and beliefs, social standing, SES, 
environment, and life circumstances determines their understanding, motivation, and abilities 
regarding their decision-making to utilize HIV preventative behaviors (Aliabadi et al., 2015; L. 
Smith et al., 2012; Traube et al., 2011), but those factors are not represented in the model.  The 
absence of these personal demographic characteristics in the model is a limitation, as it does not 
provide the complete process involved in initiation of HIV prevention decision-making (Traube 
et al., 2011).  Despite this limitation, the IMB skills model represents factors shown to influence 
initiation of HIV risk reduction behaviors, and is consistent with health-related and HIV-negative 
MSM’s condom-use decision-making processes.  
The literature shows investigators to use this model to study condom usage in HIV-
negative MSM (Macapagal et al., 2016), PLWH medication adherence and retention in care 
(Amico et al., 2005; Amico et al., 2009; Horvath et al., 2014; Rongkavilit et al., 2010; L. Smith 
et al., 2012), and to develop and test interventions (Aliabadi et al., 2015; Chang et al., 2014).  To 
account for variances in HIV prevention behavioral decision-making, Aliabadi et al. (2015) 
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states that using a qualitative approach is appropriate with the IMB skills model so information 
can be elicited using dialogue and open-ended questions.  Adherence to this recommendation is 
apparent, as the IMB skills model is commonly applied in large qualitative studies using semi-
structured interviews and focus groups (Chang et al., 2014; Horvath et al., 2014; Macapagal et 
al., 2016; Rongkavilit et al., 2010) with samples utilizing 96 (Macapagal et al., 2016) to 312 
participants (Horvath et al., 2014).  Therefore, the evidence validates the investigator’s chosen 
methodology for conducting this exploration into HIV-negative MSM’S PrEP initiation decision-
making processes.   
MSM and PrEP 
Despite FDA approval in 2012, there is a paucity of literature on PrEP initiation decision-
making in any population.  Most of the available literature pertains to PrEP’s pre-approval 
clinical trials, effectiveness and efficacy, health professionals’ perspectives, and clinic start-ups.  
Therefore, this literature review establishes the knowledge base for the proposed study by 
synthesizing the available evidence of MSM’s PrEP interest, initiation, and decision-making.  
Interest 
Although only 25% of MSM in America report being knowledgeable of PrEP (Al-
Tayyib, Thrun, Haukoos, &Walls, 2014; Raifman, Flynn, & German, 2017), PrEP interest is 
high in the MSM community.  Studies show MSM’s PrEP interest arises from a desire to 
promote health and enhance sexual pleasure (Brooks et al., 2012; Collins et al., 2016; Gamarel & 
Golub, 2015;Garcia & Harris, 2017; Golub, Gamarel, Rendina, Surace, & Lelutiu-Weinberger, 
2013; Mimiaga, Closson, Kothary, & Mitty, 2014; Oldenburg et al., 2016; Taylor et al., 2014).  
These studies sampled anywhere from 19 to 699 MSM in serodiscordant relationships through 
semi-structured interviews, focus groups, and online and paper questionnaires in Boston, MA; 
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Pittsburg, PA; San Juan, Puerto Rico; and Atlanta, GA.  PrEP is believed to empower MSM to 
practice proactive HIV prevention as opposed to post-exposure reactivity (Oldenburg et al., 
2016).  During PrEP clinical trials, MSM study participants were motivated to participate to 
“protect themselves” and to assist in preventing future infections (Taylor et al., 2014, p. 875).  
Due to condom failures and inconsistent use, MSM found comfort in PrEP’s added protection 
(Collins et al., 2016).  The added protection reduces anxiety and shame associated with risky 
sexual behaviors, as well as reduces fears of contracting the virus when MSM have AI with a 
person with a positive or unknown HIV status (Brooks et al., 2012; Collins et al., 2016; Mimiaga 
et al., 2014; Oldenburg et al., 2016; Taylor et al., 2014).    
Researchers found that MSM believe an increase in UAI will be a motivating factor 
leading to their peers’ decision to initiate PrEP (Brooks et al., 2012; Collins et al., 2016; Garcia 
& Harris, 2017; Golub et al., 2013; Oldenburg et al., 2016; Perez-Figuerora et al., 2015; D. 
Smith, Toledo, Smith, Adams, & Rothenberg, 2012; Taylor et al., 2014).  Risk compensation is 
the purposeful increase in HIV risky behaviors while taking PrEP (Blackstock et al., 2016; 
Calabrese et al., 2014; Calabrese & Underhill, 2015; Karris et al., 2014; Yagoda & Moore, 
2016).  Findings from PrEP clinical trials did not show any evidence of risk compensation to 
occur (CDC, 2014b; Marcus et al., 2013; McCormack et al., 2016; Mugwanya et al., 2013), but it 
is speculated that PrEP may lead to intentional UAI for increased intimacy and pleasure (Collins 
et al., 2016; Gamarel & Golub, 2015), which is lost when using condoms (Calabrese et al., 2012; 
Calabrese & Underhill, 2015; Higgins & Wang, 2015).  These perspectives, however, are only 
assumptions, as the problem is that MSM’s PrEP initiation decision-making processes are 
unknown.   
Initiation 
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Gilead® surveyed U.S. retail pharmacies about the occurrence of patients filling a PrEP 
prescription for the first time during 2012 and 2015 (NAM, 2018).  During the three year period, 
49,158 patients were dispensed their initial PrEP prescription from a reporting pharmacy (NAM, 
2018).  Most patients initiating PrEP are White (74%) followed by Hispanics (12%), African-
Americans (10%), and Asians (4%) (NAM, 2018).  This data also show males (79%) to initiate 
PrEP more commonly than women (NAM, 2018).  Lastly, the data indicates that PrEP patients 
are older in age, as 8% of patients are younger than 25 years of age (NAM, 2018).  This recent 
data from Gilead® is similar to initial statistics about PrEP patients, as Rooney (2013) reported 
the average PrEP patient is 37 years of age and male.  Furthermore, researchers consistently 
report most current and former PrEP patients are MSM (Krakower et al., 2015; Rooney, 2013; 
Tellalian et al., 2013).  Despite MSM being the most common PrEP consumers, approximately 
3% of the MSM population are or have ever initiated PrEP (Krakower & Mayer, 2015).  The 
literature offers speculated reasons as to why PrEP initiation is low, not only in MSM, but 
nationally as well.   
Poor PrEP initiation is speculated to be the result of structural barriers (Auerbach et al., 
2015; Flash et al., 2014; Oldenburg et al., 2016; Perez-Figueroa et al., 2015; Rolle et al., 2017; 
Taylor et al., 2014; Underhill et al., 2014; D. Smith et al., 2012).  Stigma is a barrier to PrEP 
initiation from survey (Dolezal et al., 2015; Eaton et al., 2014; Oldenburg et al., 2016), focus 
group (D. Smith, et al., 2012; Taylor et al., 2014), and semi-structured interview studies (Collins 
et al., 2016; Golub et al., 2013; Perez-Figuerora et al., 2015).  These studies have occurred 
throughout the U.S., but primarily in areas with high HIV rates and MSM populations:  Atlanta, 
GA; Baltimore, MD; Boston, MA; New York, NY; Pittsburg, PA; San Juan, Puerto Rico, and 
Seattle, WA utilizing samples of 14 to 699 MSM.  PrEP patients are stigmatized as “Truvada 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 67 
 
whores”, undermining HIV prevention and PrEP initiation (Calabrese & Underhill, 2015; Haire, 
2015).  Perceived negative stigma and judgmental reactions from peers and health professionals 
are believed to deter MSM from seeking and initiating PrEP (Auerbach et al., 2015; Collins et 
al., 2016; Dolezal et al., 2015; D. Smith, et al., 2012); however, this is only a presumption.    
Another barrier to PrEP initiation is inaccessibility due to high cost and lack of insurance 
coverage (Oldenburg et al., 2016; Perez-Figueroa et al., 2015; Rolle et al., 2017; D. Smith et al., 
2012; Taylor et al., 2014).  Patients are more willing to use PrEP if it is conveniently available at 
minimal or no cost (Golub et al., 2013; D. Smith et al., 2012).  Insurance coverage and cost does 
not only implicate the ability to purchase the drug, but returning for required routine follow-up 
care at least quarterly (Oldenburg et al., 2016; Perez-Figueroa et al., 2015; Rolle et al., 2017; D. 
Smith et al., 2012; Taylor et al., 2014).  Rolle et al. (2017) conducted a study among 184 PrEP 
eligible young Black MSM to understand PrEP initiation in this population in the absence of 
accessibility and cost barriers.  In this MSM sample, 63% (n=116) expressed PrEP interest and 
were notified that participation provided them with access to the medication and required follow-
up care at no cost (Rolle et al., 2017).  Despite these favorable conditions, only 34% (n=63) 
actually initiated PrEP (Rolle et al., 2017); however, the study provides no evidence explaining 
how participants made their decision.  Even in the absence of structural barriers, initiation was 
less than optimal, therefore, leading this investigator to presume that the decision to initiate PrEP 
to encompass more than overcoming structural barriers, and reiterates the need for the proposed 
study’s inquiry into MSM’s PrEP initiation decision-making processes.   
Decision-making 
This literature review contained two publications regarding PrEP decision-making in 
MSM.  Garcia and Harris (2017) analyzed survey results from their study of 159 Latino MSM 
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currently taking PrEP in San Antonio, TX.  Garcia and Harris (2017) found that the main reason 
for initiating PrEP was that the participants had multiple sex partners (34.7%) and did not want 
to become HIV infected (40%).  Only 1.6% of the sample evaluated engagement in condom-less 
sex as a reason to initiate PrEP (Garcia & Harris, 2017).  One other article explored MSM PrEP 
patients’ experiences taking PrEP in a real-world context.  Parker et al. (2015) conducted 
qualitative interviews of 24 MSM PrEP patients in Providence, RI.  Most participants engaged in 
inconsistent or condom-less sex and did not use any other HIV preventative behaviors (Parker et 
al., 2015).  The participants were currently on PrEP and had been on the regimen for at least 
three months prior to study participation.  Patient interviews surrounding PrEP experiences 
included a variety of topics:  cost and insurance issues, risk compensation, interest, and which 
medical specialties were providing PrEP.  Parker et al. implied that MSM’s decisions to initiate 
PrEP were made in order to reduce their risk or concern of contracting HIV. Additionally, 
participants reported that despite being on PrEP, choosing to use condoms is still a complex 
process; however, the participants did not show evidence of risk compensation, as there was not 
a reported increase in HIV risky encounters and behaviors (Parker et al., 2015). 
Other available evidence on PrEP initiation decision-making is speculative.  From this 
review, two articles provided knowledge of MSM’s condom-use decision-making in the 
hypothetical context of PrEP.  Koblin et al. (2011) inquired about the efficacy of PrEP’s 
influence on condom use decision-making among a sample of 630 MSM who engaged in both 
UAI and in AI while under the influence of alcohol or non-injection drugs.  At the time the study 
was conducted, PrEP’s efficacy was definitively unknown; therefore, Koblin et al. (2011) 
utilized PrEP’s efficacy uncertainty as a variable to gauge condom-use decision-making.  Most 
of Koblin and colleagues’ high-risk sample reported that they would eliminate condom-use only 
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if PrEP has a moderate to maximal efficacy, as it reduces the level of HIV concern for 
contracting the virus (Koblin et al., 2011).  Although this evidence reiterates the importance HIV 
concern plays in HIV-prevention decision-making, this evidence would have more significance if 
conducted in a sample with less HIV risk factors.  This HIV high-risk sample already engaged in 
UAI in the absence of PrEP, and this investigator believes the research purpose would have had 
more meaning in a sample of MSM reporting consistent condom use.  Therefore, these results 
only validate the need for PrEP availability.   
On the other hand, Hoff et al. (2015) qualitatively explored anticipated condom use 
among 48 MSM in HIV-negative concordant (n=26) and discordant couples (n=22) (Hoff et al., 
2015).  Findings were not conclusive, as results equally reported participants to continue and 
discontinue condoms in conjunction with PrEP (Hoff et al., 2015).  Additionally, most 
participants viewed the decision to initiate PrEP to be made after engaging in an explicit 
conversation with their partner (Hoff et al., 2015).  Although seemingly favorable, these results 
do not provide any significance, as the investigators did not collect couples’ current condom-use 
habits.  Therefore, the effect PrEP would have on condom-use in this sample cannot be 
determined.  In regards to decision-making, this evidence does not provide any data on MSM’s 
PrEP initiation decision-making processes, as the study’s occurred in the hypothetical context of 
PrEP.   
MSM and PrEP Literature Synthesis  
This evidence concluded that MSM’s PrEP initiation decision-making process is 
currently insufficient for understanding this phenomenon. Demographic and statistical data on 
PrEP initiation demonstrates that the most HIV-vulnerable population, MSM, is initiating PrEP.  
Although that data is optimal, these survey findings cannot determine these patients HIV risks 
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and PrEP clinical indications, or their decision-making processes to initiate PrEP.  Evidence 
from Hoff et al. (2015) and Koblin et al. (2011) is speculative, and Garcia and Harris’s (2017) 
research findings only reveal that MSM initiate PrEP out of the behaviors and factors they 
perceive to increase their HIV risk and concern.  While this is a part of decision-making, this 
evidence does not provide the depth necessary to contribute to decision-making literature, as the 
factors and processes involved in how MSM derive to their decision is absent.   
Knowledge Gap 
Research into MSM's PrEP initiation decision-making is imperative.  The literary 
findings cause one to presume that MSM to currently have HIV prevention misconceptions and 
may have misconceptions about PrEP.  PrEP is a complementary regimen, and is to be used in 
combination with other HIV prevention behaviors, especially consistent condom use (CDC, 
2014b).  This review’s synthesis of the few studies specific to MSM and PrEP showed MSM 
have a misconception about this requirement, and demonstrates that MSM will require support, 
education, and behavioral counseling when considering PrEP initiation.  Due to the implications 
of decision-making evidence, research into PrEP decision-making from actual patients is 
necessary (Hoff et al., 2015; Koblin et al., 2011) to understand what MSM patients know and 
understand about PrEP.   
The proposed study is foundational evidence to fill this knowledge gap.  Decision-
making details what and how individuals consider and evaluate the different factors surrounding 
a choice or option (Poortaghi et al., 2015; Popejoy, 2005).  The study’s objective is to explore 
how HIV-negative MSM decide to initiate PrEP based on their:  (a) PrEP knowledge and HIV 
concern(s)/risk(s); (b) personal and social motivations to initiate PrEP; and (c) behavioral skills 
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and abilities to adhere to PrEP.  Knowledge from this study details the factors and aspects that 
are considered and weighed during the PrEP initiation decision-making process.   
Summary 
In summary, the personal endeavor of decision-making makes a qualitative approach 
appropriate, as this methodology gives voice to the emic view and participants’ realities and 
perspectives (Streubert, 2014; Toles & Barroso, 2014b).  Health professionals, however, should 
be cautious in determining study implications, as even in the presence of consistent and 
replicated evidence, personal and social perspectives and circumstances make generalizing study 
findings difficult (Bauermeister et al., 2009; Campbell et al. 2014; Goldenberg et al., 2015; 
Greene et al., 2014; Herrmann et al., 2015; Neville & Adam, 2009).  Despite the transferability 
limitations, decision-making research is still valuable, as decision-making research allows health 
professionals to clarify patients’ knowledge and understanding (Clifford et al., 2017; Dugas et 
al., 2017; Llic et al., 2015; Mead et al., 2013).  Information gleaned from the proposed study 
educates nurses about the topics and techniques needed to support and coach patients during this 
process.  This study lays the foundation for nursing research, as future studies are replicated to 
develop and refine these findings.  Additionally, this foundational study can contribute to the 
development and testing of decision tools and interventions, which can be used to assist and 
educate patients during PrEP initiation decision-making process.  That evidence can determine 
the best strategies for achieving MSM HIV PrEP prevention success. 
The literature shows health-related decision-making to be an individual process of 
weighing different personal, social, and knowledge factors surrounding that behavior or choice 
(Poortaghi et al., 2015; Popejoy, 2005).  While the literature exhibits a consensus that these are 
the primary factors involved in health-related decision-making, there is no consensus on how 
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each individual evaluates and views these factors.  These factors are value dependent, influenced 
by previous and current circumstances (Allan & Harden, 2014; Bui et al., 2014; Clifford et al., 
2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol 
et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016).   Research also 
demonstrates individuals perform health behaviors consciously or subconsciously aware of 
health concerns (Poortaghi et al., 2015), but MSM’s condom-use decision-making found HIV 
concern to be consistently a part of the process (Balan et al., 2013; Bauermeister et al., 2009; 
Campbell et al. 2014; Neville et al., 2016; Neville & Adams, 2009).  This investigator concludes 
concern to be an influential factor into HIV prevention behavior decision-making, which now 
extends to PrEP initiation.  PrEP initiation is deliberate, as it is initiated purposefully and 
intentionally out of a personal HIV concern.  Two types of concern are apparent in the literature 
(i.e., HIV concern regarding susceptibility and concern about living with the virus), and both 
concern types have merit in deciding HIV preventative behaviors and this exploration. 
The CDC’s compendium demonstrates that knowledgeable health professionals are 
integral to increasing MSM’s use of risk-reduction behaviors, as MSM need support and 
guidance from a professional, trusted resource, or program knowledgeable in HIV prevention in 
order to increase utilization of HIV risk reduction behaviors (CDC, 2017a, 2017c).  Additionally, 
the compendium revealed that MSM are receptive to the counseling and support rendered by 
health professionals with a respectful and non-judgmental rapport.  Health professionals’ abilities 
to intervene during the decision-making process are imperative for MSM, as this review shows 
misconceptions regarding HIV prevention behaviors still exist.  PrEP initiation presents potential 
risks unlike any other HIV preventative intervention (i.e., acquired drug resistance (ADR), 
nephrotoxicity, bone density loss, and unknown adverse events) (CDC, 2014b), making 
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knowledge of the understandings, motives, and abilities MSM patients have determining their 
decisions to initiate PrEP imperative to their overall health.  
While studies by Garcia and Harris (2017) and Parker et al. (2017) offer some evidence 
into this population’s decision-making, these investigations’ research designs and questions only 
validate and confirm MSM initiate PrEP to prevent HIV, which is a known and appropriate 
clinical indication.  Structural barriers are believed to be factors in MSM’s decision-making 
process, but this belief has not been evaluated.  Research in PrEP decision-making from actual 
patients is necessary to understand the phenomenon of PrEP initiation (Hoff et al., 2015; Koblin 
et al., 2011).  The proposed investigation contributes to filling this knowledge gap, as the 
purpose is to explore MSM’s decision to initiate PrEP based upon their evaluation and 
perceptions pertaining: (a) PrEP knowledge and HIV concern(s)/risk(s); (b) personal and social 
motivations to initiate PrEP; and (c) behavioral skills and abilities to PrEP adherence. 
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Chapter 3:  Methodology 
The methodology for this study was Sandelowski’s qualitative description.  Qualitative 
description is rooted in naturalistic research and constructivism, used to gather, understand, and 
describe individuals’ authentic experiences (Colorafi & Evans, 2016; Neergaard et al., 2009; 
Polit & Beck, 2012; Sandelowski, 2000, 2010; Willis, Sullivan-Bolyai, Knafl, & Cohen, 2016).  
Naturalistic research is best when studying a new phenomenon, so that participants can speak 
their truth, uninfluenced by outsiders’ expectations, as each individual’s personal, social, and 
environmental factors shape human experiences, and this methodology focuses on understanding 
the contextual, cultural, personal, and social aspects of a phenomenon (Creswell, 2013; Frey et 
al., 1999; Polit & Beck, 2012; Willis et al., 2016).  
Health-behavioral decision-making is the process of weighing different factors 
surrounding a behavior or choice, which determines if one will implement or not implement the 
respective behavior or choice (Poortaghi et al., 2015; Popejoy, 2005).  Decision-making is 
individualistic and value dependent, determined by one’s previous and current experiences and 
circumstances (Allan & Harden, 2014; Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017; 
Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al., 2011; Poortaghi et 
al., 2015; Popejoy, 2005; Schmidt et al., 2016; Tranberg et al., 2016).  Other factors commonly 
involved in health-behavioral decision-making include one’s knowledge and perspectives about 
health, the behavior, and the disease (Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017; 
Hamilton et al., 2016; Keatley et al., 2013; Newson et al., 2013; Nichol et al., 2011). The 
personal nature of decision-making is congruent with qualitative description’s philosophical 
view to understand and describe authentic experiences (Colorafi & Evans, 2016; Neergaard et 
al., 2009; Sandelowski, 2000, 2010; Willis et al., 2016).   
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The Information-Motivation-Behavioral (IMB) skills model guided this inquiry, as it 
conceptualizes HIV risk-reduction decision-making to include an individual's knowledge, 
motivation, and skills regarding the HIV prevention behavior (Aliabadi et al., 2015; Amico et al., 
2005; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016; L. Smith et al., 2012).  
In this framework, knowledge includes all the information, both accurate and mythical, about the 
preventative behavior; motivation encompasses social and personal support and perspectives 
regarding the behavior; and behavioral skills are the necessary abilities to perform the behavior 
(Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & 
Fisher, 1992; Macapagal et al., 2016); however, MSM’s HIV prevention literature showed that 
HIV concern is also a factor in their decision-making.  Therefore, consistent with the model’s 
concepts and the literature, this study explored HIV-negative MSM’s PrEP initiation decision-
making based on their (a) PrEP knowledge and HIV risk(s)/concern(s); (b) personal and social 
motivations to initiate PrEP; and (c) behavioral skills and abilities to PrEP adherence.  Similar to 
decision-making literature, a qualitative approach is best when using this model, as the use of 
dialogue and open-ended questions will allow the phenomenon to be explored in-depth (Aliabadi 
et al., 2015).   
Conducting one-on-one semi-structured interviews was the method for collecting data, as 
it offered several benefits to the study’s findings and participants.  One-on-one interviews 
provided each participant increased anonymity given the stigma surrounding their sexual identity 
and PrEP (Calabrese & Underhill, 2015; Haire, 2015).  This method allowes an exploration into 
participants' PrEP initiation decision-making processes authentically and uninfluenced by others, 
giving a voice to the emic view (Hutchinson, Wilson, & Wilson, 1994; Streubert, 2014).  Lastly, 
this qualitative research may have provided a therapeutic benefit to participants, as expressing 
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their feelings and perspectives in an open conversation could have fostered an internal feeling 
and sense of acknowledgement, catharsis, purpose, and empowerment (Hutchinson et al., 1994). 
Conducting this study with a qualitative description design implicates clinical practice 
and future studies.  Qualitative description is appropriate when there is a need to answer 
questions influencing clinical practice (Sandelowski, 2000).  Additionally, qualitative studies are 
also indicated and useful in research instrument development (i.e., decision aids and coaching 
strategies) (Toles, & Barroso, 2014b).  Health professionals are advocates in patients’ decision-
making processes, rendering support and education to patients when choosing the treatment 
course and option best suited and congruent with patients' self-identified health goals (Carvajal et 
al., 2017; Chong et al., 2013; Mead et al., 2013; Popejoy, 2005; Rose et al., 2017; Stacey et al., 
2008; Tariman & Szubski, 2015; Thom et al., 2016).  This study’s findings of MSM’s 
knowledge, motivations, and skills to initiate PrEP revealed this sample’s PrEP knowledge, and 
their perceptions regarding their HIV risk(s)/concern(s) also revealed their understanding about 
HIV.  With this data, health professionals are able to identify opportunities to assist patients in 
resolving occurrences of internal and external conflict, PrEP and HIV etiology 
misunderstandings, or other concerns when deciding to initiate PrEP.  Findings from this study 
help identify factors influencing MSM’s PrEP initiation decision-making process and may 
provide content for health professionals to educate, support, and coach patients during this 
process.  The proposed study is foundational, extending the knowledge base of health-behavioral 
decision-making, HIV prevention, and MSM and PrEP initiation, contributing to future 
development of evidenced-based strategies and tools best for counseling and supporting MSM 
during this process leading to HIV prevention success through PrEP initiation.  This chapter 
details the study procedures the investigator followed to conduct this study. 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 77 
 
Study Procedures 
Study procedures explicitly describe the process for recruiting and collecting data from 
participants.  For a qualitative investigation to be trustworthy, the study procedures must match 
and align with the research objective, literature findings, theoretical framework, and 
methodology (Colorafi & Evans, 2016; Neergaard et al., 2009).  Although the timeframe for 
performing and conducting a study from start to completion cannot be predetermined, the 
investigator anticipated this study to be conducted over a twelve-month period.  Appendix C 
displays the timeline of study milestones from study approval to study closure.     
Human Subjects’ Protection  
Protecting the safety and confidentiality of research participants included receiving the 
appropriate approvals and securing participant data.  The investigator received approval from 
Kennesaw State University’s (KSU) Institutional Review Board (IRB) in March 2018, and 
adhered to their research and ethical principles.  Additionally, the investigator sought and 
received approvals from identified and consenting PrEP practices’ administrations and research 
departments between March and August of 2018.  Interested patients meeting the inclusion 
criteria underwent informed consent, and after giving written informed consent, the participant 
was enrolled into the study, assigned a participant identification (PID) number, and provided a 
pseudonym.  When disseminating this study's findings in publications or conference 
presentations, the investigator will refer to the participants using their pseudonym or PID 
number. 
Upon the completion of the written consent and enrollment forms, the documents were 
scanned and saved onto a password protected and encrypted thumb drive.  All hardcopy forms 
were locked and maintained in the investigator’s office.  Each participants’ audio recordings, 
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transcripts, data analyses, and field notes were identified according to the participant’s PID 
number and scanned and saved on the thumb drive. Study related materials (i.e., thumb drive, 
audio recordings, transcripts, etc.) were kept in a locked cabinet in the investigator’s office.  This 
information will be stored in the investigator’s locked office three years post-study closure or 
according to KSU’s IRB’s guidelines.  Once the span of time has expired, all study related 
materials will be shredded and discarded according to KSU's guidelines.  
Setting 
 The setting is the place where participant recruitment will occur.  Participants were 
recruited from identified clinics with from providers offering PrEP and PrEP services; however, 
interviews occurred at the recruitment clinic, public library, office, conference room or location 
providing participants with comfort, privacy, and anonymity.   
Identify PrEP clinics.  Recruitment for qualitative studies typically occur in an area 
commonly affiliated with, or frequented by the study population of interest (Toles & Barroso, 
2014a).  The proposed study sought to identify HIV-negative MSM's PrEP initiation decision-
making process; therefore, participant recruitment targeted MSM PrEP patients.  Since PrEP is a 
preventative regimen, there is no funding source for these clinics, as federal and state programs 
like the AIDS Drug Assistance Program (ADAP), and Ryan White Care Act Part B only fund 
HIV/AIDS’ treatment efforts, not prevention efforts (Horberg & Raymond, 2013; McMahon et 
al., 2014).  As a preventative regimen, any clinician with prescribing authorities or capabilities 
can prescribe PrEP, but from this investigator’s own experience, most PrEP clinics are started as 
another service or discipline within an HIV clinic.  Additionally, patients are referred by word of 
mouth from peers or from accessing a service in a facility that provides PrEP.    Therefore, the 
investigator identified clinics with health professionals known and documented to offer PrEP 
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services in the states of Alabama and Georgia.  The investigator searched the Greater Than AIDS 
website, https://greaterthan.org/get-prep/PrEP, a site used to provide HIV/AIDS information 
including clinics and providers known to offer PrEP.  The investigator also identified PrEP 
clinics and providers by gathering information from Alabama’s and Georgia’s state health 
departments' HIV/AIDS division, and Appendices D and E provide a list of those identified 
clinics and providers.  Due to slow recruitment, the investigator identified other PrEP clinics and 
providers in other parts of the Southern U.S. using the Greater Than AIDS website and 
respective state health departments' HIV/AIDS divisions.  Specifically, the investigator contacted 
clinics in Florida, Mississippi, and Louisiana to gauge their interest in participating.   
Access PrEP clinics.   Once identified, the investigator contacted the PrEP clinics for 
permission to recruit study participants.  Each contacted practice received a recruitment 
invitation letter and study synopsis (see Appendices F and G, respectively).  The investigator 
requested a face-to-face meeting with the necessary administration and staff to further describe 
the study and to answer any questions; however, most correspondences occurred through 
electronic mail (email) and phone conversations.  Once granted permission to recruit, the 
investigator provided recruitment handouts and posters (see Appendix H and I, respectively) to 
those consenting facilities.  Clinic staff disseminated or made the recruitment materials available 
and visible to patients in waiting areas and examination rooms.  By this recruitment strategy, 
patients made the choice to participate in the study, which was thought to make providers feel 
more comfortable with supporting the study, as the investigator did not have access to patient 
records.  The handout had a brief study synopsis and the investigator’s contact information.  
With the permission of the facility, the investigator was willing to be on-site during clinic hours 
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at least once a week to recruit and answer questions from staff and patients.  Given the fact that 
these clinics provided services and care to PLWH, such permissions were not granted.     
Sample 
Although qualitative descriptive researchers commonly use purposeful sampling, as it 
gives researchers immediate access to the population specifically experiencing the investigated 
phenomenon (Colorafi & Evans, 2016; Neergaard et al., 2009; Sandelowski, 2000), but the 
investigator used convenience and snowball sampling.  Convenience sampling is “the use of the 
most readily accessible persons” as research participants (Haber, 2014, p. 236), as participant 
recruitment occurred at PrEP clinics that were not specific to serving MSM alone.  As the 
investigator identified study participants, snowball sampling occurred as she asked participants 
to refer the study to other potential study participants (Polite & Beck, 2012).   
In qualitative studies, an exact sample size is difficult to predict, as data saturation 
determines the sample size.  Although an exact number of participants can be difficult to 
estimate, researchers have given guidance on potential sample size for qualitative research 
studies.  Recommendations for understanding the essence of experiences tend to have a sample 
of six (Sandelowski, 1995).  Mason (2010) stated that the average sample size used in doctoral 
qualitative research studies was 31.  For a fairly homogenous group, data saturation could occur 
with a sample size of 12 (Boddy, 2016).  Similarly, Toles and Barroso (2014a) concluded that a 
sample size of less than 30 participants is best given the significant amount of text to be 
analyzed.  A systematic review reported qualitative descriptive sample sizes to use between 11 
and 20 participants (Kim, Sefcik, & Bradway, 2017).  Lastly, Parker et al.'s (2015) qualitative 
inquiry of MSM PrEP patient experiences used 24 participants. Therefore, given the variances in 
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qualitative studies’ sample size, the investigator anticipated a sample size of 10 to 30 participants 
in order to achieve data saturation.   
Inclusion criteria.  To be eligible for this study, participants had to meet all of the 
following inclusion criteria at the time of consent: (a) assigned a sex of male at birth; (b) 18 
years of age or older; (c) verbally confirm engagement in anal intercourse (AI) with men; (d) 
currently taking PrEP; (e) began taking PrEP in the past six months; (f) verbally confirm being 
HIV-negative; (g) read, speak, understand, and write English; and (h) provide written informed 
consent. 
Participant recruitment.  Participant recruitment began when a patient voluntary 
contacted or approached the investigator by phone or on-site for study information.  The 
investigator provided an overview of the study, and asked three questions:   
1. Did you start taking PrEP in the last six months?   
2. Do you have sex with men?  
3. Are you at least 18 years of age?  
If the participant answered “no” to any of the questions then they did not meet the study’s 
criteria.  If the participant answered “yes” to all questions, the investigator made an appointment 
with the patient.  The participant was instructed that during this appointment the informed 
consent and study requirements will be reviewed.  Additionally, the participant was told to bring 
their PrEP prescription bottle to validate they were taking PrEP.  Participants were encouraged to 
ask any questions pertaining to the study.  The investigator told the participant to allot for two 
hours, as after the consenting process concluded, the interview began.  Although this did not 
occur in this study, participants had the option to separate the consenting and interview 
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processes.  In that event, the initial appointment was anticipated to last up to an hour to conduct 
the informed consent process only.   
The investigator and participant discussed potential dates, times, and locations for this 
meeting.  The investigator was aware that depending on space and availability, utilizing the 
clinic to meet with participants was not be feasible or guaranteed.  Therefore, the investigator 
proposed a secondary interview location, offering participant anonymity and confidentiality.  A 
public library, office, or conference room with a closed door offered the necessary privacy and 
anonymity for participants.  Due to safety concerns, if a mutual location and time could not be 
agreed upon, the investigator declined pursuing any further research activities with the 
participant.   
During the initial appointment, the investigator determined the patient’s eligibility.  First, 
the participants confirmed they (a) were assigned a sex of male at birth; (b) were 18 years of age 
or older; (c) engaged in AI with men; (d) were currently taking PrEP; (e) began taking PrEP in 
the past six months; (f) were HIV-negative; and (g) could read, speak, understand, and write 
English.  To verify the participant’s PrEP status, the investigator looked at the prescription bottle 
verifying that Truvada was dispensed to the consenting participant within the past month.  
Second, the investigator detailed the study requirements: (a) informed consent, (b) one 60-minute 
audio recorded interview, and (c) completion of a demographic form.  Participants were 
informed that after completing the interview and demographic form they would be compensated 
with a $30 Visa® credit gift card for their time.  The investigator detailed the steps taken to 
protect their confidentiality, and clarified any study related questions.  Lastly, the investigator 
reiterated that participation was voluntary, as consent could be withdrawn at any time without 
penalty, and had no impact on care or services receiving at the current or any PrEP location.  If 
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the participant agreed to the research procedural terms, the participant underwent the informed 
consent process.  
Informed Consent 
Each eligible and willing participant underwent informed consent.  The participant was 
given the most currently approved consent form (see Appendix J), which detailed the study 
purpose and procedures, and the investigator read and reviewed the form with the participant.  
All study questions were answered at that time and at any point during study enrollment.  For 
participants unwilling to provide consent, the investigator discontinued all study procedures with 
the participant.  In the future, if the participant wished to be a part of the study, they would have 
to contact the investigator.  Consenting participants provided their legal signature in the indicated 
areas on two copies of the most current and approved consent form.  The investigator likewise 
signed in the appropriate places on both copies.  The investigator and participant each kept one 
of the signed consent forms to keep for their records.  The research participant had the right to 
withdraw their consent verbally at any time during study enrollment.   
Researcher-participant Relationship 
Trust, respect, and empathy are actions believed to establish rapport with the participant, 
so that the participant can be authentic during the interviews (Dang, Westbrook, Njue, & 
Giordano, 2017).  A neutral relationship and rapport tactics allow participants to not feel judged 
by their answers, or respond in a manner perceived to be pleasing to the investigator (Dang et al., 
2017); therefore, the investigator maintained a neutral and impartial stance and relationship with 
participants.  Additionally, the investigator built rapport by completing agreed upon tasks (i.e., 
return phone calls, timeliness of appointments and meetings), being open and honest in 
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answering participants’ questions, and respecting participants’ choices (i.e., study participation, 
sexual behaviors, PrEP initiation, and information uncovered during interviews).      
Study Enrollment  
Once written consent was attained, the participant was enrolled in the study.  The 
investigator completed the Study Enrollment Form (see Appendix K), which documented the 
participant’s eligibility.  The participant was assigned a PID number, beginning with PID-001, 
and was provided or assigned a pseudonym.   
Research Instruments 
In qualitative research, the primary research tool is the interviewer (Creswell, 2013), but 
participants dominated the discussion, with the investigator guiding the interview.  The 
investigator followed the six-item interview guide (see Appendix L), asking probing questions to 
gather more information or gain more clarity regarding the responses.  The demographic form 
(see Appendix M) was completed by the participant at the end of the interview which collected 
the participants’ age, race, ethnicity, annual income, PrEP start date, AI behaviors, number of 
sexual partners in the previous 3 months, and condom-use percentage.  The interview guide and 
demographic form were specifically developed for this study.   Although this weakens the 
validity and reliability of the tool, the theoretical framework was used to construct the guide.  
Immediately after completing the interview, the investigator took field notes, documenting 
participants’ nonverbal and/or emotional behaviors.   
Conducting Interviews 
Participant interviews occurred after written consent was obtained.  Although this did not 
occur during this investigation, the investigator devised a contingency plan for patients wishing 
to separate the consenting and interviewing processes.  In those circumstances, the investigator 
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would have scheduled the interview immediately after the patient provided written informed 
consent.  When scheduling the interviews, the investigator would have utilized the same 
procedures identified in the initial appointment procedure.  Conducting participant interviews in 
the same location as the initial appointment would have been encouraged, but not guaranteed.  
Pre-interview procedures.  Prior to each interview, the investigator self-identified all 
assumptions and biases related to MSM and PrEP.  These self-identified assumptions were 
written down and bracketed.  Bracketing is the process of the investigator acknowledging 
personal biases regarding the phenomenon and clarifying how those biases can influence and 
misconstrue the interpretation of the participants' interviews (Toles & Barroso, 2014b).  For this 
study, the investigator identified and reported personal feelings, beliefs, and experiences 
pertaining to PrEP and MSM.  Twenty-four to 48 hours before meeting with a participant, the 
interviewer confirmed the interview location, date, and time with the participant.  The 
investigator documented the confirmation or any changes to the agreed upon plans on the study 
participant's enrollment form.  This allowed time to prepare for the interview, and ensured the 
setting still met the anonymity and confidentiality requirements.   
Interview procedures.  During the interview, the investigator followed the six-item 
interview guide.  The interviewer had bottled water and tissues on site for participants' use.  
Additionally, the interviewer utilized two audio recording devices during the interviews.   
Post-interview procedures.  Post-interview, there were requirements for both participants 
and the investigator.  Participants completed the demographic form, and the investigator gave the 
participant a $30 Visa® credit gift card.  Each participant acknowledged receiving compensation 
at that time by completing the indicated area on the demographic form.  Once completed, the 
participant was un-enrolled from the study.  The investigator took field notes, to capture 
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participants’ nonverbal and/or emotional behaviors they exhibited during the interview.  Post-
interview, journaling is encouraged as it allows the investigator to bracket biases before 
conducting additional interviews (Toles & Barroso, 2014b).  Therefore, the investigator also set 
aside time for reflective journaling to identify personal biases about participants’ responses.   
Data Analysis  
 Descriptive statistics.  Descriptive statistics only described the sample’s demographics, as 
no inferences were based on this information.  Specifically, means were used to describe the 
sample’s age, number of sex partners, and condom-use rate, while percentages described 
ethnicity, race, annual income, and sexual behaviors.   
Transcribing interviews.  In qualitative studies, data analysis entails the process of 
transcribing the interview raw data, which determines the study's findings and results (Toles & 
Barroso, 2014a, 2014b).  The investigator used the paid transcription services of Rev.com, 
https://www.rev.com/, to have the audio recordings from the interviews transcribed verbatim.  
The interviews were submitted for transcription within 24 hours of completing the interview.  
After receiving the transcript, the investigator performed a transcript audit while listening to the 
interview within 48 hours of receiving the transcribed interview to verify the transcript’s 
accuracy.   
Inductive content analysis.  After verifying the transcript’s accuracy, the data was 
analyzed using a content analysis approach. Content analysis is used commonly in qualitative 
description studies (Neergaard et al., 2009; Sandelowski, 2000; Vaismoradi, Turunen, & Bondas, 
2013).  The purpose of content analysis is to analyze text to describe its characteristics “by 
examining who says what, to whom, and with what effect” (Vaismoradi et al., 2013, p. 400).  
The findings of the content analysis reveal “a true insider perspective”, that adds to the study’s 
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credibility (Neergaard et al., 2009, p. 4).  An inductive approach was warranted due to the 
absence of previous research pertaining to the phenomenon (Elo & Kyngas, 2008).   
This investigator followed the inductive content analysis process of Elo and Kyngas 
(2008) (see Appendix N), which encompasses three phases:  preparation, organizing, and 
reporting.  In the preparation stage, the interviewer thoroughly and carefully read the transcribed 
interviews and acquired an understanding of the main ideas.  From the main ideas, the 
investigator selected themes that emerged regarding this sample’s PrEP initiation decision-
making process.  The investigator then asked who, what, when, where, and why regarding the 
content.  The investigator organized the themes through open coding, as she wrote notes and 
headings that described the content, and this process was repeated multiple times.  The headings 
were transferred to coding sheets that were grouped into broader abstract categories.   
The investigator used peer checking to verify the accuracy of the analysis.  Peer checking 
involves the use of an external colleague or committee to validate the investigator’s findings and 
conclusions (Colorafi & Evans, 2016; Houghton et al., 2013; Neergaard et al., 2009).  The 
investigator had an assembled four-member research oversight committee, but peer checking 
occurred with the committee chairperson.  The investigator submitted the content analysis results 
electronically (i.e., email) of the first two interviews to the chairperson within 24 hours of 
completing the analysis of the second interview.  The chairperson provided feedback within five 
to seven business days.  Once the chairperson believed the investigator was analyzing the data 
competently, or to their standards, the analysis results were then submitted to the committee 
chairperson after analysis completion of every fourth interview.  This collaboration ensured that 
the investigator’s analyses were evaluated and confirmed by an experienced qualitative 
researcher.  As more interviews were collected that allowed more understanding, the investigator 
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had to revert to the preparation and organizing phases.  Lastly, in reporting and disseminating the 
study findings, the investigator detailed the content analysis process, explained the connection 
between the data and concluded results, and used actual participant phrases and statements to 
demonstrate authenticity.   
Interviews were ongoing until data saturation of the themes representing MSM’s PrEP 
decision-making process was reached.  Data saturation is “the point in the data collection process 
when no new concept-relevant information is being elicited” (Kerr, Nixon, & Wild, 2010, p. 
271).  After data analysis reflected that data saturation had been reached, the investigator 
conducted two more interviews to ensure no new concepts were missed.  At this point, the study 
closed to recruitment.  The investigator informed the participating PrEP clinics of the study’s 
closure to participant accrual, and requested that they discard any remaining recruitment 
materials.   
Trustworthiness 
Trustworthiness is the reliability of study findings based upon the consistency and 
appropriateness of research procedures (Colorafi & Evans, 2016; Toles & Barroso, 2014b).  
Criticality improves rigor and trustworthiness, as it is the thought process leading to research 
decisions and procedures (Neergaard et al., 2009), and the investigator was critical in conducting 
research procedures.  Trustworthiness occurred on a continuum, requiring the investigator to 
remain objective, neutral, and consistent in performing research procedures throughout the 
investigation (Colorafi & Evans, 2016; Neergaard et al., 2009).   
The most appropriate methodology was selected given the study’s question, purpose, 
literature review findings, and theoretical framework, which increased the trustworthiness of the 
study's results (Fulton & Krainovich, 2014).  Currently the literature lacks evidence of MSM’s 
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PrEP initiation decision-making, and qualitative description was the best method, as the study 
objectives were to gather and identify aspects of the phenomenon.  Qualitative description is a 
naturalistic research approach, which allows investigators to gather information based on the 
sampled populations' human experiences, which are shaped by each individual’s personal, social, 
and environmental factors (Creswell, 2013; Frey et al., 1999; Willis et al., 2016).  In developing 
the interview guide, the investigator used the definitions and concepts of the study's theoretical 
framework, the IMB skills model.  Utilizing the study's theory to design study instruments 
increased rigor and study trustworthiness, as it demonstrated the research to be theory driven 
(Stewart & Klein, 2016).   
All study procedures were consistent and clearly identified prior to study conduction, 
which contributed to this study’s trustworthiness.  The identified recruitment and consenting 
procedures were followed for each participant.  Trustworthiness was established by asking open-
ended questions that allowed participants to speak freely telling their story unimpeded (Colorafi 
& Evans, 2016).  During interviews, the interviewer did not interject thoughts, or finish 
participants' sentences or thoughts.  These procedures ensured that the data collected was 
context-rich with the truth as seen and perceived by the participant (Colorafi & Evans, 2016; 
Neergaard et al., 2009).  
Trust in the data analysis process required the methods used in evaluating the data to 
follow a consistent and logical pattern and approach (Colorafi & Evans, 2016; Toles & Barroso, 
2014b).  Following the pre-identified inductive content analysis process, which explains the 
coding process also increased credibility of the findings (Colorafi & Evans, 2016).  Additionally, 
the investigator instituted journaling and bracketing to maintain the investigation’s objectivity 
and transparency.  Journaling and bracketing allowed the investigator to recognize and 
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acknowledge biases, increasing trustworthiness, as the interviewer did not distort the emic view 
(Toles & Barroso, 2014b).   
Another method to maintain trustworthiness was confirmability, which is the process for 
evaluating and verifying the results from the study's data analysis (Neergaard et al., 2009).  The 
investigator utilized peer checking to accomplish confirmability, verifying the accuracy and 
credibility of the transcribed interviews and content analysis results, respectfully (Colorafi & 
Evans, 2016; Houghton et al., 2013; Neergaard et al., 2009).  Adhering to these qualitative 
traditions, data analysis and collection occurred simultaneously (Colorafi & Evans, 2016).  
Additionally, the investigator reported findings using actual participants’ phrases and statements 
to link data to the results (Elo & Kygnas, 2008).  This upholds authenticity and credibility, as 
participants’ voices were heard (Neergaard et al., 2009).  The investigator was the only 
researcher conducting this process, which built trustworthiness and the credibility of the findings 
as there was no variance in how the interviews were conducted, reviewed, and interpreted 
(Colorafi & Evans, 2016; Toles & Barroso, 2014b).   
The investigator was well equipped and knowledgeable to function as the principal 
investigator for this study.  She had previous experience as a research coordinator in several 
medical and health-care specialties including HIV/AIDS.  Due to her clinical research 
experience, she was knowledgeable and familiar in research regulations and principles.  She 
shadowed in different PrEP clinics to further understand the population served and the clinic 
flow and process.  Additionally, her passion and commitment to advancing the knowledge 
regarding HIV prevention reaffirmed that she had the capacity to conduct this study with the 
appropriate research integrity.   
Summary 
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This study was conducted following Sandelowski’s qualitative descriptive research 
approach.  The absence of evidence regarding MSM’s PrEP initiation decision-making and the 
individualistic phenomenon of decision-making made a qualitative descriptive approach 
befitting.  Qualitative description is appropriate when investigations are conducted to explore 
individual’s authentic experiences, as a way to seek to gather, understand, human experiences 
from the perspectives of the actual source (Colorafi & Evans, 2016; Neergaard et al., 2009; Polit 
& Beck, 2012; Sandelowski, 2000, 2010; Willis et al., 2016).  The study’s implications are 
consistent with this naturalistic research methodology, as qualitative studies are indicated for 
developing tools and interventions for clinical practice (Toles & Barroso, 2014b).  From this 
study, health professionals will know what this sample of MSM understood about HIV and PrEP, 
which can be used to identify opportunities to assist current and future patients in resolving 
occurrences of uncertainties and misconceptions about PrEP and HIV.   
The investigator identified PrEP providing clinics in the states of Alabama and Georgia 
first and later expanded to other clinics in the Southern U.S.  Practices agreeing to support the 
investigator’s study were sent IRB approved recruitment handouts and posters to make available 
to their patients.  Interested participants had to voluntarily contact the investigator to express 
interest in study participation.  For those patients, the investigator reviewed the study criteria and 
requirements in depth, and if the patient had no uncertainties or objections, they were provided 
informed consent.  Audio-recorded one-on-one interviews was the method for collecting data, 
and the investigator used the study specific and theory-derived six-item interview guide.  The 
investigator utilized a paid transcription service to have interviews transcribed verbatim, and 
interviews were on-going until data saturation was achieved.  At that point, the investigator 
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conducted two more interviews to ensure no emerging themes were missed.  The investigator 
projected the sample size to be 10-30 participants.   
To ensure the study findings were deemed rigorous, the investigator instituted certain 
procedures and parameters to ensure trustworthiness.  The investigator was critical in making 
research decisions, and remained objective throughout the investigation.  Given the study’s 
question, purpose, literature review findings, and theoretical framework, the most appropriate 
methodology, qualitative description, was selected for conducting this study.  The investigator 
followed all study procedures consistently according to the predefined procedures.  The 
interview guide was developed using the definitions and concepts of the study's theoretical 
framework, and contained open-ended questions that allow participants to speak freely 
unimpeded.  During data analysis, the investigator compiled appropriate descriptive statistics to 
summarize the sample, and followed the three-phase inductive content analysis process of Elo 
and Kyngas (2008) to analyze and identify the common themes describing the phenomenon.  The 
investigator performed reflective journaling and bracketing to identify biases and assumptions 
regarding PrEP and MSM.  In disseminating study findings, the investigator used actual 
participants’ phrases and statements to ensure participants’ voices were heard (Neergaard et al., 
2009).  Lastly, the investigator reported that these findings cannot be transferred to the larger 
MSM population, and are relative to this sample and possibly of MSM PrEP patients with similar 
demographics and circumstances.     
During this study, the identities of study participants was protected and remained 
confidential.  The researcher adhered to KSU’s IRB and participating PrEP clinics' guidelines.  
Data collection occurred after participants gave voluntary written informed consent, at which 
point the participant were assigned a PID and pseudonym.  Upon the completion of study related 
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documents, the investigator scanned and saved them onto a password protected and encrypted 
thumb drive.  The hardcopy forms were kept locked and maintained in the investigator’s office.  
This information will remain secured in the investigator’s locked office three years post-study 
closure or according to KSU’s IRB’s guidelines.  Once the span of time has expired, all study 
related materials will be discarded according to KSU's guidelines.    
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Chapter 4:  Findings 
HIV pre-exposure prophylaxis (PrEP) initiation decision-making process is relatively 
unknown.  The purpose of this study was to explore this phenomenon in HIV-negative men who 
have sex with men (MSM) engaging in protected or unprotected anal intercourse (AI).  
Therefore, the following research question was proposed:  How do HIV-negative MSM, 
engaging in protected or unprotected AI, decide to initiate PrEP?  Study objective was to explore 
how this population decided to initiate PrEP based on the evaluation and perceptions pertaining 
to their:  (a) PrEP knowledge and HIV risk(s)/concern(s); (b) personal and social motivations to 
initiate PrEP; and (c) behavioral skills and abilities to adhere to PrEP.  
This chapter details the findings from this study’s data analysis.  The investigator used 
descriptive statistics to summarize the sample’s demographics, and described the themes that 
emerged from participants’ semi-structured interviews.  Referring to participants by their 
pseudonyms, the investigator quoted phrases and statements to link and define relationships 
between these themes.  Through open coding, the themes were organized into five broader 
categories:  HIV-risk acknowledgement, HIV concern, PrEP understanding, PrEP accessibility, 
and PrEP consideration, and the investigator detailed these categories to be the major concepts in 
a conceptual model detailing this sample’s PrEP initiation decision-making process.   
Participant recruitment occurred between March and August of 2018.  Although the 
investigator contacted 16 known PrEP clinics in Alabama, Georgia, Louisiana, Florida, and 
Mississippi, eight responded in agreeing to receive and post IRB approved study recruitment 
materials in their clinics.  Appendix O provides a list of those participating PrEP clinics.  
Fourteen participants consented, enrolled, and completed the study requirements.  This 
predominantly African American sample (10/14, 71%) ranged in age from 20-59 years, with a 
mean age of 34 years.  Fifty-seven percent (8/14) of the sample completed some form of post-
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secondary education, and most participants had an annual income of either less than $20,000 
(6/14, 43%) or between $20,001 and $40,000 (5/14, 36%).  Table 1 provides the demographic 
information for each participant.  
Table 1 
Participant Demographic Data   
PID* Age Ethnicity Race Education** Annual Income  
001 28 Non-Hispanic African-American High school <$20,000 
002 33 Non-Hispanic White College $40,001- $60,000 
003 21 Non-Hispanic African-American College $20,001- $40,000 
004 49 Non-Hispanic White Graduate school  >$80,000 
005 31 Non-Hispanic White College $20,001- $40,000 
006 33 Non-Hispanic African-American High school <$20,000 
007 27 Non-Hispanic African-American High school <$20,000 
008 49 Non-Hispanic African-American High school <$20,000 
009 30 Non-Hispanic African-American High school <$20,000 
010 51 Non-Hispanic African-American College $20,001- $40,000 
011 48 Non-Hispanic African-American College $20,001- $40,000 
012 33 Non-Hispanic African-American College $40,001- $60,000 
013 20 Non-Hispanic Other College $20,001- $40,000 
014 24 Non-Hispanic African-American High school <$20,000 
* Participant Identification Number 
** Highest level of education completed 
 
Emerging Themes 
Application of Elo and Kyngas’ (2008) three phase inductive content analysis (see 
Appendix N) revealed several themes to emerge regarding this sample’s PrEP initiation decision-
making process.  The interviewer thoroughly, carefully, and repeatedly read the transcribed 
interviews and acquired an understanding of the main ideas.  The investigator selected a theme, 
being either a word or a phrase that best described the main ideas.  Themes regarding PrEP 
knowledge were revealed to be perceptions and understanding of PrEP’s indications, benefits, 
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risks, and consequences.  HIV risks and concern themes included susceptibility from risky 
behaviors and factors, deception/lack of disclosure, and HIV/sexually transmitted 
infection/disease (STI/STD) exposure scares.  Additionally, this sample’s HIV concern 
encompassed both physiological fears and social implications from contracting the virus.  
Although social motivations were not apparent in this data, personal motivations were revealed 
to be added protection and peace-of-mind that initiating PrEP provided.  Cost and availability of 
services were the themes associated with the sample’s behavioral skills and abilities to adhere to 
PrEP.  The data demonstrated these themes were weighed and evaluated, leading to their 
decision to initiate PrEP.  The investigator analyzed the transcribed interviews to assess and 
understand how the identified themes were rationalized as factors a part of this sample’s PrEP 
initiation decision-making processes.  From that analysis, five broader and more abstract 
categories:  HIV-risk acknowledgement, HIV concern, PrEP understanding, PrEP accessibility, 
and PrEP consideration were revealed to detail this sample’s PrEP initiation decision-making 
process.  The investigator’s process for discovering these five categories are discussed below.   
HIV-risk Acknowledgment  
Participants were asked about their perceived HIV risks, and each openly admitted to 
knowing the behaviors and factors placing them at HIV risk.  Table 2 lists the overall HIV-risk 
behaviors and factors reported by the sample, and Table 3 summarizes the sample’s reported 
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Table 2 
Participants’ Overall Reported HIV-risk Behaviors & Factors 
# Participants Reporting Behaviors & Factors 
14 HIV status deception/ lack of disclosure   
10 Multiple sex partners  
10 Inconsistent/no condom use 
6 Open/casual/impulsive sex 
5 HIV MSM disparity  
4 Sex with partner with an unknown HIV status 
2 Sex with partner with HIV 
2 Sex with partner with an STI 
3 Engaging in sex 
3 Condom failures (breaks) 
2 Having sex cognitively impaired 
2 HIV prevalence (geographic region) 
1 Threat of physical violence or sexual assault  
 
Table 3  
Participants’ Reported AI & Sexual Behaviors* 






Yes = Y No = N 
Anal sex 
(receptive) 
Yes = Y No = N 
Oral sex (give) 
Yes = Y No = N 
Oral sex 
(receptive) 
Yes = Y No = N 
001 
30 75 Y N N N 
002 
8 20 Y Y Y Y 
003 
10 0 Y N Y Y 
004 
5 0 Y Y Y Y 
005 
4 0 Y Y Y Y 
006 
1 50 Y N N Y 
007 
0  -- --  --  --  --  
008 
2 100 Y N N N 
009 
4 100 N Y Y Y 
010 
0  -- --  --  --  --  
011 
3 90 N Y N N 
012 
3 100 Y N Y N 
013 
3 25 Y Y Y Y 
014 
8 80 Y N Y Y 
*Refers to behaviors that occurred in the previous 3 months 
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As Tables 2 and 3 indicate, this sample admitted to engaging in several sexual behaviors 
placing them at risk for HIV.  The most commonly reported HIV-risk behaviors were having 
multiple sex partners, using condoms inconsistently or not at all, and engaging in 
open/casual/impulsive sex.  The responses indicated that these behaviors were the norm for this 
sample prior to initiating PrEP; however, the study did have an outlier.  One participant reported 
that due to the availability of PrEP, he deliberately changed his sexual behaviors, increasing his 
HIV risks for the purpose of initiating PrEP.  Dan, age 49 described, 
I had one long-term relationship from the age of 18 to 25 in college.  [So for] seven years, 
[I was with] one person.  Uh, 25 to 47 [I had] one relationship, monogamous, [and] I've 
only recently branched out, because I honestly feel like I missed out on a lot of sexual 
exploration in my youth that I wish to make up lost time, and PrEP seemed like the only 
logical way to do that.   
Without PrEP, Dan said, “I would not be putting myself out there with multiple people.  No, I 
would not.”  Acknowledging the risks accompanied by this new behavior, prompted Dan’s 
initiation of PrEP. 
Although sexual behaviors were significant HIV risk factors, as Table 2 indicates, HIV 
deception was the most commonly non-behavioral perceived HIV risk factor.  HIV deception 
was discovered to be the deliberate act of a person with a known HIV-positive status lying about 
or withholding their positive status from their partner prior to a sexual encounter.  Ace 
commented, “I’ve learned a lot of people don't disclose themselves,” and Beyonce echoed this 
sentiment stating,  
No one will tell the truth when you ask.  I mean you be sitting there having a general 
conversation with someone, and y'all are discussing sex things.  Okay, well if it's 
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comfortable enough for us to discuss sex, we should be comfortable enough to discuss 
our status.  And, for some odd reason, a lot of them don't like to discuss their status.   
Participants conveyed and shared their personal experiences regarding peers being 
actually deceived by an HIV-positive partner.  Participants did not have to experience or be 
personally involved in HIV deception in order to perceive it as a risk factor, as participants 
repeatedly voiced HIV deception as an HIV risk from listening and hearing stories from peers.  
Bruce reiterated, “Yeah, they're gonna lie, and I find that too often. And I know people be 
deceptive and try to get what they want.”  Participants believed that deception is done 
maliciously as Steve said he has heard “horror stories of men purposely infecting others.”  Dre 
further explained his experience, “I've encountered people who just don't give a fuck, and they're 
just like, ‘Well I've got it, and nobody told me that they had it.  So I'm just gonna give it [to] 
somebody else.’”  Beyonce shared his story of learning about his best friend contracting HIV due 
to deception, and that experience was key to his decision to initiate PrEP as he stated, “When I 
found out my best friend was HIV positive, I knew right then I needed to do something.  Because 
if you can be with a man that says he loves you, and yet, he basically took your life from you, 
then, I mean, what makes me different from [him]?”  Today, HIV deception is perceived to be 
easier, due to the advances in HIV care and treatment, as PLWH look no different from those 
who are HIV-negative.  Percy confirmed this perception from his experience with a former 
partner who was positive, “He looks very nice, like you wouldn’t even [have thought he was 
positive].  HIV doesn't have a face or anything.”   
The impact on acknowledging HIV deception and the lack of disclosure was seen by this 
sample to significantly increase HIV risk and was a factor in their decision to initiate PrEP.  Ace 
declared, “On a scale of 1 to 10, I would say 10, [with] 10 being the greatest,” and Alex admitted 
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that concerns about HIV deception “was like one of the major factors [be]cause you can trust 
somebody but you're never 100% sure.”  The ease and frequency in which this sample perceived 
HIV deception to occur created a sense of distrust in potential or current sexual partners.  
Participants, Dan and Poomp blatantly expressed that it is difficult to trust and take people at 
their word, as Dan said, “people will lie to your face“, while Poomp responded that, “[you] just 
can’t believe them or trust them”.  Even Bishop commented that “it's kind of hard to trust 
anything with anybody now,” and Dre said, “There are so many people lying about their status 
and stuff.”  Additionally, participants voiced that lies are told regardless of the relationship type 
or affection a partner can honestly have for the other.  Beyonce detailed his experience of a 
friend contacting HIV after being deceived by a partner  
Even if you with a person that says they love you, no matter what, you still can't trust 
them, not these days.  Because this guy sle[pt] beside you every night, and sa[id] he loves 
you, and he cares about you, but when you asked him, what was his status, he sat there 
and blatantly lied to you, and said that he was negative, knowing that he was positive. 
And now you have to live with this. 
That acknowledgement of deception and distrust created a heightened sense of fear and 
concern.  Jay expressed, “I'm just afraid, right now.  There [are] so many people [out] here just 
telling you, ‘They ain't got this, and I know my status.’  I don't believe that anymore.”  
Additionally, participants did not feel they had a way to confirm a partner’s status, as Dre 
responded, “I don't really fuck with positive guys, but you don't really know who's really what 
here, because a lot of people aren't telling a lot of things."  That inability to truly know or verify 
a person’s HIV status was concerning, which was rationalized as a reason to initiate PrEP since 
they believed people to be dishonest and deceptive regarding their actual HIV status.  PrEP 
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provided added protection from contracting HIV, as Bill explained that he tried “to take 
somebody at their word, but sometimes that's just not enough.”  In a similar way, Alex described, 
“Somebody can tell you, ‘Oh yeah, I'm fine.’  They can even show you their paperwork and 
everything. You still don't know 100%.  People lie, and they can really, really deceive you, so it's 
best to keep yourself covered and checked.”   
STI or HIV scares and experiences were also commonly recognized as an HIV risk factor 
encouraging this sample’s decision to initiate PrEP.  Justin and Bishop both expressed an STI 
scare convinced them of their HIV risk.  In these instances, participants had known about PrEP 
before the exposure scare, as Justin admitted that he “thought about the pill [PrEP] months 
before,” but did not perceive initiating PrEP to be necessary.  The threat of contracting an STI 
made the threat of HIV real and apparent.  Bishop recalled his exposure scare to influence his 
decision to initiate PrEP, “I had been hearing a lot about PrEP anyhow [and] I didn't really think 
nothing of it at that time then.  Then after I got intimate with this guy and I realized the condom 
had popped then, I was like, “Yeah maybe it's a sign you need to go ahead and take PrEP”.  Alex 
experienced an HIV exposure scare, triggering his decision to initiate PrEP.  After having a 
protected sexual encounter, Alex became sick, and he immediately thought he had contracted the 
virus.  Regarding that feeling of thinking he contracted HIV he said, “I'd never been that nervous 
or scared.  Even though during that encounter, I was safe, but I still was like, 'Okay, this doesn't 
feel right.'  And I was to the point where like, you know what, I don't want this to happen again.  
I don't like this feeling."  On the other hand, Dre actually contracted gonorrhea and detailed that 
experience to prompt his decision to initiate PrEP, as he thought, “You know what? Let me go 
ahead and give it a try. . . If I can easily catch a STD like that [then] I can easily catch something 
else." 
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When asked to explain the impact their perceived HIV risks including sexual behaviors 
and factors had on the decision to initiate PrEP, all participants verbalized that these experiences 
or encounters made the threat of contracting HIV real and probable.  That particular threat made 
them acknowledge their HIV risks, and was a catalyst for making them believe initiating PrEP 
was necessary given their risks. Dre stated 
I'm at risk, you know?  Very much so at risk. And I feel like I'm just always a step away 
from being the people that [are HIV positive].  I don't look down on positive people or 
anything like that, it's just I could become that.  So let me take the steps now to not 
become that.  Like another statistic. 
This data thus showed that in this sample’s PrEP decision-making process, HIV-risk 
acknowledgement was a part of the process.  For this sample, the acknowledgement came in the 
person’s own time, based on their own perception and understanding of HIV.  Additionally, the 
acknowledgment resulted from a self-assessment of how much the individual believed they were 
at risk for contracting HIV.  Due to acknowledging his HIV-risks, Dre initiated PrEP as “an extra 
precautionary step”.  He went on to explain his decision-making:     
I was tired of having sex when condoms break or slip off, tired of people lying about their 
status, tired of running into people who were positive.  That's a lot.  And I finally was 
like, “You know what I definitely need to go ahead and get on this”. . . I'm sexually 
active, I'm grown, so I need to be an adult about [it].   
Bill initiated PrEP based on his acknowledged HIV risks by stating, “I know me, and I know 
how much I hook up,” and Bruce responded that “I just thought it was just a wonderful thing to 
do as a preventative measure, [be]cause I'm gonna have sex.”  Without acknowledging their 
HIV-risks, the act of considering and initiating PrEP was unnecessary, because the individual 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 103 
 
perceived the threat of HIV to be absent, extremely low, or insignificant.  Due to their 
recognized risks, PrEP was viewed as a proactive approach to HIV prevention, as Ace stated, 
“Just in case I come across someone that is positive, I don't wanna be trying, I wanna prevent 
from getting HIV”.  Participants were driven to remain negative as Dre reiterated, “I'm not going 
to become one of yall [an HIV positive person] . . . I'm not going to let it [HIV] take me.  I'm not 
going to become another statistic, and PrEP keeps me from becoming another statistic.”   
HIV Concern 
Participants were asked about their perception regarding HIV.  Due to the advances in 
HIV care and treatment, this sample recognized the disease is manageable and a chronic disease, 
as PLWH on treatment can live a normal life.  Ace stated, “I look at it as any other thing, like 
diabetes and cancer”.   Bill speculated that contracting HIV is “something that you can manage.” 
Despite this optimal perspective, participants still viewed HIV negatively, as Dan expressed, 
“My first instinct is, 'Ew, gross’, and then my second reaction is sympathy.”  This sample 
continuously described HIV to be a devastating disease, inflicting mental and physical hardships.  
Bill recalled HIV-positive peers to discuss having “episodes [when they] don't feel good because 
of [their] status," and Justin thought that HIV “shortens your lifespan.”  For this sample, HIV has 
not escaped its deadly history.  HIV’s morbidity and mortality of the 1980s is unforgettable, as 
Jeff recalled an HIV-positive friend dying from Cryptosporidium to be a “pretty gruesome 
death,” as he described his friend to have “really suffered.”  Logically, participants recognized 
HIV to be a chronic disease, but it is challenging to be fearless of HIV.  Therefore, there is a 
conflict between present day’s HIV and HIV of the 1980s.  Additionally, the data indicated that 
HIV is placed on a higher pedestal than other STIs due to HIV’s mortality and incurability.  
Percy explained that the treatment regimen for other STIs is more favorable or easier to deal 
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with, as “you can take a pill, get a shot in your butt, boom, [and it goes] away.  HIV, they ain't 
got no cure for that yet.”  Steve explicitly explained HIV’s distinction and separateness from 
other STIs by stating,  
In our heads, when it comes to HIV, limiting your exposure to that [is priority, because] 
the rest of that stuff seems treatable.  HIV is the king of king’s disease when it comes to 
STIs.  That is the number one [STI], and of course, we are from a generation that we 
weren't necessarily around when HIV was definitely a practical genocide of gay men . . . 
And now, yes, it is treatable, and people consider it under control, but I was just always 
taught [that] it's not a disease to fear, but [to] have a fearful respect of, it's something you 
shouldn't fuck around with.    
Participants were then asked about their perception regarding the impact HIV has on the 
lives of PLWH. Consistent with this sample’s HIV fears, they expressed that HIV significantly 
and negatively affects the lives of that population.  HIV was viewed as a life altering, 
devastating, and changing disease.  Percy speculated his reaction if he ever contracted the virus:   
“I feel like that would like break my self-esteem. I feel like mentally I would be like everywhere, 
emotionally I'd be broke down. I used to tell myself that I would probably have committed 
suicide.”  Dre expressed similar feelings and reaction about receiving a positive diagnosis as he 
stated,   
Oh my lord, I've thought about that so many times. Yeah, I'm always just on edge. It 
would be a whole 360 for me.  So much stuff would change, honestly. I would still have a 
life, but I would feel like I fucked myself over . . . I would really feel bad about [it, and], 
I would be down on myself if I was to become positive.  I would feel like I fucked myself 
over. 
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The devastation arises from the social implications from contracting HIV, as HIV’s social 
consequences were perceived as more feared and damaging than the physical impact of living 
with HIV.  Repeatedly, participants described PLWH to experience depression, discrimination, 
judgment, and abandonment from peers and family; however, participants viewed the most 
significant change from contracting HIV to be within the context of romantic and sexual 
relationships.  Dre commented that PLWH are stigmatized and can be “seen as damaged goods,” 
and he actually emulates that perception, as he refuses to date someone positive stating, “I'm not 
interested in getting to know you [an HIV positive person].  It's just, no."   Bill admitted to 
hearing PLWH state:  “You know if I wasn't positive, this [dating/romantic] situation might have 
been different."  The perception from this sample is that PLWH face and experience rejection 
routinely due to their status.  Jay stated that for those PLWH that have been honest and upfront 
with him about their status, have prefaced the disclosure with a statement like “You may not like 
me anymore, because I'm HIV positive."   
Participants were asked to explain the impact their HIV concern had on their PrEP 
initiation decision-making process.  The physical and social consequences of living with HIV 
was indicated as a driving factor for them to initiate PrEP.  PrEP provided added HIV protection 
to reduce their chances of contracting the disease.  Participants were cognizant that it only takes 
one encounter to contract HIV, and they decided to initiate PrEP to reduce the chances of 
encountering a lifelong battle with HIV.  Alex stated he initiated PrEP, because he did not want 
to be in the position to say, “This one mistake has changed my life drastically,” and Dre believed 
that “HIV is costly . . . and I'm not even talking about costly as far as money. It's costly for your 
life.”  Initiating PrEP was viewed to be rather easy and simple than enduring the life changing 
alternative, as Dre explained, “I see PrEP like this, I voluntarily take this pill so that I don't have 
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to take a regular mandatory pill for the rest of my life."  Participants did not want to deal with the 
social challenges associated with being HIV positive, especially in romantic and social 
situations.  Participants sympathized with PLWH having to disclose their positive status to 
someone they genuinely liked or loved, as Percy stated, “I know it's hard”.  Percy continued by 
stating 
Right now, I don't have to sit here and give a guy this sob story on how I contracted this 
[virus], and how they don't have to worry because I'm undetectable, and how I’m taking 
my medicine. [I’m not] worrying about if he's gonna continue talking to me, or if I'm 
gonna hear from him after I told him this. You know, like getting involved with 
somebody.  Then you tell them something like that and you really like them, and you 
trust them with that information, and then they go out and bash your name. Then I'm 
hearing stuff about me that I told only this person. I don't wanna go through all that.  
 Although not a part of the decision-making process, the data indicated that the added HIV 
protection garnished from initiating PrEP initiation changed some participants’ sexual 
encounters.  For some participants, the peace of mind from the added protection improved 
quality and pleasure during sex.  Steve said, “It makes you feel a lot more freer. . . Not having 
that fear, knowing you're protected, it truly opens you up”.  Three participants’ PrEP initiation 
indicated occurrences of risk compensation, as they changed sexual behaviors, increasing HIV 
and other sexual risks.  The investigator has already reported that Dan initiated PrEP for the 
purpose of engaging in risky sex, and he admitted to having, “more sexual partners, [with] full 
exchange of fluids."  On the other hand, Bill stated, “[I am] a lot more brave than I used to be . . . 
I'm more open to meeting up with people and having less conversation and more action with 
them if that's what they're into. Also, trips out of town, there's bars you can hook up at, and you 
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have yourself a real good time.”  Dre admitted that “being on PrEP has made me a lot more open 
to raw sex with somebody that I trust.”  Only one patient reported that he believed initiating 
PrEP decreased his sexual libido, as Justin stated that since initiation of PrEP “the [sexual] desire 
is not there.” 
PrEP Understanding  
In order to make a decision to initiate PrEP, one has to be aware of the regimen.  While 
not a part of the decision-making process, participants voiced their opinions and concerns about 
society’s awareness and knowledge of PrEP, and their insight provides context to PrEP initiation 
decision-making.  A few participants believed most people know about PrEP, as Ace gave his 
perspective saying, “Well it's just that, out of 100 people, I think probably it's a 60% chance that 
people know;” however, this is not the popular opinion.  For the participants who chose to speak 
about society’s PrEP awareness, most expressed concern, as they perceived there to be a lack of 
PrEP awareness, especially in MSM and other HIV vulnerable populations.  Steve described his 
experience from finding out about PrEP, “When I learned about it I was like, ‘Wait a minute, I'm 
sorry.  This drug exists?’ And not knowing that it was public knowledge for years, I was like, 
‘So this drug exists.’ I don't know why everyone doesn't know about this."  In a similar way, Bill 
detailed that “There's a lot of people [that] just don't know.  Even in the gay community, [they] 
don't know a whole lot about it [PrEP].”  Beyonce said some of his previous sexual partners were 
oblivious to PrEP, as he reported, “A lot of them have been like, 'What is that?' And I'm like 'Oh 
my goodness.'”  Although MSM is an HIV vulnerable population, adolescents and young adults 
were also identified as an HIV vulnerable group lacking PrEP awareness and knowledge.  Jeff 
stated “I think it should really be pushed towards our younger generations,” and his reasoning 
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was that “our younger generations are more sexually charged and they are more [likely to] 
experiment with sex with different partners, with different men, women, [or] alcohol.” 
 Specific to the decision-making process, participants were asked their initial impressions 
of PrEP.  For this sample, participants learned about PrEP from either one of three entities:  
health professional (6/14, 43%), peer or partner (3/14, 21%), or social event/advertisement (5/14, 
36%).  Upon initially learning about PrEP, patients formulated different types of preconceived 
notions and misconceptions about PrEP.  Dre stated, ”My feelings of it were very iffy back 
then,” which “kind of kept me from really getting on it.”  Participants experienced moments of 
disbelief, as they found it difficult to believe that a medication existed for HIV prevention.  Some 
participants initially perceived PrEP to be fake or a placebo pill that does not really work to 
prevent HIV.  Percy said, “I was thinking that it was like a gimmick.  I didn't know if it was 
proven to prevent HIV.  I didn't think it would be effective, honestly.”  Others initially thought 
PrEP to be a scheme, presenting users with a false sense of protection that causes them to 
eventually contract the virus or increases one’s HIV risk.  Jeff said, “At first I was like, is it 
going to lean me towards saying that I’m going to become that way,” while Beyonce thought, “it 
gon' give me HIV”.   
Participants were also confused about PrEP’s clinical indications.  Jay said, “I thought it 
was to cure HIV,” and even Jeff grappled with initiating PrEP, as he stated, “I don't want anyone 
thinking that I got HIV”.  Bill said, “What is confusing to me about it, or at the time was, the 
medication itself.  That it didn't really make sense to me that this was something that you take if 
you already had it.”  Data showed the consequences of these misconceptions to be significant, as 
Justin commented that ”a lot of people look at PrEP, and the way that it's put out in the streets is 
if you're on PrEP, you have HIV.”  Dre reiterated this social perception of PrEP stating there is 
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“a lot of suspicion, a lot of stigma. . . Like a lot of people think that I'm positive because I'm' on 
PrEP.”  The data showed the consequence of this confusion to be continued social 
misconceptions and negative stigma surrounding PrEP, as Justin explained, “A lot of people run 
from people that say that they're taking PrEP.”  Additionally, those with PrEP interest or 
indications are deterred from seeking PrEP, as Jeff stated, “People are scared to ask [about 
PrEP], because people want to know why [are] you asking.”  Dre stated that “people either feel 
like either you're promiscuous if you're on PrEP, or you're lying about your status."  From this 
sample’s perception, these societal stigmas and misconceptions occur because, PrEP information 
is not clear in the beginning, as Bill went on to explain that the available PrEP information was 
“very vague to start with [and] the basic things of it were not so simple.”  
Despite participants’ awareness of the social perceptions and stigma about PrEP, social 
motivations were not apparent in this sample’s PrEP initiation decision-making process.  As the 
data indicated above, participants were cognizant of the stigma surrounding PrEP, but those 
perceptions and opinions, were not revealed to be directly involved in the decision-making 
process.  Participants did not state that their decision to initiate PrEP to be driven or dependent 
by the potential reaction of anyone, including peers, partners, or family members.  Dre addressed 
the lack of social motivation in his decision-making process stating, “I don't give a fuck about 
the stigma.  I don't give a fuck about what you've got to say.  I feel like we should take advantage 
of these programs that are here to help us.” 
Whether out of confusion or a desire to know more, after learning about PrEP, each 
participant gathered more information.  Participants primarily performed internet searches on 
PrEP to seek clarifying information.  Beyonce said, “Uh, google” was his means for conducting 
research, as he stated, “I had to go through google.”  Similarly, Justin said “I just typed it in [the 
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search engine] and then I read a small paragraph about it.”  Only one participant reported to 
make his decision from accessing empirical evidence about PrEP’s chemical make-up and 
efficacy reports, as Dan “did a little bit of research into the biochemistry of it all and made a 
decision.”   
Some participants gathered more information by consulting with a health professional, 
and the data showed these participants expressed feeling more at-ease and comfortable making 
their decision.  Alex, who worked in a health-care facility discussed it with a pharmacist, as 
“That's the main person I talked to, was our pharmacist.  And she was like okay, these are the 
benefits to it, but these are the risks.”  Steve stated that “sitting down with your doctor that you 
know and trust, and just breaking it down very simply” was significantly helpful in him making 
his decision.  He continued by stating 
I talked to my doctor, and I made him give me a 30 minute breakdown on literally the 
history of the pill for HIV treatment and then evolving into PrEP.  It was incredible to 
hear, and it was at this time I was like, “I understand.”  Somebody sat down and 
explained the science of it, and the history, and where it came from . . . When something 
[gets] broken down to you in layman terms, but not shortened to a 30 second commercial, 
but maybe a four or five minute video, that's what you need.   
However, not all available PrEP information from health professionals is accurate.  Steve shared 
his experience of discussing PrEP with his local pharmacist on the length of time it takes before 
PrEP becomes effective in the body.  Steve recalled, “Some said ten days. Some said two to three 
weeks. Some said 30 days.”   
Even though not all PrEP information available is of equal merit and accuracy, 
participants did express that they came to understand PrEP to be complementary.  This sample 
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acknowledged that PrEP does not create HIV invincibility, and therefore is to be used in 
conjunction with condoms and other risk-reduction practices, as Jay stated that, “they told me, 
you still have to use condoms.”  Bill thought PrEP to be a magic pill initially, granting him 
permission to engage in any risk behavior, as he said, "Woohoo, I can do whatever I want now;” 
however, after gaining more education, Bill realized that PrEP is like any other non-abstinence 
prevention method, as “nothing [else] is 100 percent” protective against HIV.  Ace reiterated this 
also by stating, “I have to make sure that I continue to [have] safe sex, continuing to use 
condoms, and taking the PrEP.”   
The data indicated that not all misconceptions and ambiguities were resolved prior to 
initiating PrEP.  Bill stated that he was not informed or understood the full implications or 
requirements of adherence.  From his perspective, he was told initially, “Well, here's your bottle, 
take your medicine.”  He did not feel that anyone gave him specific instructions that PrEP “needs 
to be [taken] the same time every day; you need to take it regularly; [and] don't miss your doses” 
in order to achieve optimal efficacy and protection.  Therefore, participants suggested that 
having clear and complete instructions and education from health professionals on how PrEP 
works to be effective, and explaining the reasons behind the follow-up schedule would make 
things less confusing.  According to Steve, the availability of in-depth patient education “just 
doesn't exist, unless you go out of your way to look for it on YouTube.  And You Tube is wrong, 
I’m sure.”   
Initiating PrEP is not without some requirements, and the data showed participants to 
factor their understanding of those aspects into the decision-making process.  PrEP’s required 
daily intake was primarily viewed as an inconvenience, but that inconvenience was not 
significant enough to deter this sample from initiating PrEP.  Jeff said, “Yeah, I was concerned, 
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but I started thinking, I take high blood pressure medicine every day, and I don't think a second 
thought about it.  It's just natural.”  Although not an aspect of the investigated phenomenon, data 
revealed that despite the inconvenience of the daily regimen, that PrEP adherence improved 
when it was associated with an activity or entity they performed on a routine basis.  Steve stated 
that a routine “absolutely helps me. It's habit building.”  Ace said, “At first it was, [challenging], 
and then eventually it became like natural. Taking it every day, like a vitamin, because I would 
put it with my vitamins, so that way I know I would see it every day, so I know to take it.”  
Beyonce reported that his job was his daily reminder or trigger to take PrEP, “I just think about it 
as, well, every day when I take the medication, it's time for me to clock in for work. So therefore, 
I need my job, I need this medicine. I need my job, I need this to stay healthy.” 
Initiating PrEP is also associated with side effects, and a few participants had serious 
concerns about PrEP’s side effects.  Knowledge of the potential side effects (i.e., nausea, 
vomiting, kidney issues, and bone density loss) caused a few participants to really question and 
the need to initiate PrEP, as the side effects were frightening and delayed initiation for some 
participants.  After learning about the side effects, Jay stated, “So then I didn’t get on it,” and 
Percy was deterred from initiating PrEP thinking, “I'm gonna stick to trying to wear condoms.” 
Although some participants were concerned about the side effects, it did not prevent them from 
initiating PrEP; however, they identified experiencing side effects would be reason enough to 
discontinue PrEP.  Jeff initiated PrEP with a disclaimer, “I was thinking that as long as I don’t 
have any [side effects] then” he would continue taking PrEP.   
Participants were asked to explain the impact their understanding of PrEP had on their 
decision to initiate PrEP.  Ultimately, despite the participants’ knowledge or perception of PrEP 
being accurate or not, participants were satisfied or accepting of their understanding of the 
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perceived benefits and risks associated with PrEP initiation, as Dre stated, "I said, 'You know 
what, let's give it a try.’"  Although uncertainties regarding how PrEP is efficacious remained, 
participants admitted to initiating PrEP, because of its indication to reduce HIV risks.  That 
knowledge alone was worth initiation, as Bishop remembered thinking, “I'll just gamble with it,” 
and Poomp also took the trial approach saying, “I just wanted to try it and see if it’d work”.   
PrEP Accessibility  
Participants were asked to explain the means and manner in which they accessed PrEP.  
The data showed that accessibility encompassed two aspects:  cost/financial means and provider 
availability.  In the PrEP initiation decision-making process, participants’ abilities to afford the 
monthly cost of PrEP was a factor.  Most participants found accessing PrEP challenging, as 
participants were aware of PrEP’s exorbitant out-of-pocket/cash price.  Table 4 provides a list of 
this sample’s reported financial means to accessing PrEP.   
Table 4 
Participants’ Financial Means to Accessing PrEP 
# of Participants Utilizing Financial Accessibility Options 
6 Assistance Program* 
3 Employer/Private Insurance 
2 Employer/Private Insurance & Assistance Program* 
1 Clinical Trial/Study 
1 State Medicaid 
1 Other Personal/family Resource 
*Program provided by PrEP clinic and/or Gilead® 
 
As Table 4 indicates, most participants utilized an assistance program sponsored by either 
the providing PrEP clinic and/or PrEP’s pharmaceutical company, Gilead®.  Only one 
participant, Dre, reported accessing PrEP as a clinical trial research subject.  Despite participants 
having different avenues to covering PrEP’s financial cost, repeatedly participants stated that 
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they would not have been able to initiate PrEP without financial assistance from the program or 
an insurance company covering most or all of the cost.  Since most participants stated that they 
accessed PrEP through an assistance program at minimal or no cost, this study could not quantify 
PrEP’s monetary value or worth, as this investigation did not inquire about the maximal dollar 
amount they would be willing to pay for PrEP.   
Even participants with private insurance and more affluent salaries placed a value limit 
on accessing PrEP.  In this instance, Dan is an outlier again, as he reported having an annual 
income greater than $80,000 and private insurance that covered 100% of PrEP’s monthly cost.  
Although he had more financial resources than any other participant, he admitted that there was a 
limit to paying for PrEP, as Dan stated, “I'm telling you that I wanted to engage in risky sexual 
behavior, but I wasn't willing to pay more [than] $100 a month . . . I wouldn't pay a lot of money 
to take PrEP, it's not that important to me.”  Another example is Alex’s situation, a health 
professional with a reported annual income range of $40,001- $60,000, but his private insurance 
declined to cover any cost of PrEP, and only covered a smaller portion of the drug after the drug 
discount card was applied.  He stated, “Initially, my health insurance, [was] like, ‘Oh no, no, 
we’re not gonna cover this,’ but then with that discount [card], they were like, ‘Okay’, [be]cause 
after the discount, it was like $200 or $300, and they were like, ‘Fine, we'll pay for it.’” Alex 
confessed that he could not afford to pay $200 or $300 a month for PrEP, and as Bill stated, 
“Even if somebody makes good money, and once your bills are paid, that doesn't leave a whole 
lot left over for something like that.  It'd be cheaper to get sick. I hate to say that, but it almost 
feels that way.”  A similar sentiment was echoed by Jeff when he stated, “I feel sorry for the 
young kids who need it and can't afford it, because they don't have any insurance.  You know it's 
almost like giving them a death sentence, for catching HIV.” 
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The other aspect of PrEP accessibility pertained to the availability of and ability to access 
PrEP services.  Without access via telemedicine or in-person, participants could not initiate 
PrEP.  This sample of MSM PrEP patients mostly lived in urban areas that had available local 
PrEP clinics and providers.  Only one participant, Bill, lived in a rural area where the nearest 
PrEP clinic was over 150 miles away.  Despite the distance, he decided initiating PrEP was 
worth having to act as his own advocate: 
I felt that it was a good option for me, and it was definitely worth kinda the struggle to 
get a referral. I've had to do all the extra work. I've had to make the phone calls, I've had 
to do the follow-ups, and stuff like that, whereas in big cities, people are like, ‘Oh, I just 
told so and so, and just got started on it after doing the testing process.’ Whereas for me 
and for other people in these more rural areas it seems like it's a little more of a challenge.  
The data did not indicate if all patients would have been willing to go through such challenges 
and adversities to access the services required to initiate PrEP.   
PrEP Consideration  
The data indicated that this sample had a period in which they weighed and considered all 
the available information they had regarding their (1) acknowledged HIV-risks; (2) HIV 
concerns, (3) PrEP understanding, and (4) PrEP accessibility.  Given their self-assessment of 
their HIV risks, knowledge and understanding about PrEP’s benefits and risks, participants 
explained that initiating PrEP was necessary, as it was thought to offer them peace of mind and 
added assurance for HIV protection.  Bill stated, “I thought PrEP was a really good choice for 
that, it's just kinda that peace of mind,” and Dre said “as long as I'm single . . . and sexually 
active, I'm going to be on PrEP . . . just as a safe umbrella.”  Dan said that PrEP allowed him to 
engage in risky sex “without thinking of the repercussions, without worrying”.  Likewise, Steve 
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initiated PrEP to take “a heavy weight off my shoulders.”  Lastly, Ace stated, “I just wanted to 
feel comfortable, just in case I did or I started to get involved with somebody else again, or got to 
the point where we were having sex.  It was a comfortable feeling, that I don't have to be always 
worried.  I just wanted to be comfortable, and PrEP’s there to kind of ease up the stress.”  
Initiating PrEP was thought to remove guilt and shame from sexual acts, as Bill said, “You don't 
feel as, ‘Oh my gosh, what did I just do?’ You don't have that immediate guilt following your 
activities, whatever they might be.”  Initiating PrEP was also a way to take control of one’s HIV 
risks before the HIV threat appeared, as it is a proactive approach to HIV prevention.  Steve 
stated, “Inviting new sexual partners into our lives, it is the safer decision . . . And it’s like you're 
taking that big boy responsibility of taking this drug to protect your life.”  These participants 
favorably valued PrEP’s benefit from their self-assessment of HIV risks and concerns, PrEP's 
benefits to risks ration, and PrEP accessibility.   
Even in the midst of challenges or uncertainties, the data showed initiating PrEP was 
considered to be worth those adversities.  Bill experienced difficulties finding a PrEP clinic, and 
the nearest clinic was over 150 miles away from his home.  Despite the logistical challenges, Bill 
stated, “I'm very glad that I did it, it's just not the easiest thing to do right now at this time.”  
Additionally, the inconveniences that come with initiating PrEP was accepted, as Steve 
reiterated, “It is worth your time and money and your patience to get on a medicine that protects 
you from a life altering disease.”  This is especially true considering the occurrences of HIV 
exposure scares or deception, as initiating PrEP was worth more than experiencing HIV scares.  
Percy stated, “I ain't fit to be going through these scares, and then worrying about if I'm clean or 
not.”  Initiating PrEP was also perceived as a way to remain HIV-conscious, as Ace described, 
“It was something that kept me on my toes for one, because you have to take it every day. And 
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every day you take it is a reminder about HIV.”  Lastly, some participants thought taking PrEP 
was just a logical decision given their susceptibility and perception regarding HIV.  Justin said 
after evaluating all of the factors that “it was really like a no brainer for me,” and Jeff said, “I 
started thinking, you either want to take this [PrEP] or want to end up becoming positive and 
taking a lot of medications or being sick.”  Additionally, given PrEP’s frequent follow-up and 
testing regimen, initiating PrEP was viewed as a form of self-accountability regarding their own 
HIV status, as Ace responded, “PrEP was something I could take, and be aware of my status, and 
be protected.  I could make sure, everything was good. . . I just wanna check myself, before I 
check somebody else.”  After considering all of these factors, the data showed that participants 
decided to initiate PrEP because that action was viewed to be worth more than not initiating 
PrEP.   
Although not a part of the investigated phenomenon, participants did discuss their PrEP 
disclosure habits including who and when they had or will disclose that they initiated PrEP.  
Participants stated that they disclosed their PrEP status to family, peers, or sexual partners, and in 
most cases, participants reported that the reaction from their disclosure was positive and 
supportive.  Bishop repeated a friend’s response from his PrEP status, “You know I think that's a 
smart move to make, to take PrEP, to keep yourself secure.”  Family members expressed a sigh 
of relief from their loved-one having additional HIV protection.  Beyonce recalled his mom’s 
reaction, “Thank the Lord, [be]cause she was like, ‘I don't wanna get that phone call,’” that he 
contracted HIV.  In a similar way, Steve stated his mother responded, “Oh, that's nice to hear.  
You know, there's a lesser chance that my kid will end up saying ‘I'm HIV positive.’”  Some 
participants did not feel the need to disclose to family and friends, as Dan stated, “There's no 
need for anybody [family or friends] to know that information.”  Participants reported that they 
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most often disclosed their PrEP initiation to sexual partners, and the reaction is one of security, 
as it provides partners with a sense of relief, affirming their partner is negative.  Dan stated, 
“Well, their reaction is that's good, [be]cause they know you have to be negative to get on it.  So 
that gives them a sense of security,” and Dre believed that potential sex partners think that upon 
hearing he is on PrEP, “Ah, he's clean . . . He's good to go.”  Although most participants reported 
a positive response from their PrEP initiation disclosure, the data showed that this was not 
everyone’s experience.  The reason for the disapproval was not known or clearly understood by 
the participants, but the data leads the investigator to assume it pertains to the negative stigma or 
misconceptions surrounding PrEP.  Bishop said he did not have many supporters, as most peers’ 
responded to his disclosure by stating, “You're stupid, I wouldn't take that stuff.”  Beyonce 
recalled a peer’s reaction from his PrEP status, “I don't know what to say. I just never thought 
you, out of all people, would decide to take PrEP.”  Percy explained that he was surprised by the 
response from a sexual partner,  
I don't think he was too happy when I mentioned about being on PrEP. He was not too 
happy about that. He said, "Oh, what, you gonna be out having sex with random people 
now?”  I said, "Is that what you think PrEP is for?" He was like, "Basically. Like PrEP is 
for people who just have sex with a lot of people."  
PrEP Initiation Decision-making (PID) Model 
The data indicated that the decision to initiate PrEP was a process that occurred after 
learning or becoming aware of PrEP.  Although this study’s findings could not determine an 
average or estimated timeframe for this sample to navigate through the process, the data 
indicated the decision to initiate PrEP was not immediate or made impulsively or frivolously.  
Instead, deciding to initiate PrEP was discovered to be a thoughtful process of weighing and 
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considering specific factors regarding HIV and PrEP seriously and meticulously.  Percy stated, 
“It definitely was a process.  Definitely… it's not something like, ‘Oh, this prevents HIV, let me 
get on it.’ Like it wasn't that.”  After learning about PrEP, Justin thought, “I have to think about 
this.  This is something that I have to process in my mental," and Dre admitted that "I still had 
like my reservations. . . I wanted to see how [other people taking PrEP] was progressing along 
before I jumped into it."  From the analysis emerged a conceptual model demonstrating the 
process determining and influencing this sample’s decision to initiate PrEP encompassing the 
data’s five emerging themes:  (1) HIV-risk acknowledgment, (2) HIV concern, (3) PrEP 
understanding, (4) PrEP accessibility, and (5) PrEP consideration.  
From the data, conceptual definitions and relationships emerged and are depicted in 
Figure 3.  Acknowledged HIV-risks is the acceptance that certain behaviors or factors place a 
real and actual threat to the individual for contracting HIV.  HIV concern is the negative and 
fearful perception that living with HIV will have on one's life and well-being.  While these two 
individual concepts do not impact or influence the other, they both impact the decision to initiate 
PrEP, as a greater belief in one’s acknowledged HIV-risks and more HIV concern was revealed 
to directly influence this sample’s decision to initiate PrEP.  PrEP understanding is the 
information, accurate or not, that the individual has about PrEP or conceives PrEP to be, which 
includes but not exclusive to PrEP’s benefits, risks, and indications.  PrEP accessibility is the 
ability to access PrEP both financially and from a prescribing clinical practice.  Both PrEP 
understanding and accessibility are separate entities that influenced and determined this sample's 
decision to initiate PrEP.  Lastly, PrEP consideration is the act of weighing and evaluating the 
need to initiate PrEP based on the four model concepts.  Like the four concepts, the result of their 
PrEP consideration was shown to influence their decision to initiate PrEP.    
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Summary 
Fourteen MSM residing in the Southern U.S. participated in the study.  The mean age for 
this predominantly African-American (10/14, 71%) sample was 34 years.  Additionally, most 
participants (6/14, 43%) identified as having a low socioeconomic status (SES) of an annual 
income of less than $20,000.  Although this sample was not significantly diverse, the findings 
were insightful, providing rich data on PrEP initiation decision-making process in a sub-sample 
of MSM.    
The data indicated this sample’s decision to initiate PrEP to be a phenomenon of 
considering specific aspects surrounding HIV and PrEP.  The emerging themes were identified 
as HIV-risk behaviors and factors, deception, and HIV/STI scares.  The data also revealed this 
sample viewed living with HIV to be burdensome and life altering, inflicting both social and 
physical hardships.  In regards to PrEP, the related themes in the decision-making process 
pertained to knowledge and understanding of PrEP’s indications, benefits, risks, costs, as well as 
the ability to afford and access PrEP services.  The data demonstrated that these themes were 
considered individually and collectively, leading to their decision to initiate PrEP.  These themes 
were organized into five broader categories:  HIV-risk acknowledgement, HIV concern, PrEP 
understanding, PrEP accessibility, and PrEP consideration.   
From the data, the PID model emerged as a conceptualization depicting this sample’s 
decision-making process.  The PID model explains these participants initiated PrEP after 
considering their perceptions, attitudes, and personal characteristics surrounding their (1) 
acknowledged HIV-risks, (2) HIV concerns, (3) PrEP understanding, (4) PrEP accessibility, and 
(5) PrEP consideration.  Additionally, the data showed this sample’s PrEP initiation decision-
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making to be a non-linear process, as there was no specific or patterned sequence in which each 
concepts was weighed or considered.   
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Chapter 5:  Conclusions and Recommendations 
HIV pre-exposure prophylaxis (PrEP) is the inaugural pharmacological HIV-preventative 
agent approved in the U.S. (CDC, 2014b).  PrEP is the fixed daily dose of Truvada, an 
antiretroviral (ART) shown to reduce HIV risk by as much as 92%, and is therefore indicated in 
HIV-negative persons with reported and documented high HIV-acquisition risk (CDC, 2014b).  
Although other at-risk groups exist, men who have sex with men (MSM) experience the most 
disparaging HIV rates in the U.S., accounting for 55% of people living with HIV (PLWH) and 
majority of new HIV infections nationally and among men each year (CDC, 2016c).  MSM’s 
engagement in anal intercourse (AI) with other men is the primary catalyst driving their HIV 
incidence disparity.  AI in MSM is the overall most common mode of HIV transmission (CDC, 
2016d), and the riskiest type of sex (CFA, 2014; Pebody, 2010).  Most current and former PrEP 
patients are MSM (Krakower et al., 2015; Krakower & Mayer, 2015; Tellalian et al., 2013); 
however currently there is a paucity of literature on PrEP initiation decision-making in any 
population.   
Guided by the Information-Motivation-Behavioral (IMB) skills model, the following 
research question was proposed:  How do HIV-negative MSM engaging in protected or 
unprotected AI decide to initiate PrEP?  The study objective was to explore how HIV-negative 
MSM decide to initiate PrEP based on the evaluation and perceptions pertaining to their:  (a) 
PrEP knowledge and HIV concern(s)/risk(s); (b) personal and social motivations to initiate PrEP; 
and (c) behavioral skills and abilities to adhere to PrEP.  A qualitative study was conducted with 
a six-item theory derived questionnaire, and analysis of the one-on-one semi-structured 
interviews of 14 MSM living in the Southern U.S. revealed several HIV and PrEP themes to be a 
part of this investigated phenomenon.  To answer the research question, this sample of MSM 
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decided to initiate PrEP by considering the perceived benefits and risks of initiating PrEP based 
on their (1) acknowledged HIV-risks, (2) HIV concerns, (3) PrEP understanding, (4) and 
accessibility to PrEP.   
  This chapter details the conclusions and recommendations drawn from the study's 
findings.  The investigator will expound on the answer to the proposed research question.  From 
the answered research question, the investigator will discuss the implications the findings have 
on the reviewed literature, as well as the health-care industry and nursing profession.  Based on 
the pre-identified study limitations, the investigator will make recommendations for future 
research.  Lastly, the investigator will make three critical conclusions drawn from these findings.   
Discussion 
This sample of HIV-negative MSM decided to initiate PrEP after assessing and 
evaluating their perceptions regarding their (1) acknowledged HIV-risks, (2) HIV concerns, (3) 
PrEP understanding, (4) PrEP accessibility, and (5) PrEP consideration.  From the data, the 
investigator was able to define and establish relationships between each of these concepts.  From 
the inductive content analysis process, these five broader categories emerged as constructs in the 
PrEP initiation decision-making (PID) model, a conceptualization of this sample’s defined non-
linear and introspective process of deciding to initiate PrEP.   
HIV risk and concern were significant factors in the PrEP initiation decision-making 
process.  HIV-risk acknowledgment was found to be the moment or event that makes the threat 
of contracting HIV real and apparent.  This acknowledgement comes in the person’s own time 
and is based on their own perception and understanding of HIV.  Additionally, the 
acknowledgment is the result of a self-assessment of how much the individual believes they are 
at risk for contracting HIV, and can be triggered by a recent, planned, or a lifetime of 
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experiences and events.  HIV concern was shown as the negative and fearful perception that 
living with HIV will have on one's life and well-being.  Like HIV-risks, participants’ HIV 
concern was discovered to evolve from their experiences and perceptions on the hardships 
encountered by PLWH and their understanding of HIV’s disease progression and manifestation.  
While these two individual concepts do not impact or influence the other, they both impact the 
decision to initiate PrEP, as a greater belief in one’s acknowledged HIV-risks and more HIV 
concern was revealed to directly influence this sample’s decision to initiate PrEP.   
Aspects of PrEP were also a part of the process including understanding and accessibility.  
PrEP understanding was the information, accurate or not, that the individual has about PrEP or 
conceives PrEP to be, which includes but is not exclusive to PrEP’s benefits, risks, requirements, 
and indications.  Participants sought additional information from various sources, and despite 
reported misconceptions or uncertainties, participants decided to initiate PrEP.  Participants 
believed that their HIV risks and concerns outweighed any lingering or existing concerns or 
uncertainties about what they knew or perceived about PrEP.  Despite the possibilities of 
participants receiving or perceiving erroneous and misconceived PrEP information, participants’ 
processed and utilized that information the same.  As more knowledge was gained, participants 
believed they had a better understanding about PrEP’s benefits, risks, and indications.  Each 
individual felt comfortable with their understanding of the information they obtained, but being 
comfortable did not alleviate all lingering thoughts, concerns, uncertainties, or inconveniences.  
Instead, they decided to initiate PrEP based on the PrEP knowledge and understanding they had 
at the time of initiation, because PrEP’s added HIV protection out-weighed those wavering 
thoughts, concerns, uncertainties, or inconveniences.  PrEP accessibility was the ability to access 
PrEP both financially and from a prescribing clinical practice.  PrEP cannot be initiated without 
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the services of health professionals, so while the investigator knows access to a provider was key 
to the decision-making process, the data could not determine the impact or influence PrEP 
services being conveniently or inconveniently located had on the decision-making process.  
Lastly, PrEP consideration was shown to be the act of weighing and evaluating the need to 
initiate PrEP based on the other four factors.  Like the four concepts, the result of their PrEP 
consideration was shown to influence their decision to initiate PrEP.  The extent and 
consideration each aspect was viewed or valued was person specific, as one person’s value 
system was demonstrated to be unique and specific to them.     
Conceptualization of this sample of MSM’s PrEP initiation decision-making process 
makes a significant contribution to the literature.  In order to understand this impact, the 
investigator will compare this data derived model to another model commonly used in HIV 
health behavioral decision-making research. The investigator will identify consistencies and 
inconsistencies these findings have to the reviewed literature.  Given the initial knowledge gap 
and study limitations, the investigator will reveal and discuss the contribution these findings 
make to the current knowledge gap on PrEP initiation in the U.S.     
Model Comparison  
The IMB skills model guided this inquiry and the resulting conceptualization of this 
sample’s PrEP initiation decision-making process is reflective of the IMB skills model.  The 
IMB skills model conceptualizes the decision to initiate HIV risk-reduction behaviors as 
involving one’s information, motivation, and skills regarding the HIV preventative behavior 
(Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et al., 2014; Fisher & 
Fisher, 1992; Macapagal et al., 2016; L. Smith et al., 2012).  Information is the knowledge, 
myths, and understanding the individual has about the preventative measure, while skills are the 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 127 
 
abilities needed to perform that behavior (Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 
2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016).  Motivation, however, 
encompasses two forms, personal and social.  Personal motivations are the attitudes, beliefs, and 
perceptions regarding the outcomes from performing or not performing that behavior, and social 
motivations are the perceived social support and acceptance from peers or partners from 
performing the behavior (Aliabadi et al., 2015; Amico et al., 2005; Amico et al., 2009; Chang et 
al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016).   
When comparing the IMB skills model to the PID model, the PID model demonstrates 
that the decision to initiate PrEP is dependent upon an individual’s acknowledgment of their HIV 
risks and out of concern from implications of living with HIV, which is congruent with the IMB 
skill model’s HIV information concept.  Additionally, the PID model shows that their decision to 
initiate PrEP was also derived by their PrEP understanding, which is the accepted perception of 
PrEP to provide added protection, and the ability to access PrEP financially and logistically, 
which mirrors the IBM skill model’s concepts of personal motivation and behavioral skills, 
respectively.  The distinction between these two models is the inclusion of social motivation and 
the absence of PrEP consideration in the IMB skills model.  Although apparent in the IMB skills 
model, the PID model does not conceptualize the influence and reactions from an individual’s 
peer group to be a part of the decision-making process.  Likewise, the PID model recognizes 
individuals take a moment to evaluate and weigh all the information they have attained (i.e., 
acknowledged HIV risks, HIV concern, PrEP understanding, and PrEP consideration) in order to 
derive that the benefit of initiating PrEP was worth given their perception of the model’s four 
other and influential entities.  
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The PID model emulates the Health Belief Model (HBM), a health behavioral theoretical 
framework historically used to investigate HIV risk-reduction decision-making.  The HBM was 
developed in the 1950s and 1960s by social psychologists Hochbaum, Rosenstock, and Kegels, 
as a cognitive representation of one’s likelihood or intention of performing health behaviors 
(Jones et al., 2014; Li et al., 2016; Montanaro & Byran, 2014; Schnall et al., 2015).  The HBM’s 
outcome of intention and not implementation was the rationale this investigator did not apply the 
HBM to guide this inquiry, but the HBM has merit in HIV related investigations.  Data analysis 
from this study revealed the PID model to represent this sample’s decision-making process for 
actually implementing the investigated behavior.  While the HBM and the PID model differ in 
outcomes, they are comparable, encompassing similar concepts and assumptions.     
The HBM depicts one’s perceptions, attitudes, and personal characteristics to explain or 
influence health behavioral decisions (Schnall et al., 2015), and shares similarities with this 
study’s data derived model.  The PID model emulates the HBM, as five concepts:  (1) 
acknowledged HIV-risks, (2) HIV concerns, (3) PrEP understanding, (4) PrEP accessibility, and 
(5) PrEP consideration were revealed to influence this sample’s PrEP initiation decision-making 
process.  Under the HBM one’s perceptions and attitudes towards the disease and behavior, 
along with one’s personal characteristics (i.e., personal demographics factors, socioeconomics 
and knowledge), are equivalent to the concepts of acknowledged HIV-risks, PrEP understanding, 
and PrEP accessibility.  One’s perception regarding HIV susceptibility/threat, severity of disease, 
and the behavioral changes’ benefits and barriers are apparent in this model as acknowledged 
HIV-risks, HIV concerns, and PrEP understanding.  Additionally, the HBM’s financial and 
personal characteristics to the particular behavior mirrors this study’s accessibility to PrEP 
services.  Given the HBM’s credibility in the field of health-behavioral and HIV research, the 
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fact that the PID model shares some similarities with the HBM, brings credibility to this data 
derived conceptualization.     
Model Assumptions  
Like the HBM, the PID model is privy to assumptions.  In order to make a decision about 
a choice or decision, one has to be knowledgeable of the choice or option.  The HBM also 
assumes individuals are rational, as their behaviors reflect their thought processes, and 
behavioral change decisions arise from a concern or threat of disease (Champion & Skinner, 
2008).  Likewise, this study and therefore the results from this study presume that participants 
instituted prevention behaviors due to HIV concerns and desire to prevent contracting the 
disease.  Therefore, both the HBM and PID models assume that the process cannot occur until 
the need for behavioral change or awareness occurs.  The data demonstrated that the fear or 
concern the individual has regarding HIV is not only an assumption, but also a factor and 
concept incorporated in the model.  Additionally, the PID model assumes that the decision-
making process occurs regardless of one’s known or assumed HIV status.  The reason HIV status 
is not a factor in initiating the process is due to the second assumption.  While PrEP is indicated 
for HIV negative persons, the data showed that PrEP misconceptions existed upon patients 
becoming aware of PrEP’s clinical indications.  Thirdly, this model also assumes the process 
does not have a defined beginning point, as the data did not indicate a sequence in which of the 
four primary concepts were considered first.  Participants were shown to go through and consider 
each of these concepts one at a time and/or simultaneously. 
These findings share consistent and inconsistent aspects with the reviewed literature 
pertaining to health-behavioral decision-making, MSM HIV prevention, and MSM and PrEP.  
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Comparing the reviewed literature to this study’s evidence identifies the contribution the findings 
make to the literature and current knowledge gap.  
Health Behavioral Decision-making  
Consistent with this investigation’s literature review and theoretical framework, this 
study found that the sample’s PrEP initiation decision-making process was an individualistic 
process of weighing and considering different factors.  Systematic and meta-analysis research 
repeatedly identified those factors to involve one’s personal and social circumstances (Poortaghi 
et al., 2015; Popejoy, 2005).  Additionally, knowledge and perspectives about health, the health 
behavior, and the disease or condition itself are also weighed in this process (Bui et al., 2014; 
Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 2013; Newson et 
al., 2013; Nichol et al., 2011).  In this study, participants readily identified the behaviors placing 
them at risk for contracting HIV, and from that acknowledgment, they perceived a genuine and 
real HIV threat to exist.  This study found participants to have an overwhelming fear of HIV 
from a lifetime of interacting with or hearing about social and health hardships associated with 
being HIV-positive.  Not wanting to endure such hardships motivated participants to initiate 
PrEP.  Participants made decisions based on their own evaluation of PrEP’s benefits, risks, and 
requirements.  Lastly, participants’ financial means greatly determined their decision to initiate 
PrEP, as all needed some form of assistance to access PrEP.  Consistent with the literature, this 
process was introspective, determined by the individual and based on their experiences regarding 
HIV and PrEP knowledge.       
Also consistent with the literature, the findings acknowledged the role of health 
professionals in health related decision-making.  The literature showed that health professionals 
play an important role in patients’ decision-making process (Chong et al., 2013; Coombs et al., 
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2016; Popejoy, 2005; Rose et al., 2017; Siouta et al., 2015; Thom et al., 2016).  For example, 
health professionals coach and support patients when deciphering between health choices 
(Popejoy, 2005; Thom et al., 2016).  Health professionals educate and clarify misunderstandings 
regarding health-care options, and they assist patients in making an appropriate decision based 
on the patient’s self-defined goals (Popejoy, 2005; Thom et al., 2016).  Additionally, the CDC’s 
compendium synthesis demonstrated that health professionals are integral to increasing MSM’s 
use of risk-reduction behaviors, as MSM need support and guidance from a professional, trusted 
resource, or program knowledgeable in HIV prevention in order to increase utilization of HIV 
risk-reduction behaviors (CDC, 2017a, 2017c).  The literature showed that patients are receptive 
to information utilizing open communication, transparency, and a non-judgmental exchange of 
information (Carvajal et al., 2017; Chong et al., 2013; Siouta et al., 2015; Thom et al., 2016).  
Although PrEP is only accessible from a prescribing practice, some participants did not perceive 
that they received such in-depth education, as they admitted to initiating PrEP with lingering 
doubt, uncertainties, and misconceptions.  On the other hand, some participants expressed that 
the counseling and education they received from health professionals was integral to them 
having a clear understanding, leading to their decision to initiate PrEP.  Additionally, participants 
who received in-depth patient education from health professionals prior to initiating PrEP 
appeared to be more assured and confident in their choice.  Therefore, consistent with the 
literature, this study’s evidence demonstrated that providing patients with complete and 
transparent PrEP education is conducive to their decision-making process.     
Inconsistent with the literature was the influence external and other social pressures had 
on this sample’s decision-making process.  The IMB skills model conceptualizes the decision to 
initiate HIV risk-reduction behaviors to include social motivations like perceived support and 
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acceptance from peers and significant others (Aliabadi et al., 2015; Amico et al., 2005; Amico et 
al., 2009; Chang et al., 2014; Fisher & Fisher, 1992; Macapagal et al., 2016).  This study’s data 
did not demonstrate such influence from peers, family members, or partners to be included in the 
process, as the data revealed the process to be introspective.  However, participants were aware 
and reported the negative and social stigmas associated with PrEP.  While social motivations 
were not seen to be directly a part of this sample’s PrEP initiation decision-making process, the 
investigator recognizes that it is possible that social motivations could have had an indirect or 
subconscious effect on this sample’s decision-making process.  Additionally, the investigator 
acknowledges that lack of social motivation in this process may not be true with other patients 
who have initiated or are deciding to initiate PrEP.    
MSM HIV Prevention  
This study’s findings share consistencies with the literature regarding HIV concern from 
susceptibility and living with the virus being a factor in MSM’s implementation of HIV 
prevention behaviors.  Systematic reviews demonstrated that HIV-negative MSM are concerned 
about contracting HIV (Balan et al., 2013; Neville & Adams, 2009; Neville et al., 2016).  
Likewise, study participants shared and expressed significant concerns and fears regarding HIV, 
as HIV was perceived as a life altering and devastating disease.  Participants repeatedly cited 
stories of PLWH to experience depression, rejection, and other social hardships, and these 
hardships were perceived to be attributed from PLWH’s HIV-positive status.  In other 
publications, MSM were shown to no longer view HIV as a serious problem or public health 
issue due to ART transitioning HIV into a chronic disease (Balan et al., 2013; CDC, 2016b; 
Neville et al., 2016; Neville & Adams, 2009).  The literature demonstrated conflict regarding the 
impact HIV concern has on MSM’s HIV prevention decision-making, and it was apparent in this 
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study.  This sample exhibited conflict, as they acknowledged PLWH can live a normal life if on 
effective HIV treatment, but they were extremely fearful of HIV’s social and physical 
implications.       
Trust was found to be a part of this sample’s decision-making process, but is inconsistent 
with the current literature.  The reviewed literature showed partner conversations and emotions 
to influence MSM’s decision-making to utilize HIV prevention behaviors.  Partner conversations 
encompass a couple’s discussion of the relationship status and HIV status and risks, and that 
information is used to determine their utilization of risk-reduction behaviors (Campbell et al., 
2014).  In addition, the literature found MSM to rely on emotions erroneously to derive the need 
to use risk-reduction behaviors (Bauermeister et al., 2009; Campbell et al., 2014; Goldenberg et 
al., 2015; Green et al., 2014).  Both partner conversations and emotions require a level of trust, 
as partners do not perceive their counterparts to be deceptive; however, this sample of MSM 
perceived there to be a significant amount of deliberate HIV deception and lack of disclosure.  
This sample found it difficult to trust people regarding their HIV statuses even within the context 
of an established or committed relationship.  This perception of deception heightened this 
sample’s HIV risks, influencing their decision to initiate PrEP as a way to take control of their 
HIV risk.   
MSM and PrEP 
Although currently PrEP initiation decision-making research is absent from the literature, 
this study’s findings are consistent with evidence regarding MSM’s interest and intention to 
initiate PrEP.  Previous studies found that MSM to be interested in PrEP to promote health and 
enhance sexual pleasure (Brooks et al., 2012; Collins et al., 2016; Gamarel & Golub, 2015; 
Garcia & Harris, 2017; Golub et al., 2013; Mimiaga et al., 2014; Oldenburg et al., 2016; Taylor 
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et al., 2014), as PrEP is perceived as a proactive form of HIV prevention as opposed to reactive 
(Oldenburg et al., 2016).  During PrEP clinical trials, the literature showed MSM subjects to 
initiate PrEP out of motivation to protect themselves from future HIV infections (Taylor et al., 
2014).  Previous investigations found patients initiated PrEP for additional HIV protection given 
their HIV risks including multiple sex partners, condom failures, and inconsistent or no condom 
use  (Collins et al., 2016; Garcia & Harris, 2017; Parker et al., 2015).  The added protection 
reduces anxiety and shame associated with risky sexual behaviors (Brooks et al., 2012; Collins et 
al., 2016; Taylor et al., 2014), and fears of contracting the virus when engaging in AI with a 
person who has a positive or unknown HIV status (Mimiaga et al., 2014; Oldenburg et al., 2016; 
Taylor et al., 2014).  This study’s evidence is consistence with the literature, as this sample 
initiated PrEP for added HIV protection due to the behaviors placing them at HIV risk (i.e., 
multiple sex partners, inconsistent condom use, condom failures, HIV deception, lack of HIV 
disclosure, AI, MSM HIV disparity, STI/HIV scares etc.).  PrEP’s added HIV protection, 
provided peace of mind, which decreased anxiety and fear during sexual encounters; however, 
this added peace of mind has caused have a dreaded consequence for some participants.   
This evidence showed that risk compensation was a consequence of PrEP initiation 
providing the added peace of mind and HIV-protection, which is consistent with the literature.  
Risk compensation is the purposeful increase in HIV risky behaviors (Blackstock et al., 2016; 
Calabrese et al., 2014; Calabrese & Underhill, 2015; Karris et al., 2014; Yagoda & Moore, 
2016).  The literature showed MSM assume their peers would initiate PrEP purposefully to 
engage in risky behaviors (Brooks et al., 2012; Collins et al., 2016; Garcia & Harris, 2017; 
Golub et al., 2013; Oldenburg et al., 2016; Perez-Figuerora et al., 2015; D. Smith et al., 2012; 
Taylor et al., 2014).  Three of the fourteen participants reported a form of risk compensation, as 
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they reported engaging in riskier sex since their initiating PrEP.  Although only one participant 
admitted that engaging in risk compensation was the reason he initiated PrEP, the fact that two 
other participants reported behaviors indicating risk compensation does give speculations about 
risk compensation influencing PrEP initiation to have some validity.            
Consistent with the literature, these findings show social barriers to accessing PrEP.  
Perceived negative stigma and judgmental reactions from peers and health professionals were 
speculated to deter MSM from seeking and initiating PrEP (Auerbach et al., 2015; Collins et al., 
2016; Dolezal et al., 2015; D. Smith, et al., 2012).  The data are consistent with the literature, as 
participants reported the negative or erroneous social perception about PrEP.  Although this 
sample did not report the social stigma to influence their decision, the investigator acknowledges 
that those social motivations could have subconsciously influenced their decision, and may 
possibly influence other at-risk individual’s decision-making process.  Cost has also been shown 
to be a barrier to initiation, as studies showed patients would be more willing to use PrEP if it 
was conveniently available at minimal or no cost (Golub et al., 2013; D. Smith et al., 2012).  
This study’s data did find financial means to be a factor in PrEP initiation, as participants openly 
voiced that they were unable to access PrEP without assistance, and this perspective was 
apparent regardless of SES.  Due to most participants accessing PrEP at minimal or no cost, the 
investigator cannot determine PrEP’s value limit to this sample.  Another aspect of accessing 
PrEP is provider and clinical services availability.  Approximately 9% to 34% of prescribing 
providers have adopted PrEP guidelines into their practices (Blackstock et al., 2016; Hakre et al., 
2016), and 30% of providers who have never prescribed PrEP believe they are unlikely do so 
(Krakower et al., 2015).  Although most of this sample did not have challenges in locating a 
PrEP provider, one participant did experience such challenges.  Therefore, this data 
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demonstrated that access due to financial or provider means is ongoing, and implicates other at-
risk individuals or populations wanting to initiate PrEP, but have accessibility constraints.   
Knowledge Gap Contribution 
Prior to this investigation, an absence of PrEP initiation decision-making inquiries in any 
population existed.  Therefore, this evidence is foundational to the current knowledge gap 
regarding PrEP decision-making.  The proposed investigation contributes to filling this 
knowledge gap, as the purpose was to explore MSM’s decision to initiate PrEP, and the findings 
revealed the factors and process involved in how this MSM sample derived to their decision.  
Additionally, the evidence confirmed that initial misconceptions about PrEP’s indications and 
requirements exist.  This study demonstrated that patients require support, education, and 
counseling when considering PrEP initiation from knowledgeable health professionals.  
Although these findings are specific for this sample of MSM, the findings provide insight into 
the factors and process of PrEP initiation decision-making, which may occur in other patient 
populations.   
Despite this contribution, study limitations restrict the magnitude these findings have on 
the literature.  The investigator utilized a qualitative description approach, as it is synonymous 
with naturalistic research, and appropriate for decision-making research.  Decision-making is the 
process in which individuals consider and evaluate different factors surrounding a choice or 
option, making it an individualistic and value dependent phenomenon (Allan & Harden, 2014; 
Bui et al., 2014; Clifford et al., 2017; Dugas et al., 2017; Hamilton et al., 2016; Keatley et al., 
2013; Newson et al., 2013; Nichol et al., 2011; Popejoy, 2005; Schmidt et al., 2016; Tranberg et 
al., 2016).  Therefore, this study’s findings are limited by respondent and interviewer bias, as 
participant dishonesty or investigator misinterpretation could have distorted the emic view, 
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leading to an inaccurate representation of this sample’s PrEP initiation decision-making process.  
To the investigator’s knowledge, this was the first investigation into PrEP initiation decision-
making in any population, therefore, the trustworthiness of these findings are restricted.  The 
investigator recognizes that other HIV-negative MSM may or may not undergo the same process 
when making their decision.  Additionally, even if the process is the same, the extent and degree 
in which these factors are perceived and evaluated could also vary.  Given the personal nature of 
decision-making, qualitative methodology, and this study being the first known inquiry into 
MSM’s PrEP initiation decision-making process, these findings are limited by transferability, 
preventing these findings from being applicable to the larger MSM population.  In light of the 
identified limitations, the investigator cautions against health professionals generalizing these 
findings to all applicable MSM patients, as these findings are transferable to this sample, and 
possibly to other MSM sharing similar social demographics, experiences, and PrEP 
accessibilities.       
Implications 
 Despite these limitations, the findings provide insight into this phenomenon, and are 
significant to the future narrative surrounding PrEP and HIV.  Specifically, these findings have 
cost saving implications for the health-care system regarding the U.S. HIV epidemic, and the 
role nursing practice, education, and research has in providing PrEP care and services.    
Health-care Industry 
These findings are foundational to gauge if and how PrEP will have an impact on the 
current MSM HIV epidemic.  HIV care and treatment is extremely expensive on the health-care 
system, costing an estimated $12.3 billion annually (CDC, 2015a).  PrEP initiation in at-risk 
groups is estimated to reduce HIV incidence by 70%, preventing 185,000 U.S. infections by 
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2020 (CDC, 2016e), and each prevented HIV infection saves an estimated $355,000 in lifetime 
HIV treatment costs (CDC, 2015a).  In order for this to be possible, individuals with PrEP 
indications have to decide to initiate the complementary regimen.     
For this sample, each participant reported having at least one high HIV risk factor, 
therefore showing that this sample of MSM were appropriate PrEP candidates.  While analysis of 
several themes lead to the discovery of five themes to entail their decision-making process, the 
data indicated that acknowledged risks and HIV concern to be heavily weighted in the process.  
This data demonstrated this predominantly African-American sample to be cognizant of the 
epidemic, and were thorough when identifying factors placing them at risk.  These findings 
implicate other individuals with significant HIV risk factors who are knowledgeable of PrEP, but 
have not decided to initiate PrEP.  Perhaps this data provides a plausible explanation for PrEP’s 
slow initiation in the U.S., as other at-risk individuals have not acknowledged their HIV risks, or 
perceived HIV epidemic to be a threat or to even exist.  Another possibility is that these other at-
risk persons are deterred from initiating PrEP due to the on-going negative and social stigma 
associated with PrEP.  
One population in particular these findings have implications for is African American 
women, as the CDC (2016d) indicates African American women to be the second highest group 
infected with HIV after MSM.  Additionally, data shows that African-American women are more 
than four times less likely to initiate PrEP than Caucasian women, as most PrEP patients are 
male (76%) and only 10% of African-Americans have initiated PrEP (NAM, 2018).  This study’s 
evidence implicates that without other at-risk populations acknowledging the epidemic or their 
risks, PrEP initiation may remain slow, and PrEP’s estimated impact will not be realized.   
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Given some of the barriers (i.e., stigma, cost, and logistics) identified from and 
experienced by this sample, this investigator believes the evidence implicates a need for 
discussing the need to devise policies that can address individuals with PrEP indications being 
able and willing to access and initiate PrEP.  This evidence implicates the need to consider the 
development of policies to improve and expand PrEP outreach and access to services to HIV-
vulnerable groups throughout the U.S.  This sample expressed disappointment in their own 
experiences and perception of society’s knowledge and awareness of PrEP.  While some 
participants acknowledged PrEP awareness is low and poor among all patient populations, most 
recognized that HIV-vulnerable populations such as MSM, youth, women, and minorities suffer 
greatly from the lack of awareness, as the CDC (2016f) identifies these groups as the most 
vulnerable to contracting HIV.  Increased and widespread PrEP education and outreach from 
knowledgeable professionals and advocates can be a mechanism to increase awareness and 
decrease PrEP’s negative stigmas and erroneous misconceptions.   
This sample also expressed difficulty in accessing PrEP without financial assistance, 
implicating the need for federal and state aid to fund PrEP preventative services just as 
HIV/AIDS’ treatment efforts are rendered through state level AIDS Drug Assistance Programs 
(ADAP), and federal Ryan White services.  Although only one participant experienced logistical 
issues to accessing a PrEP provider in their local area, this one occurrence does give speculation 
that such challenges are apparent for other at-risks persons in areas lacking PrEP services.  
Previous evidence demonstrated that the limited number of PrEP providers is not merely an act 
of a knowledge deficient.  Less than 20% of sampled providers in the U.S. have ever prescribed 
PrEP (Krakower et al., 2015; Tellalian et al., 2013), and 30% of providers who have never 
prescribed PrEP believe they are unlikely do so in the future (Krakower et al., 2015).  These 
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limitations give reason for the need for devising strategies to overcome such challenges.  
HIV/AIDS’ advocates should consider lobbying for the opportunity to discuss instituting funding 
and policies to support providing PrEP-care through telemedicine capabilities, or by requiring 
health professionals to inform patients about PrEP and the clinics in their local and neighboring 
areas that can provide such services.   
Nursing Profession  
These findings allow nursing to improve practice and education PrEP standards.  Most 
participants engaged in risky sexual behaviors prior to PrEP initiation (i.e., multiple sex partners, 
using condoms inconsistently or not at all, and engaging in open/casual/impulsive sex), and this 
evidence reminds nurses to provide risk reduction counseling regardless of the patient’s decision 
to initiate PrEP.  The evidence showed the rationale behind this sample’s decision to initiate 
PrEP.  The identified themes (i.e., HIV risks, fears, concerns; and PrEP risks, benefits, and 
requirements) can be used as a guide to provide in-depth PrEP patient education during the 
screening and initiation process.  The data showed that participants initiated PrEP without having 
a complete understanding of or accurate information about PrEP’s requirements and efficacy.  
Nursing practice can utilize this evidence to implement in-depth PrEP patient-education, 
ensuring that patients are explicitly educated about the correlation between adherence and 
efficacy, as well as PrEP’s effectiveness timeframes.  Initiating PrEP was revered as a form of 
proactive prevention which gave participants more control of their HIV risks and peace of mind; 
however, as a result, risk compensation was noted from a few participants, implicating the need 
for nursing practice to educate patients that PrEP is complementary, requiring the 
implementation of traditional risk-reduction behaviors in combination with PrEP.  Another 
aspect identified in the decision-making process is the impact affordability had on initiation, as 
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all participants admitted to being PrEP’s cash price to be exorbitant.  From this evidence, nursing 
practice can better advocate for patients, ensuring that all are aware of PrEP access and financial 
assistance programs.     
This study’s evidence is foundational for nursing research, establishing a new knowledge 
base for PrEP initiation inquiries to build upon.  Future inquiries can replicate this study design 
utilizing a larger sample size, to further evaluate and explore these findings.  Replicated studies 
can refine the data derived conceptual model, and are necessary before transferring the findings 
to the larger population (Houghton et al., 2013).  Although this data is specific to MSM in the 
Southern U.S., this evidence can be foundational to investigating PrEP initiation decision-
making in other patient populations and U.S. regions.  As more evidence is generated, sequential 
findings can lead to the development of evidenced-based PrEP initiation decision-making 
practice interventions and tools, which can lead to devising and implementing evidenced based 
strategies for achieving PrEP initiation success.     
Recommendations for Future Research 
This evidence adds to the PrEP initiation literature, but as foundational evidence, there 
are opportunities for future research.  Given the limitations and implications associated with this 
inquiry into a new phenomenon, the investigator recommends replication of this study utilizing 
more MSM PrEP patients in the Southern U.S.  PrEP initiation decision-making should also be 
studied in different patient demographics to determine differences and similarities among the 
populations.  Although foundational for PrEP initiation, this data does not address other aspects 
of post-PrEP initiation, including adherence, risk compensation, decision-making to continue or 
discontinue PrEP, and long-term efficacy.  Therefore, inquiries into these aspects surrounding 
PrEP initiation are recommended in all populations initiating PrEP.  Investigation into these 
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other PrEP aspects provides a comprehensive account of PrEP implementation in the U.S., and 
PrEP’s ability to have the estimated impact on the HIV epidemic in the U.S. 
Conclusions 
This investigation into MSM’s PrEP initiation decision-making process was shown to be 
a personal and introspective phenomenon.  This evidence shares consistencies with the reviewed 
literature and extends the knowledge base on health-behavioral decision-making, MSM HIV 
prevention, and MSM and PrEP.  Although these findings are limited and not readily applicable 
to all MSM or other patient populations, these findings are significant to PrEP initiation in the 
U.S., as three significant conclusions are drawn from this data.  The investigator concludes that 
the decision to initiate PrEP is a serious endeavor.  Secondly, PrEP is still a negatively 
stigmatized regimen, which has implications for PrEP initiation in the future.  Therefore, health 
professionals involved in any aspect of rendering PrEP services should be adequately educated to 
combat misconceptions and misunderstandings.     
The data showed that in spite of PrEP’s benefits to provide added HIV protection, 
participants engaged in serious thought process prior to initiating PrEP.  Participants did not take 
this decision lightly, as analysis of the data emerged a comprehensive process in arriving at the 
decision.  Each participant did not report being overzealous or eager to initiate PrEP just to reap 
the benefits of having added HIV protection, instead the process was comprehensive and an 
evaluation encompassing these five concepts (1) HIV-risk acknowledgment, (2) HIV concern, 
(3) PrEP understanding, (4) PrEP accessibility, and (5) PrEP consideration.  Although more 
evidence is needed on risk compensation in the context of PrEP initiation, this evidence showed 
that participants are not initiating PrEP with the intent to engage in riskier HIV and sexual 
behaviors.    
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Although this sample did not show social motivations and social stigmas to influence 
their decision-making process, the data indicated that a significant amount of erroneous and 
negative information exist about PrEP.  As the literature suggested, these social motivations can 
influence decision-making process whereby deterring other at-risk populations from initiation 
(Auerbach et al., 2015; Collins et al., 2016; Dolezal et al., 2015; D. Smith, et al., 2012).  
Therefore, health professionals have to be knowledgeable of these social perceptions and 
opinions, so that they can be prepared to address these misconceptions with the patients and 
communities being served, especially those experiencing the highest HIV incidence and 
prevalence.     
Lastly, this evidence leads to the conclusion that all health professionals providing any 
aspect of PrEP services should be knowledgeable to provide accurate PrEP patient-education.  
Health professionals play a significant role in patients’ decision-making processes (Chong et al., 
2013; Coombs et al., 2016; Popejoy, 2005; Rose et al., 2017; Siouta et al., 2015; Thom et al., 
2016).  Since PrEP is only accessible from the services of health professionals, ideally, there 
should not be a reason a patient whom has initiated PrEP should have lingering uncertainties or 
misunderstandings about PrEP.  Health professionals that are involved in any aspect of PrEP 
care, beginning with screening, to initiation, to dispensing, to follow-up care, and discontinuation 
are charged to provide education at any interim during this care continuum.  Given PrEP’s 
uniqueness to traditional risk-reduction behaviors, this study’s evidence requires health 
professionals to be vigilant and proactive in the PrEP care and patient education provided.   
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Appendix A:  CDC’s MSM HIV Prevention Evidenced-based Behavioral Interventions (EBIs) 
Name Level Facilitator & Description Effectiveness 




Group Facilitator:  African-American males 
 
Description:  Delivery of six-2 hour sessions over a 3 weeks 
and two-2-hour booster sessions at 16 & 18 weeks post-
intervention.   
Good 
Many Men, Many 
Voices (3MV) 
 
Group Facilitator:  Peer-to-Peer 
 





Community Facilitator:  Outreach Team of MSM peers 
 
Description:  A team of 10-15 young gay men design and 
carry out  our integrated activities:  (1) formal outreach, (2) 
informal outreach; (3) “M-group”; & (4) ongoing publicity 
campaigns that provide skill building, practice correct 
condom-use, & safer-sex negations 
Good 
No Excuses/ Sin 
buscarexcusas 
 
Group Facilitator:  Technology (video) & Peer counselor 
 
Description:  One 45-minute soap-opera style video in English 





Individual  Facilitator:  Licensed mental health professional 
 





Community Facilitator:  Trusted & respected community leaders 
 
Description:  MSM community leaders are trained to engage 




Individual  Facilitator:  Virtual facilitator   
 
Description:  Three 60-90 minute counseling sessions 




Individual  Facilitator:  Professional Counselor 
 
Description:  One 30-50 minute Personalized Cognitive 
Counseling (PCC); One booster counseling session three 




Individual  Facilitator:  Peer-to-Peer 
 




Individual Facilitator:  Technology (video) & male facilitator 
 
Description:  One  20-minute video (culturally adapted for 





Individual  Facilitator:  Professional Therapist 
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Appendix B:  Applied Theoretical Frameworks in CDC’s Compendium Interventional Studies 
Intervention Name Theoretical Framework(s) 
Males of African-
American Legacy 
Empowering Self  
(MAALES) 
 
• Theory of Reasoned Action/Theory of Planned Behavior 
• Empowerment Theory  
• Critical Thinking and Cultural Affirmation Model 
 
Many Men, Many 
Voices (3MV)  
 
 
• Social Cognitive Theory  
• Behavioral Skills Acquisition Model  
• Transtheoretical Model of Behavior Change  




• Diffusion of Innovations Theory 
No Excuses/ Sin 
buscarexcusas 
 





• Gold’s Model of “on-line” versus “off-line” self-appraisal of risk 
behavior  
• Model of Relapse Prevention 
 
Popular Opinion 
Leader (POL)  
• Diffusion of Innovations 
POWER 
 




• Bandura’s Theory of self-regulation  
• Transtheoretical Model 
• Gold and colleagues concept of self-justification for high risk sexual 




• Conflict Theory of Decision-Making 
VOICES/VOCES • Health Belief Model  
• Theory of Reasoned Action 
 
Young Men’s Health 
Project 
 
• Motivational Interviewing 
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Appendix C:  Tentative Research Study Timeline 
Research Tasks Month: 1 2 3 4 5 6 7 8 9 10 11 12 
Institutional Review Board (IRB)   
Submission for Approval 
 X X           
Study Open to Enrollment    X X X X X X X X X X  
Recruitment    X X X X X       
Data Collection     X X X X X X X X   
Data Analysis    X X X X X X X X   
Results & Implications 
Dissemination 
  X X X X X X X X X X  
IRB Submission for Closure            X X 
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Appendix D:  List of PrEP Clinics in Alabama* 
City   Clinic Name, Address, & Phone Number  
Alexander City Health Services Center - Alex City 
218 South Central Ave  
Alexander City, AL 35010  
256-832-0100 
Anniston Health Services Center - Hobson City 
608 Martin Luther King Dr  
Anniston, AL 36201  
256-832-0100  
Birmingham Birmingham AIDS Outreach  
205 32nd Street S 
Birmingham, AL 35233 
Phone: (205) 322-4197 
Birmingham The 1917 Clinic at UAB 
Community Care Building 
908 South 20th Street 
Birmingham, AL 35294-2050 
Phone: (205) 934-1917 
Huntsville Thrive Alabama 
600 St. Clair Ave., Building 3 
Huntsville, AL 35801 
Phone: (256) 536-4700 
Fax: (256) 536-4117 
Montgomery Medical AIDS Outreach  
2900 McGehee Road 
Montgomery, AL 36111 
Phone: (334) 280-3349 
Toll Free: (800) 510-4704 
Tuscaloosa Five Horizons Health Services 
2720 6th St. 
Tuscaloosa, AL 35401 
Phone: (205) 759-8470 
*List of practices/clinics providing PrEP as of 02122018 in Alabama from Greater Than AIDS 
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Appendix E:  List of PrEP Clinics and Providers in Georgia* 
City   Clinic Name, Address, 
& Phone Number  
Clinic Name, Address, 
& Phone Number 
Clinic Name, Address, 
& Phone Number 
Atlanta  Absolute CARE 
2140 Peachtree Rd. NW  
Suite 232  
Atlanta, GA 30309  
404-231-4431 
AID Atlanta 
1605 Peachtree Rd. NE  
Atlanta, GA 30309  
404-870-7762 
Atlanta ID Group 
275 Collier Road  
Suite 450  
Atlanta, GA 30309  
404-355-3161 
Atlanta Druid Hills Primary 
Care 
1700 Briarcliff Road NE  




230 Peachtree Road NW  
Suite 1800  
Atlanta, GA 30303  
404-526-1145 
Family Healthcare of 
Atlanta PC 
1935 Howell Mill Rd 
NW  
Atlanta, GA 30318  
404-355-2000 
Atlanta Frieda Millhouse-Jones 
MD - Laureate Medical 
Group Midtown 
550 Peachtree Street NE 
550 Peachtree Street NE  
Suite 1550  
Atlanta, GA 30308  
404-892-2131 
Fulton County Board of 
Health 
10 Park Place South, SE  





Dunwoody Road  
Suite 600  
Atlanta, GA 30342  
404-256-4111 
Atlanta Infectious Disease of 
Atlanta, LLC 
735 Piedmont Ave. NE  




1800 Howell Mill Rd.  




619 Rankin Street NE  
Atlanta, GA 30308  
404-874-3102 
Atlanta Intown Primary Care 
2215 Cheshire Bridge 
Rd  
Atlanta, GA 30324  
404-541-0944 
Intown Primary Care 
730 Ponce De Leon Pl.  
Unit B  
Atlanta, GA 30306  
404-541-0944 
Someone Cares LGBT 
& Ally Resources 
Center 
236 Forsyth Street  
Suite 204  
Atlanta, GA 30303  
678-921-2706  
Atlanta Southside Medical 
Center 
1046 Ridge Avenue SW  
Atlanta, GA 30315  
404-688-1350 
Dr. T. Douglas Gurley 
659 Auburn Ave NE  
#156  
Atlanta, GA 30312  
404-888-0228 
 
Decatur Oak Grove Family 
Medicine 
2840A Lavista Road  
Decatur, GA 30033  
404-639-9180  
 
Ponce Primary Care 
402 Ponce de Leon 
Avenue  
Decatur, GA 30300  
404-537-2521  
Positive Impact Health 
Centers 
523 Church St  
Decatur, GA 30030  
404-589-9040  
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Fort Valley Peach County Health 
Department 
406 East Church Street  
Fort Valley, GA 31030  
478-825-6939  
  
Lawrenceville Gwinnett Clinic - Webb 
Gin 





Macon Macon Bibb County 
Health Department 
171 Emery Highway  
Macon, GA 31217  
478-745-0411 
  
Marietta Someone Cares Inc. of 
Atlanta EDIC 
1950 Spectrum Circle 
SE  
Suite 145  
Marietta, GA 30067  
678-921-2706  
  
Snellville Gwinnett Clinic 
Snellville 
2764 West Main Street  
Snellville, GA 30078  
770-978-3388 
  
Tucker ID Consultants, PC 
1370 Montreal Road  
Suite 130  





North Central District 
Houston County Health 
Department 
98 Cohen Walker Drive  




*List of practices/clinics providing PrEP as of 02122018 in Georgia from Greater Than AIDS 
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Appendix F:  Invitation Letter 
PORTIA Thomas, (DNSc), MSN-CNE, MPH 
Nursing Doctoral Candidate 
Kennesaw State University  
Dissertation Research Proposal 





Recipient Company Name  
Recipient Address 
 
Dear Recipient Name,  
 
I am writing to let you know about an opportunity to participate in a research study about HIV Pre-
exposure prophylaxis (PrEP) decision-making.  Portia Thomas, a nursing doctoral candidate at Kennesaw 
State University, is conducting the study to explore men who have sex men’s (MSM’s) decision-making 
process to initiate PrEP.   
 
I am seeking your assistance and support with recruiting participants.  I understand that your first priority 
is patient safety and confidentiality, and I certainly agree with and respect this responsibility.  Therefore, I 
request permission to recruit your patients by posting and providing study advertising posters and 
handouts in your clinic patient areas (i.e., exam rooms and waiting areas).  The advertisements will have 
all of my contact information so interested patients can follow-up with me at their choosing.  
 
Please review the attached study synopsis for further details. I will be following up with you in the 5-7 
business days to determine your interest in assisting me with my research. If you have any questions or 
concerns before then, please feel free to contact me at your convenience by phone: 334-425-8516 and/or 
email:  pthoma48@students.kennesaw.edu.  
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Appendix G:  Study Synopsis 
Dissertation Study Synopsis 
TITLE:  Exploring Men who have sex with men’s (MSM’s) Pre-exposure Prophylaxis (PrEP) Initiation 
Decision-making Process  
 
TITLE ACRONYM:  His PrEP Decision 
 
Investigator’s Information: Portia Thomas, (DNSc), MSN-CNE, MPH 
           Mobile:  334-425-8516  
           Email: Pthoma48@students.kennesaw.edu 
 
Investigator’s University: Kennesaw State University in Kennesaw, GA 
          URL:  http://www.kennesaw.edu/ 
 
Program/Department:  WellStar School of Nursing 
 Doctorate of Nursing Science (DNS) 
 
Dissertation Committee Chairperson:  Richard Sowell, PhD, Professor 
 470-578-6062 
  rsowell@kennesaw.edu  
 
INTRODUCTION:  The MSM HIV epidemic continues to thrive in the U.S., as MSM account for 
majority of current and past HIV/AIDS diagnoses.  MSM’s HIV incidence rate is 44 times higher than in 
other men and 40 times higher than in women (Centers for Disease Control & Prevention [CDC], 2016b), 
and at this rate the CDC (2016a) estimates that 1 in 6 MSM will contract the virus in their lifetime.  HIV 
prevention is the key to stopping MSM’s current and predicted HIV incidence in the U.S. (CDC, 2016a; 
Fan, Conner, & Villarreal, 2014).   
 
HIV pre-exposure prophylaxis (PrEP)is the newest HIV prevention modality, as HIV’s first 
pharmacological prevention agent.  PrEP is the fixed daily dose of Truvada in HIV-negative persons with 
reported and documented high HIV-acquisition risk (CDC, 2014).  Clinical trial data show that in the 
event of an exposure, PrEP is efficacious, reducing HIV seroconversion by as much as 92% (CDC, 2014; 
Koenig, Lyles,& Smith, 2013).  Experts estimate that PrEP initiation in at-risk groups can reduce HIV 
incidence by 70%, and prevent 185,000 U.S. infections by 2020 (CDC, 2016c).  Each prevented HIV 
infection saves an estimated $355,000 in lifetime HIV treatment (CDC, 2015).  Therefore, PrEP initiation 
in at-risk groups can significantly change the current HIV epidemic in the U.S. and MSM population.  
 
Most current and former PrEP patients are MSM (Krakower et al., 2015; Krakower & Mayer, 2015; 
Tellalian, Maznavi, Bredeek, & Hardy, 2013), but currently there is no research exploring their decision-
making process to initiate PrEP.  The purpose of this study is to explore PrEP initiation decision-making 
process of HIV-negative MSM engaging in protected and unprotected anal sex.  Decision-making details 
what and how individuals consider and evaluate the different factors surrounding a choice or option 
(Poortaghi et al., 2015; Popejoy, 2005).  Knowledge from this study may be a step to gauge if PrEP can 
have the estimated impact on the HIV epidemic and change the current MSM HIV disparity.  MSM's 
PrEP initiation decision-making process can inform nursing practice on factors that influence PrEP 
decision-making and how MSM rationalize initiating PrEP based on their HIV and PrEP perceptions and 
understanding.  With this knowledge, nurses can be able to identify opportunities to assist patients during 
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the decision-making process, and clarify HIV and PrEP misunderstandings and misconceptions.  This 
study’s findings can be used to educate nurses on ways to counsel and support MSM considering PrEP.  
This study can contribute to future development and testing of MSM PrEP initiation decision tools and 
interventions, which can lead to devising and implementing evidenced based strategies for achieving 
PrEP initiation success. 
 
OBJECTIVES:  The study objectives are to explore how HIV-negative MSM decide to initiate PrEP 
based on the evaluation and perceptions pertaining to their: (a) PrEP knowledge and HIV 
concern(s)/risk(s); (b) personal and social motivations to initiate PrEP; and (c) behavioral skills and 
abilities to adhere to PrEP.   
 
STUDY DESIGN:  This study will be conducted following Sandelowski’s (2000, 2010) approach to 
qualitative description, which is rooted in naturalistic and constructivism research, used to gather, 
understand, and describe individuals’ authentic experiences.   
 
SETTING:  Clinics with providers offering PrEP and PrEP services. 
 
DURATION OF STUDY:  Approximately 4-6 months.  
 
SAMPLE SIZE:  10-30 participants  
 
PARTICIPANT COMPENSATION:  Participants will be compensated once with a $30 Visa® credit 
gift card.   
 
SAMPLE SELECTION:  Participants must meet the following inclusion criteria: (a) assigned a sex of 
male at birth; (b) 18 years of age or older; (c) verbally confirm engagement in sex with men; (d) currently 
taking PrEP; (e) began taking PrEP in the past six months; (f) verbally confirm being HIV-negative; (g) 
read, speak, understand, and write English; and (h) provide written informed consent. 
 
DATA COLLECTION PROCEDURE:  Each participant will undergo one 60-minute one-on-one semi-
structured interview with questions to elicit information regarding their PrEP initiation decision-making 
process.  At the completion of the interviews, participants will complete a demographic form. 
 
DATA ANALYSIS PROCEDURE:  Descriptive statistics will describe the sample’s demographics.  
Interviews will be transcribed verbatim, and will follow Elo and Kyngas’ (2008) three-phase inductive 
content analysis process.  
  
REFERENCES:  
Center for Disease Control & Prevention (CDC). (2014). Preexposure prophylaxis for the  
prevention of HIV infection in the United States- 2014 clinical practice guidelines. Retrieved 
from http://www.cdc.gov/hiv/pdf/guidelines/PrEPguidelines2014.pdf 
Centers for Disease Control and Prevention (CDC). (2015). CDC’s HIV prevention progress in  
the United States. Retrieved from https://www.cdc.gov/hiv/dhap/progress/index.html 
Centers for Disease Control and Prevention (CDC). (2016a). HIV among gay and bisexual men.  
Retrieved from: https://www.cdc.gov/hiv/pdf/group/msm/cdc-hiv-msm.pdf  
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Appendix I: “His PrEP Decision" Recruitment Poster 
HIS PREP DECISION STUDY 
His PrEP Decision study is recruiting research participants. The 
purpose of this study is to gather information on your decision to 
initiate PrEP.  Your perspective on this will help nurses better 
understand this process, so we can improve how we support you 
& future patients during this process.  
 
YOU CAN BE A PART OF THE 
STUDY IF YOU ARE. . .  
 A  man who has sex with men  
 Currently taking PrEP & began 
taking PrEP in the past 6 months 
 At least 18 years of age  
 Read & speak English 
 
EXTRA STUDY DETAILS 
INCLUDE . . . 
 You WILL need to be able to give 
one 60-minute interview  
 You WILL recieve $30.00 
compensatation for your time  
 If interested or for more 
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Appendix J:  “His PrEP Decision" Informed Constent Form 
SIGNED CONSENT FORM 
 
Title of Research Study: Exploring Men who have sex with 
men’s (MSM’s) Pre-exposure Prophylaxis (PrEP) Initiation 
Decision-making Process 
 
Research Study Acronym:  His PrEP Decision 
 
Researcher's Contact Information: Portia Thomas, DNSc, MSN-CNE, MPH  




The nurse-researcher, Portia Thomas, of Kennesaw State Universityis conducting a study.   You 
are being invited to participate because you started taking PrEP and have identified as being a 
man who has sex with men (MSM). Before you decide to participate, you should read this form 
carefully. If you have questions regarding this consent or study, please ask at any time. 
 
Description of Project 
 
The purpose of the study is to understand how you came to thedecision to start taking PrEP.The 
nurse-researcher wants to know the factors and process you considered that led to your decision. 
As a participant,you will be asked to share your story as an MSM, thoughts and concerns about 
HIV, and your journey to starting PrEP. 
 
Explanation of Procedures 
 
Participation in this study requires you to undergo a one-on-one60-minute interview with the 
researcher.  The researcher will discuss with you dates, times, and a location that makes you 
comfortable, and will not interfere with the nurse-researcher’s ability to listen to your responses 
or audio-record the interview.  You are the expert in PrEP initiation decision-making, so you will 
beasked and are encouraged to answer the questions openly and honestly.You will also be 




To participate in this study, you will need to complete a one 60-minute interview with the nurse-
researcher and fill out a demographic form.  Therefore, the total required time for this study is 
approximately 65 minutes.  
 
 
MSM'S PREP INITIATION DECISION-MAKING PROCESSES 189 
 
Risks or Discomforts 
 
There are no physical or bodily risks from participating in this study. However, talking about 
your decision to startPrEPon a recording device may make you uncomfortable.  Additionally, the 
interviewerwill ask questions about your sexual history and behaviors and beliefs about HIV and 




There are no guaranteed benefits from you participating in this study. By taking part in this 
study, the nurse-researcher hopes to give you a voice and opportunity to tell your story about a 
decision you made. Your words and responses can inform doctors and nurses about ways to 




After you complete the interview and demographic form, you will be compensated for your time 




Protecting the confidentiality of your information is thefirst priority.  Aftersigning this form, you 
will be assigned an identification number and be asked to provide a fictional name. The fictional 
name is to be used during the interviews instead of your legal name.  If you cannot think of a 
fictional name, one will be provided for you.  
 
Inclusion Criteria for Participation 
 
You must meet all of the following criteria in order to participate in this study:  (a) assigned a 
sex of male at birth; (b) 18 years of age or older; (c) verbally confirm engaging in anal sex with 
men; (d) currently taking PrEP; (e) began taking PrEP in the past six months; (f) verbally 
confirm being HIV negative; (g) read, speak, understand, and write English, and (h) provide 




I agree and give my consent to participate in this research project.  I understand that participation 




Signature of Participant or Authorized Representative, Date  
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___________________________________________________     
  




PLEASE SIGN BOTH COPIES OF THIS FORM, KEEP ONE AND RETURN THE OTHER 
TO THE INVESTIGATOR 
 
Research at Kennesaw State University that involves human participants is carried out under the 
oversight of an Institutional Review Board.  Questions or problems regarding these activities 
should be addressed to the Institutional Review Board, Kennesaw State University, 585 Cobb 
Avenue, KH3403, Kennesaw, GA 30144-5591, (470) 578-2268.  
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Appendix K “His PrEP Decision" Study Enrollment Form 
Consent & Enrollment Date:  ________________ 
Participant ID:  PID- _________  Pseudonym:  _____________________________ 
Interview Details: 
Scheduled Interview Date & Time _________________________________________________ 
Scheduled Location ____________________________________________________________ 
____________________________________________________________________________ 
 
Interview Details Confirmation Notes:          
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
              
END OF PAGE 1 OF 2 STUDY ENROLLMENT FORM  
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INCLUSION CRITERIA 
Circle “Yes” to confirm the patient meets the following criteria, if not circle “No"   
1. Assigned a male sex at birth Yes/ No 
2. 18 years of age or older Yes/ No 
3. Verbally confirm to engage in anal intercourse (AI) with men Yes/ No 
4. Currently taking PrEP Yes/ No 
5. Began taking PrEP in the past six months Yes/ No 
6. Verbally confirm a HIV-negative status Yes/ No 
7. Read, speak, understand, and write English Yes/ No 
8. Provide written informed consent Yes/ No 
 
1. Does the patient meet ALL of the INCLUSION criteria?  YES, or NO  
If “YES” the participant is ELIGIBLE, if “NO” the participant is INELIGIBLE.   
2. This participant is (circle one) INELGIBLE/ ELIGIBLE.  
Research Personnel Completing Enrollment form & process please complete the area below.  
________________________________________________         ________________ 
Print Name  Signature     Date (mm/dd/yyyy) 
         
 
 
END OF PAGE 2 OF 2 STUDY ENROLLMENT FORM  
 
This portion of the paper was 
purposefully left blank 
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Appendix L: “His PrEP Decision "Script& Interview Guide 
PID-______________      Interview Date: _________________ 
 
Thank you for taking the time to speak with me today. You are the expert in taking PrEP, and I need to 
learn from you how you came to that decision. I am interested in your story, so there is no right or wrong 
answer. Please share as much as you feel comfortable.    
1. How do you identify your sexuality (gay, bisexual, or MSM)? Tell me about you and your 
story of being and becoming aware and accepting of your identity in the South.  (target 10 
minutes) 
Are you open about your sexuality with family and friends? How did you decide to whom you 
would disclosure your sexual orientation? 
Tell me about your family, friends, and partners and how they affect your life.   
2. Are you sexually or romantically involved with anyone? If no, in the past 1-2 years? (target 
10 minutes) 
Do you have a partner or are you married? Is this a long term or casual relationship?  
Are you sexually monogamous? Did you have a discussion about being monogamous or not? Tell 
me about the discussion.    
Do you know if your partner is HIV positive or negative? If negative, are they on PrEP? 
Besides PrEP, what other protections do you take to prevent getting HIV? 
Do you implement these behaviors consistently or how to you decide when or with who to take 
prevention precautions? 
 
3. Tell me about your thoughts and concerns about your HIV risks. (target 10 minutes) 
What behaviors place you at risk for getting HIV?  
What are your thoughts and concerns about becoming HIV infected? 
Do you know or have you met anyone with HIV?  
What has been your experience with people living with HIV?  
What have you heard others say about people living with HIV? 
 
4. Tell me how you came to know about PrEP. (target 10 minutes) 
How did you learn about PrEP? What did you think about it? 
What led you to wanting to know more about PrEP? 
Do you know other men who are on PrEP and what has been their experience (what have they 
told you about PrEP)? 
How did you find your PrEP provider? 
What concerns do you have about being on PrEP? (taking it every day, cost, going to the doctor 
every 3 months for monitoring or what other concerns you might have). 
How has being on PrEP changed your sexual behaviors? Explain.  
Do you feel being on PrEP has changed your risk of getting HIV? Explain how. 
Do your friends, family and/or partner(s) know you are on PrEP? How do they feel about it? 
5. Tell me how you decided to start PrEP. (target 15 minutes) 
Tell me about factors or any events that made you feel PrEP would be right for you (i.e., life 
experiences, specific event or occurrence, your HIV risk/concerns, your understanding of PrEP). 
Tell me more about the process you went through in deciding to start PrEP.   
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Was it an immediate decision once you learned about it or did you take a period of time to 
consider it? 
6. You have given me a lot of insight into your decision-making in starting PrEP. I appreciate 
your willingness to share your story with me. Is there anything else you want to tell me 
about you or your journey to beginning PrEP? (target 5 minutes) 
 
END OF INTERVIEW GUIDE 
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Appendix M: “His PrEP Decision” Demographic Form 
 
PID- _____________     Interview Date:  ________________ 
Patient Information  
1) Pseudonym: __________________          2) Ethnicity (select one): ☐ Hispanic ☐ Non-Hispanic 
 
3) Age: _______________ 
 
4) Race (select one):  ☐American Indian  ☐Alaska Native 
  ☐Asian  ☐Black or African American 
  ☐Native Hawaiian ☐Other ________________ 
  ☐Pacific Islander ☐White  
          
5) Highest education level completed  ☐ Less then high school 
(select one):              ☐ High school        
☐ College (associate, bachelor, or technical school) 
☐ Graduate school  
 
6) Annual Income (select one):  ☐ less than $20,000 ☐ $20,001- $40,000 
   ☐ $40,001- $60,000 ☐$60,001- $80,000         
   ☐more than $80,000 
 
7) When did you start taking PrEP? Date ________________  
 
8) Including all sexual encounters, how many sex partners have you had in the last 3 months? 
_________________ 
 
Regarding the sexual encounters asked about in question 8, answer questions 9 and 10.   
9) What percentage (0%-100%) of the time did you use condoms? _______________ 
 
10) Which behaviors did you practice?(Check all that apply) 
☐Anal sex (bottom)      ☐Anal sex (top)      ☐Oral sex (give)        ☐Oral sex (receive)  
 
Please sign acknowledging that you received your $30 Visa® credit gift card. 
_________________________________________  ____________________ 
Participant'sPseudonym Signature    Date     
_________________________________________  ____________________ 
Interviewer's Signature      Date   
END OF DEMOGRAPHIC FORM 
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Appendix N:  Inductive Content Analysis Process 
The following details the three-phase process of inductive content analysis according to Elo and 
Kygnas (2008).   
I. Preparation 
1. Read through the transcribed narratives several times to acquire a feeling and 
understanding of the main ideas 
2. Select the unit of analysis, either a word or theme, that emerges from the narrative   
3. Make sense of the data by asking:  Who, what, where, when, and why regarding 
the content  
II. Organizing 
1. Begin open coding by writing notes and headings (that describe all aspects of the 
content) while reading through the narratives 
2. The open coding process is repeated until as many as necessary headings are 
written down  
3. The headings are transferred to coding sheets, and the headings are grouped into 
broader and more abstract categories 
4. Abstraction follows which is naming each category using content related words 
5. Perform peer checking with oversight research committee throughout this process 
III. Reporting  
1. To enhance trustworthiness, detail the content analysis process clearly and 
sufficiently  
2. To improve reliability, explain the link between the data and results 
3. Use actual participants’ phrases and statements to show authenticity  
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Appendix O:  Study Recruitment Sites 
Clinic Name City, State Date Flyers Received  
Birmingham AIDS Outreach Birmingham, AL  6/4/2018 
The 1917 Clinic at UAB Birmingham, AL  3/20/2018 
Medical Advocacy & Outreach Montgomery, AL  3/19/2018 
Five Horizons Health Services Tuscaloosa, AL  3/15/2018 
AID Atlanta Atlanta, GA  4/27/2018 
Empowerment Resource Center Atlanta, GA  5/24/2018 
CrescentCare Health & Wellness Center New Orleans, LA  5/11/2018 
Someone Cares Atlanta  Marietta, GA  6/5/2018 
 
 
